urlscan.io logo urlscan.io
SecurityTrails logo

www.globalpharmainsights.com Open in urlscan Pro
143.204.89.87  Public Scan

Go To Rescan Add Verdict Report
Submitted URL: http://app.go02.informamarkets.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEA...
Effective URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesiv...
Submission: On June 12 via api from US
 Behaviour Indicators
Similar DOM Content API
Verdicts

Summary

This website contacted 59 IPs in 9 countries across 40 domains to perform 296 HTTP transactions. The main IP is 143.204.89.87, located in Seattle, United States and belongs to AMAZON-02, US. The main domain is www.globalpharmainsights.com.
TLS certificate: Issued by Amazon on May 7th 2020. Valid for: a year.
This is the only time www.globalpharmainsights.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 141.145.8.14 43898 (ORCL-AM-OPC1)
1 1 141.145.8.13 43898 (ORCL-AM-OPC1)
53 143.204.89.70 16509 (AMAZON-02)
6 2a00:1450:400... 15169 (GOOGLE)
3 2a02:26f0:10c... 20940 (AKAMAI-ASN1)
1 1 178.79.245.72 22822 (LLNW)
1 178.79.227.128 22822 (LLNW)
16 216.58.210.2 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
5 2a00:1450:400... 15169 (GOOGLE)
2 18.202.93.59 16509 (AMAZON-02)
1 143.204.89.116 16509 (AMAZON-02)
2 2a00:1450:400... 15169 (GOOGLE)
4 2606:4700::68... 13335 (CLOUDFLAR...)
12 2a01:4a0:1338... 201011 (NETZBETRI...)
1 18.202.138.86 16509 (AMAZON-02)
1 1 66.117.28.86 15224 (OMNITURE)
4 147.75.102.199 54825 (PACKET)
2 143.204.89.107 16509 (AMAZON-02)
5 2a03:2880:f01... 32934 (FACEBOOK)
3 2a00:1450:400... 15169 (GOOGLE)
21 72.247.226.64 16625 (AKAMAI-AS)
1 172.217.18.2 15169 (GOOGLE)
1 15.236.175.233 16509 (AMAZON-02)
2 2a02:26f0:10c... 20940 (AKAMAI-ASN1)
3 34.251.220.194 16509 (AMAZON-02)
1 35.178.2.28 16509 (AMAZON-02)
3 2a03:2880:f11... 32934 (FACEBOOK)
2 2a00:1450:400... 15169 (GOOGLE)
1 54.171.1.253 16509 (AMAZON-02)
2 147.75.101.5 54825 (PACKET)
57 143.204.89.87 16509 (AMAZON-02)
2 151.101.36.84 54113 (FASTLY)
9 2a00:1450:400... 15169 (GOOGLE)
3 2a02:26f0:10c... 20940 (AKAMAI-ASN1)
1 1 178.79.245.71 22822 (LLNW)
1 178.79.227.0 22822 (LLNW)
16 172.217.22.34 15169 (GOOGLE)
7 2a00:1450:400... 15169 (GOOGLE)
1 143.204.89.121 16509 (AMAZON-02)
5 2606:4700::68... 13335 (CLOUDFLAR...)
1 15.236.9.100 16509 (AMAZON-02)
1 147.75.100.189 54825 (PACKET)
2 3 172.217.21.194 15169 (GOOGLE)
1 3.8.225.221 16509 (AMAZON-02)
2 2a00:1450:400... 15169 (GOOGLE)
2 3 185.33.221.90 29990 (ASN-APPNEX)
2 3.229.100.58 14618 (AMAZON-AES)
1 34.254.3.164 16509 (AMAZON-02)
2 35.241.8.149 15169 (GOOGLE)
1 2 52.211.146.59 16509 (AMAZON-02)
1 5 72.247.224.172 16625 (AKAMAI-AS)
15 18 34.241.194.225 16509 (AMAZON-02)
2 2 54.93.143.252 16509 (AMAZON-02)
1 18.156.0.31 16509 (AMAZON-02)
1 72.247.225.98 16625 (AKAMAI-AS)
1 69.173.144.138 26667 (RUBICONPR...)
1 2 70.42.32.95 22075 (AS-OUTBRAIN)
1 185.64.190.80 62713 (AS-PUBMATIC)
1 1 2a00:1288:f03... 10310 (YAHOO-1)
1 151.101.13.44 54113 (FASTLY)
1 2 18.196.179.110 16509 (AMAZON-02)
1 2 3.120.19.19 16509 (AMAZON-02)
1 2 34.98.64.218 15169 (GOOGLE)
1 54.84.119.213 14618 (AMAZON-AES)
296 59
1    141.145.8.14 (Amsterdam, Netherlands)

ASN43898 (ORCL-AM-OPC1, NL)
app.go02.informamarkets.com
1    141.145.8.13 (Amsterdam, Netherlands)

ASN43898 (ORCL-AM-OPC1, NL)
s734445500.t.eloqua.com
53    143.204.89.70 (Seattle, United States)

ASN16509 (AMAZON-02, US)
PTR: server-143-204-89-70.fra50.r.cloudfront.net
www.globalpharmainsights.com
6    2a00:1450:4001:81f::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.googletagservices.com
adservice.google.de
googleads.g.doubleclick.net
3    2a02:26f0:10c:382::1e80 (Ascension Island)

ASN20940 (AKAMAI-ASN1, EU)
assets.adobedtm.com
1    178.79.245.72 (Italy)

ASN22822 (LLNW, US)
PTR: vps-014.fra.llnw.net
video.limelight.com
1    178.79.227.128 (Italy)

ASN22822 (LLNW, US)
PTR: https-178-79-227-128.vie.llnw.net
s.delvenetworks.com
16    216.58.210.2 (Mountain View, United States)

ASN15169 (GOOGLE, US)
PTR: fra16s07-in-f2.1e100.net
securepubads.g.doubleclick.net
2    2a00:1450:4001:809::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
b1ff9ba2a5a6fa8f594604dadd847edf.safeframe.googlesyndication.com
38683bacb692dc3ca6a4b9092b6a8b4e.safeframe.googlesyndication.com
5    2a00:1450:4001:820::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
tpc.googlesyndication.com
2    18.202.93.59 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-18-202-93-59.eu-west-1.compute.amazonaws.com
dpm.demdex.net
1    143.204.89.116 (Seattle, United States)

ASN16509 (AMAZON-02, US)
PTR: server-143-204-89-116.fra50.r.cloudfront.net
tags.crwdcntrl.net
2    2a00:1450:4001:825::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.googletagmanager.com
4    2606:4700::6812:fb0 (United States)

ASN13335 (CLOUDFLARENET, US)
assets.pinterest.com
12    2a01:4a0:1338:28::c38a:ff0a (Germany)

ASN201011 (NETZBETRIEB-GMBH, DE)
use.typekit.net
1    18.202.138.86 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-18-202-138-86.eu-west-1.compute.amazonaws.com
informaglobalexhibitions.demdex.net
1    66.117.28.86 (United States)

ASN15224 (OMNITURE, US)
cm.everesttech.net
4    147.75.102.199 (Central, Hong Kong)

ASN54825 (PACKET, US)
PTR: pkt-ams-k2-shared-ingress10
static.hotjar.com
script.hotjar.com
vars.hotjar.com
2    143.204.89.107 (Seattle, United States)

ASN16509 (AMAZON-02, US)
PTR: server-143-204-89-107.fra50.r.cloudfront.net
s.dpmsrv.com
5    2a03:2880:f01c:8012:face:b00c:0:3 (Ireland)

ASN32934 (FACEBOOK, US)
connect.facebook.net
3    2a00:1450:4001:815::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.google.com
21    72.247.226.64 (United States)

ASN16625 (AKAMAI-AS, US)
PTR: a72-247-226-64.deploy.static.akamaitechnologies.com
z.moatads.com
px.moatads.com
1    172.217.18.2 (United States)

ASN15169 (GOOGLE, US)
PTR: fra15s28-in-f2.1e100.net
www.googleadservices.com
1    15.236.175.233 (Paris, France)

ASN16509 (AMAZON-02, US)
PTR: ec2-15-236-175-233.eu-west-3.compute.amazonaws.com
informaglobalexhibitions.d3.sc.omtrdc.net
2    2a02:26f0:10c:28a::19fd (Ascension Island)

ASN20940 (AKAMAI-ASN1, EU)
p.typekit.net
3    34.251.220.194 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-34-251-220-194.eu-west-1.compute.amazonaws.com
ml314.com
1    35.178.2.28 (London, United Kingdom)

ASN16509 (AMAZON-02, US)
PTR: ec2-35-178-2-28.eu-west-2.compute.amazonaws.com
geo.moatads.com
3    2a03:2880:f11c:8183:face:b00c:0:25de (Ireland)

ASN32934 (FACEBOOK, US)
www.facebook.com
2    2a00:1450:4001:824::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.google.de
1    54.171.1.253 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-54-171-1-253.eu-west-1.compute.amazonaws.com
in.hotjar.com
2    147.75.101.5 (Central, Hong Kong)

ASN54825 (PACKET, US)
PTR: pkt-ams-k2-shared-ingress16
vc.hotjar.io
script.hotjar.com
57    143.204.89.87 (Seattle, United States)

ASN16509 (AMAZON-02, US)
PTR: server-143-204-89-87.fra50.r.cloudfront.net
www.globalpharmainsights.com
2    151.101.36.84 (Amsterdam, Netherlands)

ASN54113 (FASTLY, US)
log.pinterest.com
9    2a00:1450:4001:80b::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.googletagservices.com
adservice.google.de
googleads.g.doubleclick.net
pagead2.googlesyndication.com
3    2a02:26f0:10c:387::1e80 (Ascension Island)

ASN20940 (AKAMAI-ASN1, EU)
assets.adobedtm.com
1    178.79.245.71 (Italy)

ASN22822 (LLNW, US)
PTR: vps-013.fra.llnw.net
video.limelight.com
1    178.79.227.0 (Italy)

ASN22822 (LLNW, US)
PTR: https-178-79-227-0.vie.llnw.net
s.delvenetworks.com
16    172.217.22.34 (United States)

ASN15169 (GOOGLE, US)
PTR: fra15s16-in-f2.1e100.net
securepubads.g.doubleclick.net
7    2a00:1450:4001:802::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
tpc.googlesyndication.com
1    143.204.89.121 (Seattle, United States)

ASN16509 (AMAZON-02, US)
PTR: server-143-204-89-121.fra50.r.cloudfront.net
tags.crwdcntrl.net
5    2606:4700::6812:eb0 (United States)

ASN13335 (CLOUDFLARENET, US)
assets.pinterest.com
1    15.236.9.100 (Paris, France)

ASN16509 (AMAZON-02, US)
PTR: ec2-15-236-9-100.eu-west-3.compute.amazonaws.com
informaglobalexhibitions.d3.sc.omtrdc.net
1    147.75.100.189 (Central, Hong Kong)

ASN54825 (PACKET, US)
PTR: pkt-ams-k2-shared-ingress1
static.hotjar.com
3    172.217.21.194 (United States)

ASN15169 (GOOGLE, US)
PTR: fra16s12-in-f194.1e100.net
www.googleadservices.com
cm.g.doubleclick.net
1    3.8.225.221 (London, United Kingdom)

ASN16509 (AMAZON-02, US)
PTR: ec2-3-8-225-221.eu-west-2.compute.amazonaws.com
geo.moatads.com
2    2a00:1450:4001:819::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)
www.google.com
3    185.33.221.90 (Netherlands)

ASN29990 (ASN-APPNEX, US)
PTR: 727.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
ib.adnxs.com
2    3.229.100.58 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-3-229-100-58.compute-1.amazonaws.com
a.dpmsrv.com
1    34.254.3.164 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-34-254-3-164.eu-west-1.compute.amazonaws.com
in.hotjar.com
2    35.241.8.149 (Ascension Island)

ASN15169 (GOOGLE, US)
PTR: 149.8.241.35.bc.googleusercontent.com
idsync.rlcdn.com
2    52.211.146.59 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-52-211-146-59.eu-west-1.compute.amazonaws.com
bcp.crwdcntrl.net
5    72.247.224.172 (United States)

ASN16625 (AKAMAI-AS, US)
PTR: a72-247-224-172.deploy.static.akamaitechnologies.com
s.adroll.com
18    34.241.194.225 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-34-241-194-225.eu-west-1.compute.amazonaws.com
d.adroll.mgr.consensu.org
d.adroll.com
2    54.93.143.252 (Frankfurt am Main, Germany)

ASN16509 (AMAZON-02, US)
PTR: ec2-54-93-143-252.eu-central-1.compute.amazonaws.com
pixel.advertising.com
1    18.156.0.31 (United States)

ASN16509 (AMAZON-02, US)
PTR: ec2-18-156-0-31.eu-central-1.compute.amazonaws.com
ups.analytics.yahoo.com
1    72.247.225.98 (United States)

ASN16625 (AKAMAI-AS, US)
PTR: a72-247-225-98.deploy.static.akamaitechnologies.com
dsum-sec.casalemedia.com
1    69.173.144.138 (Frankfurt am Main, Germany)

ASN26667 (RUBICONPROJECT, US)
pixel.rubiconproject.com
2    70.42.32.95 (United States)

ASN22075 (AS-OUTBRAIN, US)
PTR: ny.outbrain.com
sync.outbrain.com
1    185.64.190.80 (United Kingdom)

ASN62713 (AS-PUBMATIC, US)
simage2.pubmatic.com
1    2a00:1288:f03d:1fa::4000 (United Kingdom)

ASN10310 (YAHOO-1, US)
ads.yahoo.com
1    151.101.13.44 (Frankfurt am Main, Germany)

ASN54113 (FASTLY, US)
trc.taboola.com
2    18.196.179.110 (Frankfurt am Main, Germany)

ASN16509 (AMAZON-02, US)
PTR: ec2-18-196-179-110.eu-central-1.compute.amazonaws.com
eb2.3lift.com
2    3.120.19.19 (Frankfurt am Main, Germany)

ASN16509 (AMAZON-02, US)
PTR: ec2-3-120-19-19.eu-central-1.compute.amazonaws.com
x.bidswitch.net
2    34.98.64.218 (United States)

ASN15169 (GOOGLE, US)
PTR: 218.64.98.34.bc.googleusercontent.com
us-u.openx.net
1    54.84.119.213 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-54-84-119-213.compute-1.amazonaws.com
in.ml314.com
Apex Domain
Subdomains		 Transfer
110 globalpharmainsights.com
www.globalpharmainsights.com
2 MB
36 doubleclick.net
securepubads.g.doubleclick.net
googleads.g.doubleclick.net
cm.g.doubleclick.net
212 KB
23 moatads.com
z.moatads.com
geo.moatads.com
px.moatads.com
399 KB
22 adroll.com
s.adroll.com
d.adroll.com
25 KB
17 googlesyndication.com
b1ff9ba2a5a6fa8f594604dadd847edf.safeframe.googlesyndication.com
tpc.googlesyndication.com
pagead2.googlesyndication.com Failed
38683bacb692dc3ca6a4b9092b6a8b4e.safeframe.googlesyndication.com
82 KB
14 typekit.net
use.typekit.net
p.typekit.net
313 KB
11 pinterest.com
assets.pinterest.com
log.pinterest.com
45 KB
8 hotjar.com
static.hotjar.com
script.hotjar.com
vars.hotjar.com
in.hotjar.com
145 KB
8 googletagservices.com
www.googletagservices.com
194 KB
6 adobedtm.com
assets.adobedtm.com
129 KB
5 google.com
www.google.com
446 B
5 facebook.net
connect.facebook.net
265 KB
4 ml314.com
ml314.com
in.ml314.com
26 KB
4 dpmsrv.com
s.dpmsrv.com
a.dpmsrv.com Failed
171 KB
4 crwdcntrl.net
tags.crwdcntrl.net
bcp.crwdcntrl.net
30 KB
4 google.de
adservice.google.de
www.google.de
2 KB
3 adnxs.com
ib.adnxs.com
4 KB
3 facebook.com
www.facebook.com
768 B
3 demdex.net
dpm.demdex.net
informaglobalexhibitions.demdex.net
2 KB
2 openx.net
us-u.openx.net
478 B
2 bidswitch.net
x.bidswitch.net
1004 B
2 3lift.com
eb2.3lift.com
737 B
2 outbrain.com
sync.outbrain.com
807 B
2 yahoo.com
ups.analytics.yahoo.com
ads.yahoo.com
2 KB
2 advertising.com
pixel.advertising.com
816 B
2 rlcdn.com
idsync.rlcdn.com
96 B
2 omtrdc.net
informaglobalexhibitions.d3.sc.omtrdc.net
896 B
2 googleadservices.com
www.googleadservices.com
23 KB
2 googletagmanager.com
www.googletagmanager.com
66 KB
2 delvenetworks.com
s.delvenetworks.com
38 KB
2 limelight.com
video.limelight.com
570 B
1 taboola.com
trc.taboola.com
283 B
1 pubmatic.com
simage2.pubmatic.com
1010 B
1 rubiconproject.com
pixel.rubiconproject.com
755 B
1 casalemedia.com
dsum-sec.casalemedia.com
1003 B
1 consensu.org
d.adroll.mgr.consensu.org
137 B
1 hotjar.io
vc.hotjar.io
116 B
1 everesttech.net
cm.everesttech.net
554 B
1 eloqua.com
s734445500.t.eloqua.com
1 KB
1 informamarkets.com
app.go02.informamarkets.com
906 B
296 40
Domain Requested by
110 www.globalpharmainsights.com www.globalpharmainsights.com
32 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.globalpharmainsights.com
17 d.adroll.com 14 redirects
17 px.moatads.com www.globalpharmainsights.com
12 use.typekit.net www.globalpharmainsights.com
use.typekit.net
12 tpc.googlesyndication.com securepubads.g.doubleclick.net
tpc.googlesyndication.com
9 assets.pinterest.com www.globalpharmainsights.com
assets.pinterest.com
8 www.googletagservices.com www.globalpharmainsights.com
securepubads.g.doubleclick.net
6 assets.adobedtm.com www.globalpharmainsights.com
assets.adobedtm.com
5 s.adroll.com 1 redirects www.globalpharmainsights.com
s.adroll.com
5 www.google.com securepubads.g.doubleclick.net
www.globalpharmainsights.com
5 connect.facebook.net www.globalpharmainsights.com
connect.facebook.net
4 z.moatads.com securepubads.g.doubleclick.net
3 ib.adnxs.com 2 redirects
3 pagead2.googlesyndication.com www.globalpharmainsights.com
securepubads.g.doubleclick.net
3 www.facebook.com www.globalpharmainsights.com
3 ml314.com z.moatads.com
ml314.com
2 us-u.openx.net 1 redirects
2 x.bidswitch.net 1 redirects
2 eb2.3lift.com 1 redirects
2 sync.outbrain.com 1 redirects
2 pixel.advertising.com 2 redirects
2 bcp.crwdcntrl.net 1 redirects tags.crwdcntrl.net
2 idsync.rlcdn.com www.globalpharmainsights.com
2 cm.g.doubleclick.net 2 redirects
2 log.pinterest.com www.globalpharmainsights.com
2 in.hotjar.com script.hotjar.com
2 www.google.de www.globalpharmainsights.com
2 vars.hotjar.com static.hotjar.com
2 googleads.g.doubleclick.net www.googleadservices.com
2 a.dpmsrv.com www.globalpharmainsights.com
2 geo.moatads.com z.moatads.com
2 script.hotjar.com static.hotjar.com
2 p.typekit.net www.globalpharmainsights.com
2 informaglobalexhibitions.d3.sc.omtrdc.net assets.adobedtm.com
2 www.googleadservices.com www.googletagmanager.com
2 s.dpmsrv.com www.globalpharmainsights.com
2 static.hotjar.com www.globalpharmainsights.com
2 www.googletagmanager.com assets.adobedtm.com
2 tags.crwdcntrl.net assets.adobedtm.com
2 dpm.demdex.net assets.adobedtm.com
www.globalpharmainsights.com
2 adservice.google.de www.googletagservices.com
2 s.delvenetworks.com www.globalpharmainsights.com
2 video.limelight.com 2 redirects
1 in.ml314.com ml314.com
1 trc.taboola.com
1 ads.yahoo.com 1 redirects
1 simage2.pubmatic.com
1 pixel.rubiconproject.com
1 dsum-sec.casalemedia.com
1 ups.analytics.yahoo.com
1 d.adroll.mgr.consensu.org 1 redirects
1 38683bacb692dc3ca6a4b9092b6a8b4e.safeframe.googlesyndication.com securepubads.g.doubleclick.net
1 vc.hotjar.io script.hotjar.com
1 cm.everesttech.net 1 redirects
1 informaglobalexhibitions.demdex.net assets.adobedtm.com
1 b1ff9ba2a5a6fa8f594604dadd847edf.safeframe.googlesyndication.com securepubads.g.doubleclick.net
1 s734445500.t.eloqua.com 1 redirects
1 app.go02.informamarkets.com 1 redirects
296 59
Subject Issuer Validity Valid
digital.hospitalar.com
Amazon		 2020-05-07 -
2021-06-07		 a year crt.sh
*.g.doubleclick.net
GTS CA 1O1		 2020-05-26 -
2020-08-18		 3 months crt.sh
assets.adobedtm.com
DigiCert SHA2 High Assurance Server CA		 2019-10-22 -
2021-10-01		 2 years crt.sh
*.hs.llnwd.net
Sectigo RSA Organization Validation Secure Server CA		 2020-05-12 -
2021-05-12		 a year crt.sh
*.google.com
GTS CA 1O1		 2020-05-26 -
2020-08-18		 3 months crt.sh
tpc.googlesyndication.com
GTS CA 1O1		 2020-05-26 -
2020-08-18		 3 months crt.sh
*.demdex.net
DigiCert SHA2 High Assurance Server CA		 2018-01-09 -
2021-02-12		 3 years crt.sh
*.crwdcntrl.net
Go Daddy Secure Certificate Authority - G2		 2019-06-13 -
2021-06-28		 2 years crt.sh
*.google-analytics.com
GTS CA 1O1		 2020-05-26 -
2020-08-18		 3 months crt.sh
*.pinterest.com
DigiCert SHA2 High Assurance Server CA		 2020-05-28 -
2021-06-10		 a year crt.sh
use.typekit.net
DigiCert SHA2 Secure Server CA		 2020-01-28 -
2022-02-01		 2 years crt.sh
static.hotjar.com
Let's Encrypt Authority X3		 2020-04-04 -
2020-07-03		 3 months crt.sh
*.dpmsrv.com
Amazon		 2019-05-14 -
2020-06-14		 a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA		 2020-05-14 -
2020-08-05		 3 months crt.sh
www.google.com
GTS CA 1O1		 2020-05-26 -
2020-08-18		 3 months crt.sh
moatads.com
DigiCert SHA2 Secure Server CA		 2020-01-17 -
2021-03-17		 a year crt.sh
www.googleadservices.com
GTS CA 1O1		 2020-05-26 -
2020-08-18		 3 months crt.sh
*.d3.sc.omtrdc.net
DigiCert SHA2 High Assurance Server CA		 2020-02-28 -
2022-03-04		 2 years crt.sh
*.typekit.net
DigiCert SHA2 Secure Server CA		 2019-12-06 -
2021-12-10		 2 years crt.sh
script.hotjar.com
Let's Encrypt Authority X3		 2020-04-04 -
2020-07-03		 3 months crt.sh
*.ml314.com
Amazon		 2020-02-17 -
2021-03-17		 a year crt.sh
*.moatads.com
DigiCert SHA2 Secure Server CA		 2019-03-12 -
2021-06-10		 2 years crt.sh
vars.hotjar.com
Let's Encrypt Authority X3		 2020-04-04 -
2020-07-03		 3 months crt.sh
www.google.de
GTS CA 1O1		 2020-05-26 -
2020-08-18		 3 months crt.sh
*.hotjar.com
Amazon		 2019-09-27 -
2020-10-27		 a year crt.sh
vc.hotjar.io
Let's Encrypt Authority X3		 2020-05-15 -
2020-08-13		 3 months crt.sh
*.google.de
GTS CA 1O1		 2020-05-26 -
2020-08-18		 3 months crt.sh
*.rlcdn.com
Sectigo RSA Domain Validation Secure Server CA		 2020-04-14 -
2021-04-23		 a year crt.sh
*.adroll.com
DigiCert SHA2 Secure Server CA		 2020-01-29 -
2021-04-29		 a year crt.sh
adroll.mgr.consensu.org
Amazon		 2019-11-06 -
2020-12-06		 a year crt.sh
ups.analytics.yahoo.com
DigiCert SHA2 High Assurance Server CA		 2020-05-27 -
2020-11-23		 6 months crt.sh
san.casalemedia.com
GeoTrust RSA CA 2018		 2020-03-02 -
2021-04-01		 a year crt.sh
*.rubiconproject.com
DigiCert SHA2 Secure Server CA		 2019-01-10 -
2021-01-14		 2 years crt.sh
*.outbrain.com
Thawte RSA CA 2018		 2019-10-29 -
2021-11-23		 2 years crt.sh
*.pubmatic.com
Sectigo RSA Organization Validation Secure Server CA		 2019-02-22 -
2021-02-21		 2 years crt.sh
*.taboola.com
DigiCert SHA2 Secure Server CA		 2020-06-01 -
2020-09-10		 3 months crt.sh
*.3lift.com
Amazon		 2019-07-17 -
2020-08-17		 a year crt.sh
*.bidswitch.net
Sectigo RSA Domain Validation Secure Server CA		 2020-04-23 -
2022-05-04		 2 years crt.sh
*.adnxs.com
DigiCert ECC Secure Server CA		 2019-01-23 -
2021-03-08		 2 years crt.sh
*.openx.net
GeoTrust RSA CA 2018		 2018-01-04 -
2020-07-09		 3 years crt.sh

This page contains 12 frames:

Primary Page: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Frame ID: A53290B6D7FABA07A0D0C8DD897BC4AD
Requests: 251 HTTP requests in this frame

Frame: https://informaglobalexhibitions.demdex.net/dest5.html?d_nsid=0
Frame ID: E684C8D0BFCCFC3642BFA489963D21DE
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssj5s6bFAJMpTdOmVJTDveAeOyRkLn_EmuYE9PEaojSFIOiTPvqnkPgN47D51TlQn375h1g3x2xK-ljVcogtAgZuUo229uXEHHqK8IWOCrGUwmt949KlgtUWB3cGcVkjYzsUq3truhOAo4lLnPsXq67EWSDXYv64luZivaFfS9b5pH319LMtfUwcLfP1JT-pBI--nF3E95YlRc6_MaubcUPrvAbkWow54b3vH6A6pQpCZ7cHNMK1_tKfvHlLZVlR2e9DktKkoEesGvfT8ALJ4WotEI1sYFhRzlnQZ5_8jZLdLpy7cZJld7J2joNAM0bih2YpvVRVakMZrwG90Sd-Set_emHzGg&sig=Cg0ArKJSzPGY3441re4hEAE&adurl=
Frame ID: 721BB2CAC654BAA92CEC8A5B13A8743A
Requests: 10 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstlrfYpBAiLtqx6wnHkZ-ekwTKOdHSo8ahZY91DeR2_T-V2YoJUpSB7PHYbwn-WeF4vSUIW-Jd5U_2QmZJ4ZkS-2zULBWADfC5gBBfeqqp3Bt1Ecs0EWWQb6Qr3lc39JXnWYV_jn-5PtbPGhnNNxMyxcTSG9g6ypI4pFokjtEaYOFEN_MxYtpjZR7du2kg2-qKtf4oWYoiklfyfJ0Il7u6InCR8jU7UGFo5_Q-IEXrvY685Lelt6DAAYpX0-QnaTFa2Tglv7YkWs_dTCsi7xBE3pW6-VirICCwZDCeiSHxWNlYQppRtGckADAzU08EV2K4FQLjMWBWOCbxSer_nY1vVLug1REs&sig=Cg0ArKJSzGgWChOG3IuNEAE&adurl=
Frame ID: D0C488C13CAF6EAD04327FF60359D472
Requests: 9 HTTP requests in this frame

Frame: https://vars.hotjar.com/box-469cf41adb11dc78be68c1ae7f9457a4.html
Frame ID: 51E09ECF957737699261D0CAC6B81866
Requests: 1 HTTP requests in this frame

Frame: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/css/ckeditor.css?qbs4lh
Frame ID: 49F505F1730241BFB6DCE6A892BBD3BB
Requests: 4 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss4WTVNljQcAab30eXO8ePmWD4JdWJ2rMTcfMjsRFSl7wY9vChxY5yJJm9c89hHZH_T2JUtpdLfEOo712rDTWgBiOFoSftmjjDACNdLf5GSal1_XmCIaG9hMIsAaAWCRHv8jWYeoqUy3iPif2PCw4hmB5qQlVGSKy1Ezjf9cutLmS28qw5uVpNQUx5xNtQLqHsDLw3aSkxhmk7EK3SaHF1OBmqiAF86B9pFmQNIEXSSW9CYqpjez59fvgBDQe98GiG-3Swj9V6TPX5nFltdJX4NQbx4KwGHARPu1KsDrJ1S_XxF4kZr6F_GqRL2Pu2sNgzD5xv3p7VP32MnJR55T0XKdDss&sig=Cg0ArKJSzHj8dlDVc5JpEAE&adurl=
Frame ID: DA962895549D2A58609152D4844E9B42
Requests: 11 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvLudxE-2G_XiLNiIVC90Yn_rWXWZ4L9BDHk3NjudnxoL8WMwqaaZW_ojr-V1NS5DvHzHjSZLeHhBbeU74u8L99_LUCkMwlSu3jqsM34Okq1Caki2UuXlTwcGQ2qmEKDZZMiYSZ74zCqdKZ62cBg1FBSkYH9s5rAWJYN1o9n4WOEOp9ZH_8fqgM0OddFw5PoJobAQ5QKAiUgn5SKWlgsqH4-OPq1GnOo8_8GOolfSWh2lCGki1J4hIg7iHGsZyUiKL2I4rOCHWcKAHUgbS1ROxJ_tADjiJEMKLMStcBw-xPqbIAo1efH1Gz6HuBFZWXAhvy6ZosaZgC_QZvuhlGyZZW5T9u&sig=Cg0ArKJSzLLcWVkSvPQUEAE&adurl=
Frame ID: A4474BF6BEE45FDFBC98A354E4F30757
Requests: 8 HTTP requests in this frame

Frame: https://vars.hotjar.com/box-469cf41adb11dc78be68c1ae7f9457a4.html
Frame ID: CFD2C27B3748D3F7AE08190FCC73FD25
Requests: 1 HTTP requests in this frame

Frame: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/css/ckeditor.css?qbs4lh
Frame ID: 4FA45E49FB3C0405AE4386BFE9A84208
Requests: 4 HTTP requests in this frame

Frame: https://bcp.crwdcntrl.net/5/ct=y/c=7499/rand=326341516/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr
Frame ID: 9BD3F984A3CBA64B11CD2830786548A2
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/210/runner.html
Frame ID: ADE837F03A430B2C40F772D680516134
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot
Full Image

Page URL History Show full URLs

  1. http://app.go02.informamarkets.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-A... HTTP 302
    https://s734445500.t.eloqua.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-A... HTTP 302
    https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture... Page URL
  2. https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • html /<(?:link|style)[^>]+"\/sites\/(?:default|all)\/(?:themes|modules)\//i
  • meta generator /^Drupal(?:\s([\d.]+))?/i
  • headers expires /19 Nov 1978/i
Overall confidence: 100%
Detected patterns
  • headers server /php\/?([\d.]+)?/i
  • html /<(?:link|style)[^>]+"\/sites\/(?:default|all)\/(?:themes|modules)\//i
  • meta generator /^Drupal(?:\s([\d.]+))?/i
  • headers expires /19 Nov 1978/i
Overall confidence: 100%
Detected patterns
  • headers server /CentOS/i
Overall confidence: 100%
Detected patterns
  • headers server /OpenSSL(?:\/([\d.]+[a-z]?))?/i
Overall confidence: 100%
Detected patterns
  • headers server /(?:Apache(?:$|\/([\d.]+)|[^/-])|(?:^|\b)HTTPD)/i
Overall confidence: 100%
Detected patterns
  • headers via /\(CloudFront\)$/i
Overall confidence: 100%
Detected patterns
  • headers via /\(CloudFront\)$/i
Overall confidence: 100%
Detected patterns
  • script /googletagservices\.com\/tag\/js\/gpt(?:_mobile)?\.js/i
Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^/]*\/[a-z]*\.js/i

Page Statistics

296
Requests

98 %
HTTPS

28 %
IPv6

40
Domains

59
Subdomains

59
IPs

9
Countries

3946 kB
Transfer

12609 kB
Size

13
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://app.go02.informamarkets.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL&s=734445500&lid=1275&elqTrackId=E371B070A114AF1717F06E662A0A7509&elq=0e925bb808be4c53ac9ae463b0b5929a&elqaid=1425&elqat=1 HTTP 302
    https://s734445500.t.eloqua.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL&s=734445500&lid=1275&elqTrackId=E371B070A114AF1717F06E662A0A7509&elq=0e925bb808be4c53ac9ae463b0b5929a&elqaid=1425&elqat=1 HTTP 302
    https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL Page URL
  2. https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 0
  • http://app.go02.informamarkets.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL&s=734445500&lid=1275&elqTrackId=E371B070A114AF1717F06E662A0A7509&elq=0e925bb808be4c53ac9ae463b0b5929a&elqaid=1425&elqat=1 HTTP 302
  • https://s734445500.t.eloqua.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL&s=734445500&lid=1275&elqTrackId=E371B070A114AF1717F06E662A0A7509&elq=0e925bb808be4c53ac9ae463b0b5929a&elqaid=1425&elqat=1 HTTP 302
  • https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Request Chain 22
  • https://video.limelight.com/player/embed.js HTTP 302
  • https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js
Request Chain 61
  • https://cm.everesttech.net/cm/dd?d_uuid=86620746516060112861991697106368209225 HTTP 302
  • https://dpm.demdex.net/ibs:dpid=411&dpuuid=XuO2dQAAA1LNClL0
Request Chain 103
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D55%26pixelIndex%3D0%26r%3D817261%26tzOffset%3D-120%26url%3Dhttps%253A%252F%252Fwww.globalpharmainsights.com%252Fmanufacturing-outsourcing%252Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%253Futm_campaign%253DHLN00GPI-ES-AWARENESS-GENERAL1%2526utm_emailname%253DHLN00GPI-ES-AWARENESS-EM1%25252F1-FEATURES%2526utm_medium%253Demail%2526utm_source%253DEloqua%2526utm_MDMContactID%253Df3bea1f6-c791-47dc-8d2d-b71160403f3f%2526utm_campaigntype%253DOthers%2526utm_sub%253DIntroducing%252520your%252520new%252520knowledge%252520platform%25253A%252520Global%252520Pharma%252520Insights%2526eM%253D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5&_=1591981686319 HTTP 307
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D55%2526pixelIndex%253D0%2526r%253D817261%2526tzOffset%253D-120%2526url%253Dhttps%25253A%25252F%25252Fwww.globalpharmainsights.com%25252Fmanufacturing-outsourcing%25252Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%25253Futm_campaign%25253DHLN00GPI-ES-AWARENESS-GENERAL1%252526utm_emailname%25253DHLN00GPI-ES-AWARENESS-EM1%2525252F1-FEATURES%252526utm_medium%25253Demail%252526utm_source%25253DEloqua%252526utm_MDMContactID%25253Df3bea1f6-c791-47dc-8d2d-b71160403f3f%252526utm_campaigntype%25253DOthers%252526utm_sub%25253DIntroducing%25252520your%25252520new%25252520knowledge%25252520platform%2525253A%25252520Global%25252520Pharma%25252520Insights%252526eM%25253D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5%26_%3D1591981686319 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?id=453945625446112413&q=xImp&v=1.x&cl=55&pixelIndex=0&r=817261&tzOffset=-120&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5&_=1591981686319
Request Chain 157
  • https://video.limelight.com/player/embed.js HTTP 302
  • https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js
Request Chain 234
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D55%26pixelIndex%3D0%26r%3D192308%26tzOffset%3D-120%26url%3Dhttps%253A%252F%252Fwww.globalpharmainsights.com%252Fmanufacturing-outsourcing%252Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%253Futm_campaign%253DHLN00GPI-ES-AWARENESS-GENERAL1%2526utm_emailname%253DHLN00GPI-ES-AWARENESS-EM1%25252F1-FEATURES%2526utm_medium%253Demail%2526utm_source%253DEloqua%2526utm_MDMContactID%253Df3bea1f6-c791-47dc-8d2d-b71160403f3f%2526utm_campaigntype%253DOthers%2526utm_sub%253DIntroducing%252520your%252520new%252520knowledge%252520platform%25253A%252520Global%252520Pharma%252520Insights%2526eM%253D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5&_=1591981688417 HTTP 307
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D55%2526pixelIndex%253D0%2526r%253D192308%2526tzOffset%253D-120%2526url%253Dhttps%25253A%25252F%25252Fwww.globalpharmainsights.com%25252Fmanufacturing-outsourcing%25252Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%25253Futm_campaign%25253DHLN00GPI-ES-AWARENESS-GENERAL1%252526utm_emailname%25253DHLN00GPI-ES-AWARENESS-EM1%2525252F1-FEATURES%252526utm_medium%25253Demail%252526utm_source%25253DEloqua%252526utm_MDMContactID%25253Df3bea1f6-c791-47dc-8d2d-b71160403f3f%252526utm_campaigntype%25253DOthers%252526utm_sub%25253DIntroducing%25252520your%25252520new%25252520knowledge%25252520platform%2525253A%25252520Global%25252520Pharma%25252520Insights%252526eM%25253D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5%26_%3D1591981688417 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?id=5483712037672564577&q=xImp&v=1.x&cl=55&pixelIndex=0&r=192308&tzOffset=-120&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5&_=1591981688417
Request Chain 259
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=5483712037672564577&pixelIndex=0&_=1591981688418 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5483712037672564577&pixelIndex=0&_=1591981688418&google_gid=CAESEDI98Gc3AD2xdiuFAbYh1JU&google_cver=1
Request Chain 271
  • https://bcp.crwdcntrl.net/5/c=7499/rand=326341516/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr HTTP 302
  • https://bcp.crwdcntrl.net/5/ct=y/c=7499/rand=326341516/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr
Request Chain 276
  • https://s.adroll.com/j/exp/IXZC4QKE6BDSVNBBOX54JQ/index.js HTTP 302
  • https://s.adroll.com/j/exp/index.js
Request Chain 278
  • https://d.adroll.mgr.consensu.org/consent/iabcheck/IXZC4QKE6BDSVNBBOX54JQ?_s=128a0949b4e3cd0b1540e0764d7c5632&_b=2 HTTP 302
  • https://d.adroll.com/consent/check/IXZC4QKE6BDSVNBBOX54JQ/?_s=128a0949b4e3cd0b1540e0764d7c5632&_b=2
Request Chain 280
  • https://d.adroll.com/pixel/IXZC4QKE6BDSVNBBOX54JQ/3BQ2N447KNEODAIZTDTY2B?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&pv=53148315847.43138&cookie=&keyw= HTTP 302
  • https://s.adroll.com/pixel/IXZC4QKE6BDSVNBBOX54JQ/3BQ2N447KNEODAIZTDTY2B/45GZFZBG65GTZP2EESFCXP.js
Request Chain 282
  • https://d.adroll.com/cm/aol/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://pixel.advertising.com/ups/55980/sync?uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&_origin=1&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA HTTP 302
  • https://pixel.advertising.com/ups/55980/sync?uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&_origin=1&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA&verify=true HTTP 302
  • https://ups.analytics.yahoo.com/ups/55980/sync?uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&_origin=1&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA&apid=UP4ad481f9-accf-11ea-8ddd-069d9e483036
Request Chain 283
  • https://d.adroll.com/cm/index/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=105&external_user_id=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&expiration=1623517690
Request Chain 284
  • https://d.adroll.com/cm/n/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://pixel.rubiconproject.com/tap.php?v=194538&nid=3644&put=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&expires=365
Request Chain 285
  • https://d.adroll.com/cm/outbrain/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://sync.outbrain.com/cookie-sync?p=adroll&uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg HTTP 302
  • https://sync.outbrain.com/cookie-sync?p=adroll&uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&rdrctExp=true
Request Chain 286
  • https://d.adroll.com/cm/pubmatic/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MzMwNiZ0bD01MjU2MDA&piggybackCookie=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&gdpr=0&gdpr_consent=BOOoKswOOoKswA2ABBENAkwAAAAXyACACYAIIA
Request Chain 287
  • https://d.adroll.com/cm/r/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://ads.yahoo.com/cms/v1?esig=1~bf4e7dc4546a90c08591652d78a230d3f2ef5733&nwid=10001032567&sigv=1&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA HTTP 302
  • https://d.adroll.com/cm/r/in?xid=E0&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA
Request Chain 288
  • https://d.adroll.com/cm/taboola/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://trc.taboola.com/sg/adroll-network/1/rtb-h/?taboola_hm=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
Request Chain 289
  • https://d.adroll.com/cm/triplelift/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://eb2.3lift.com/xuid?mid=4714&xuid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&dongle=c85e HTTP 302
  • https://eb2.3lift.com/xuid?ld=1&mid=4714&xuid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&dongle=c85e&gdpr=1&cmp_cs=&us_privacy=
Request Chain 290
  • https://d.adroll.com/cm/b/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=44&user_id=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg HTTP 302
  • https://x.bidswitch.net/ul_cb/sync?dsp_id=44&user_id=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
Request Chain 291
  • https://d.adroll.com/cm/x/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://ib.adnxs.com/setuid?entity=172&code=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
Request Chain 292
  • https://d.adroll.com/cm/l/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://idsync.rlcdn.com/377928.gif?partner_uid=72e8f56d5d3182422aec6c74d070adf8
Request Chain 293
  • https://d.adroll.com/cm/o/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ HTTP 302
  • https://us-u.openx.net/w/1.0/sd?id=537103138&val=72e8f56d5d3182422aec6c74d070adf8 HTTP 302
  • https://us-u.openx.net/w/1.0/sd?cc=1&id=537103138&val=72e8f56d5d3182422aec6c74d070adf8
Request Chain 294
  • https://d.adroll.com/cm/g/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&xid_ch=f&advertisable=IXZC4QKE6BDSVNBBOX54JQ&google_nid=adroll5 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_sc&google_nid=artb&google_hm=cuj1bV0xgkIq7Gx00HCt-A HTTP 302
  • https://d.adroll.com/cm/g/in

296 HTTP transactions

Resource
Path		 Size
x-fer		 Type
MIME-Type
gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir
www.globalpharmainsights.com/manufacturing-outsourcing/
Redirect Chain
  • http://app.go02.informamarkets.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6...
  • https://s734445500.t.eloqua.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c7...
  • https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN...
113 KB
20 KB 		Document
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
17afef309710eda771474c7ad11cfae6dcf96285a01357e1f338cc110edbf0b6
Security Headers
Name Value
X-Content-Type-Options nosniff nosniff
X-Frame-Options SAMEORIGIN

Request headers

:method
GET
:authority
www.globalpharmainsights.com
:scheme
https
:path
/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
none
sec-fetch-mode
navigate
sec-fetch-user
?1
sec-fetch-dest
document
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
200
content-type
text/html; charset=utf-8
date
Fri, 12 Jun 2020 17:07:14 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-content-type-options
nosniff nosniff
x-powered-by
PHP/7.2.31
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
cache-control
public, max-age=300
x-ua-compatible
IE=edge,chrome=1
content-language
en
x-frame-options
SAMEORIGIN
x-generator
Drupal 7 (http://drupal.org)
link
<https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir>; rel="canonical",<https://www.globalpharmainsights.com/node/191>; rel="shortlink"
set-cookie
aucp13n=9lj32o; expires=Sun, 05-Jul-2020 20:40:33 GMT; Max-Age=1999999; path=/; domain=.globalpharmainsights.com; secure SSESSabb96de343dde80a1e2e8a1591776328=1V-ta355Fa76eVK6Gov1q2tK_cJ9IAd-EgRQtIJN6Cc; expires=Sun, 05-Jul-2020 20:40:34 GMT; Max-Age=2000000; path=/; domain=.globalpharmainsights.com; secure; HttpOnly
etag
"1591981633-1-https://www.globalpharmainsights.com"
last-modified
Fri, 12 Jun 2020 17:07:13 GMT
content-encoding
gzip
vary
Cookie,Accept-Encoding
x-cache
Hit from cloudfront
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
Uv9I2fG_dwShMbvK0tSdHhwAquoMf3oIeVysxmQfBnrtLs-hYOsh2w==
age
51

Redirect headers

Cache-Control
private,no-cache, no-store
Pragma
no-cache
Content-Type
text/html; charset=utf-8
Expires
-1
Location
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Set-Cookie
ELOQUA=GUID=B3CDD57E10E2462797F86F0920203621; domain=.eloqua.com; expires=Mon, 12-Jul-2021 17:08:05 GMT; path=/;SameSite=None; secure ELQSTATUS=OK; domain=.eloqua.com; expires=Mon, 12-Jul-2021 17:08:05 GMT; path=/;SameSite=None; secure
P3P
CP="IDC DSP COR DEVa TAIa OUR BUS PHY ONL UNI COM NAV CNT STA",
X-Content-Type-Options
nosniff
Date
Fri, 12 Jun 2020 17:08:04 GMT
Content-Length
731
css_PpiQEI-azlEmknynFVbTW6pWwXhVPT_fbABYbBL6JWQ.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 		2 KB
1 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_PpiQEI-azlEmknynFVbTW6pWwXhVPT_fbABYbBL6JWQ.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /
Resource Hash
3e9890108f9ace5126927ca71556d35baa56c178553d3fdf6c00586c12fa2564
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 29 May 2020 22:06:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1191692
x-cache
Hit from cloudfront
status
200
content-length
922
last-modified
Thu, 07 May 2020 03:02:16 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag
"39a-5a5061bb444b8"
vary
Accept-Encoding
content-type
text/css
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
gtWkyKGn7V2RjPoQYwtOH1qsNQ8lNXzPo39QYbLJy6JV9xxf_OJcZg==
expires
Fri, 12 Jun 2020 22:06:32 GMT
css_b2lxsoMjuDz1VEsoXFy0Cgo8pcav1Ny1N-EHn8knPc0.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 		19 KB
4 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_b2lxsoMjuDz1VEsoXFy0Cgo8pcav1Ny1N-EHn8knPc0.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
6f6971b28323b83cf5544b285c5cb40a0a3ca5c6afd4dcb537e1079fc9273dcd
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 12:04:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
709400
x-cache
Hit from cloudfront
status
200
content-length
3400
last-modified
Thu, 04 Jun 2020 03:46:25 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"d48-5a739fd2ae2f0"
vary
Accept-Encoding
content-type
text/css
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
a-fLCdT1Txp7xnYb_KgDSh1TJEpSS0HTiYwtgvW2k-3Yje89CnXX5Q==
expires
Thu, 18 Jun 2020 12:04:44 GMT
css_EMysOwdNz4P_aEBvy91ee-H45803PIdurHGMjmMp-B4.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 		17 KB
4 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_EMysOwdNz4P_aEBvy91ee-H45803PIdurHGMjmMp-B4.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
10ccac3b074dcf83ff68406fcbdd5e7be1f8e7cd373c876eac718c8e6329f81e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 02 Jun 2020 00:37:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
923406
x-cache
Hit from cloudfront
status
200
content-length
3876
last-modified
Tue, 28 Apr 2020 23:04:16 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"f24-5a461d9cdee40"
vary
Accept-Encoding
content-type
text/css
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
hhCae_cuTL2t5Wl6T7FbbsmYUtKCqWwS4ZlXP5zzMk6GKwLDIMORxQ==
expires
Tue, 16 Jun 2020 00:37:59 GMT
css_fIVgxWnE83pCcIB_bpOeDbuIS61SfKIUkuXnxkQZul4.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 		36 KB
6 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_fIVgxWnE83pCcIB_bpOeDbuIS61SfKIUkuXnxkQZul4.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
7c8560c569c4f37a4270807f6e939e0dbb884bad527ca21492e5e7c64419ba5e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 12:40:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
102474
x-cache
Hit from cloudfront
status
200
content-length
5883
last-modified
Thu, 04 Jun 2020 03:47:14 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"16fb-5a73a0013d5f8"
vary
Accept-Encoding
content-type
text/css
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
myh_qmiNWXAorDzWGFDQfVqaFFeVb2_d1NhspbziY-Ec55hQ6J7JuA==
expires
Thu, 25 Jun 2020 12:40:11 GMT
css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 		771 KB
103 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
0fb3fd54954e792633886c230ead89609bc9799ba792ba1c38b9fa905595caae
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112091
x-cache
Hit from cloudfront
status
200
content-length
105279
last-modified
Wed, 10 Jun 2020 03:24:35 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"19b3f-5a7b262142168"
vary
Accept-Encoding
content-type
text/css
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
XCVCN0Qcd8NfLNSdCQgk7IMopE2t53GuEurQd8q8JJpV-F41sMvUjw==
expires
Thu, 25 Jun 2020 09:59:54 GMT
gpt.js
www.googletagservices.com/tag/js/ 		43 KB
14 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7848437d39e9a43e7c809b181413a624a1563db3e24439c03115a8fea68fcc57
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"540 / 341 of 1000 / last-modified: 1591967721"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
14524
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:05 GMT
header.png
www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/ 		12 KB
13 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/header.png
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
f3398fb55770fb83d26d8537073b425b2b9c64f8652a74a0a17a17d35c8cd834
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 03:37:26 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
739839
x-cache
Hit from cloudfront
status
200
content-length
12472
last-modified
Thu, 04 Jun 2020 02:32:06 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"30b8-5a738f35f8c84"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
8H3XkhfAvPUggh5eAHOPjC1T57dvAYYeKQHAqvH0v6JK-2YLqHbq5w==
expires
Thu, 18 Jun 2020 03:37:26 GMT
CPHI%20Online%20TEAL%20LOGO%20no%20border.png
www.globalpharmainsights.com/sites/cphi.com/files/styles/hp_widget_program_standard/public/ 		14 KB
14 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/hp_widget_program_standard/public/CPHI%20Online%20TEAL%20LOGO%20no%20border.png?itok=WDbHTO0d
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
6228e9180404b87bdd1d53f6d32ceecd1e73407ae40c6d5851a12fa0caba889d
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 05 Jun 2020 12:34:31 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
621213
x-cache
Hit from cloudfront
status
200
content-length
14117
last-modified
Fri, 17 Apr 2020 14:46:33 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"3725-5a37d9d975f40"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
T7MqLDkv9CZR1n9J_zdQPDu8wJJtIZKnaj9nqndjD7IHquK37laIcg==
expires
Fri, 19 Jun 2020 12:34:31 GMT
HLN00CPO-Gilead-distribution.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_featured_standard/public/ 		57 KB
57 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_featured_standard/public/HLN00CPO-Gilead-distribution.jpg?itok=uJBDDbK5
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
32565490c2301442c897cf7c812b98f4543036571824c424e123735ccbd19137
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 08:34:21 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
30825
x-cache
Hit from cloudfront
status
200
content-length
58070
last-modified
Wed, 13 May 2020 08:45:23 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"e2d6-5a58399d31e50"
content-type
image/jpeg
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
BFuvmiv0z-2WaeiDgpt9EseQ-bwZKw3h12Wudtthc8pgOcu32KvFCQ==
expires
Fri, 26 Jun 2020 08:34:21 GMT
account-default-image.png
www.globalpharmainsights.com/sites/all/themes/penton_core_theme/images/ 		5 KB
5 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/all/themes/penton_core_theme/images/account-default-image.png
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
12260d8e3e5f7c60dfda5731f3b77e1748c45fe480bec2d0cee49616dd48ae04
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 16:01:23 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
4002
x-cache
Hit from cloudfront
status
200
content-length
5140
last-modified
Fri, 12 Jun 2020 11:06:47 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"1414-5a7e112b78fcc"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
BCDszlf8TBd8A9NIcWhyd63XHvmP3sVuTjGrk9u35GkddnUdCCOF3g==
expires
Fri, 26 Jun 2020 16:01:23 GMT
CPhI%20India_CoT.png
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 		2 KB
2 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/CPhI%20India_CoT.png?itok=FLPd7SgR
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /
Resource Hash
0444c8c10665ee4ae69b68f021bf722af7e87b5bb2e52ba9bcb9d8b741e98ae1
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 04:54:16 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
44029
x-cache
Hit from cloudfront
status
200
content-length
1691
last-modified
Thu, 16 Apr 2020 08:52:03 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag
"69b-5a3648bf85c80"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
frOLru6tzYxfuVWQybppHLf93q2rm38pf4LswFjOrymxZs8m0Hw_ig==
expires
Fri, 26 Jun 2020 04:54:16 GMT
HLN00CPO-Remdesivir-Gilead.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 		2 KB
2 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/HLN00CPO-Remdesivir-Gilead.jpg?itok=2ZaOW6BX
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
1a57e0006d9f342948a1fe2394bc31e62f529a5394c037ce0efcd92d0bd1da55
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 09:11:28 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
287797
x-cache
Hit from cloudfront
status
200
content-length
1842
last-modified
Wed, 06 May 2020 10:00:41 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"732-5a4f7d636cbd0"
content-type
image/jpeg
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
YLHk6T_Yx9hgwTeNYss7B9Lcb3Bx_fGuOTwCGr9lgFswP3WMmi4g7Q==
expires
Tue, 23 Jun 2020 09:11:28 GMT
HLN00CPO-Continuous-manufacturing-cogs.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 		2 KB
3 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/HLN00CPO-Continuous-manufacturing-cogs.jpg?itok=YD6TVkcM
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
240d40d23dcebd0e448df4c2b45863b27c86f706f8a53a79c3b4b98ce193b67b
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 08:36:45 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
30680
x-cache
Hit from cloudfront
status
200
content-length
2307
last-modified
Fri, 12 Jun 2020 08:34:21 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"903-5a7def19fb820"
content-type
image/jpeg
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
Xdt7XlK5i3fFa_1O3yIRwLX2SDS48E_CoVBVymrkps5x4bJBXoeVnQ==
expires
Fri, 26 Jun 2020 08:36:45 GMT
HLN00COP-COVID-19-weekly-tracker.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 		2 KB
2 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/HLN00COP-COVID-19-weekly-tracker.jpg?itok=o-1CYn9m
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /
Resource Hash
e4dff53a6d9d1b0557739d82c88285e80935eb9fa580043136af323748cab6ee
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 30 May 2020 10:33:15 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
1146890
x-cache
Hit from cloudfront
status
200
content-length
1683
last-modified
Thu, 16 Apr 2020 08:16:22 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag
"693-5a3640c57d488"
content-type
image/jpeg
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
u0QKTDDkz4eDIE90ZSHLb4R5ZN29JMXGP5ANDV7Sq78nocPrkVf-yQ==
expires
Sat, 13 Jun 2020 10:33:15 GMT
footer.png
www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/ 		11 KB
12 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/footer.png
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
e46041e34d5f1093b7b2c0858814e0e6468b9b6a80426a23d54230239ed92026
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 03:37:27 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
739838
x-cache
Hit from cloudfront
status
200
content-length
11655
last-modified
Thu, 04 Jun 2020 02:22:15 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"2d87-5a738d02a09ca"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
Q1VV3Wu811jxLtkrxxSBOepTSsP563aIJweQl9ELSe5uLX1V2GTXCA==
expires
Thu, 18 Jun 2020 03:37:27 GMT
js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		97 KB
35 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /
Resource Hash
fcf899b8ada8e170270c258e868822185d358321f37aeed0c6f3b27d37be6323
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 29 May 2020 22:06:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1191692
x-cache
Hit from cloudfront
status
200
content-length
34910
last-modified
Thu, 07 May 2020 03:06:03 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag
"885e-5a50629326688"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
ykumDRCmyj4rX5xCnfesaktWeBHwOOjubrsQTDt_QmW0VGT1a8GE2A==
expires
Fri, 12 Jun 2020 22:06:32 GMT
js_s3L_uC35AiN5EGYY533su-jccnLRp2aKpOnjgPLbo34.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		20 KB
7 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_s3L_uC35AiN5EGYY533su-jccnLRp2aKpOnjgPLbo34.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
b372ffb82df9022379106618e77decbbe8dc7272d1a7668aa4e9e380f2dba37e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112090
x-cache
Hit from cloudfront
status
200
content-length
6931
last-modified
Wed, 10 Jun 2020 03:26:19 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"1b13-5a7b26851d908"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
TEChKYQdStwRHREIMml7JnhErqFZOHsLJBEY1ziTXw-WrQxVT2WSrQ==
expires
Thu, 25 Jun 2020 09:59:55 GMT
launch-560312491757.min.js
assets.adobedtm.com/100e8b570010/c89496dc0f21/ 		178 KB
50 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:10c:382::1e80 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
6ab81fba1ff6dbfb3aac51f5a2a8b1a5a4bc58cbeeac086de3f6e838cb3c93cf

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
gzip
last-modified
Wed, 27 May 2020 12:11:50 GMT
server
AkamaiNetStorage
etag
"1dd9abe35bae1a8805e8349a0bd9dfcb:1590581510.227931"
vary
Accept-Encoding
content-type
application/x-javascript
status
200
cache-control
max-age=3600
accept-ranges
bytes
timing-allow-origin
*
content-length
51138
expires
Fri, 12 Jun 2020 18:08:05 GMT
js_I-uzEZ6lB_oNELbin5YHol-LXruj-gjGpig7o5Yiy3g.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		166 KB
48 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_I-uzEZ6lB_oNELbin5YHol-LXruj-gjGpig7o5Yiy3g.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
23ebb3119ea507fa0d10b6e29f9607a25f8b5ebba3fa08c6a6283ba39622cb78
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 12:40:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
102474
x-cache
Hit from cloudfront
status
200
content-length
48418
last-modified
Thu, 04 Jun 2020 03:47:14 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"bd22-5a73a001558b0"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
IjEonC4bDE6eDCVMv6IL2eQuszRrUi3RBMqx8QaOBTIwiFAUXxGk0w==
expires
Thu, 25 Jun 2020 12:40:11 GMT
js_13l6iCSWqEmXf4TMDp51TAkvk6FN2jCQAjkAuVSOeqo.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		15 KB
4 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_13l6iCSWqEmXf4TMDp51TAkvk6FN2jCQAjkAuVSOeqo.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
d7797a882496a849977f84cc0e9e754c092f93a14dda3090023900b9548e7aaa
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 12:04:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
709401
x-cache
Hit from cloudfront
status
200
content-length
3712
last-modified
Thu, 04 Jun 2020 03:46:26 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"e80-5a739fd32dde8"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
5gHGXDDWSB4uOqqb7X_IuDWumiWTipR6_52BvuufHktVuksU8UjSmQ==
expires
Thu, 18 Jun 2020 12:04:44 GMT
js_FoO86KRzi68_J27zYA1BNIfKpwyO0UJ-deA5Irn5IQ8.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		5 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_FoO86KRzi68_J27zYA1BNIfKpwyO0UJ-deA5Irn5IQ8.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
1683bce8a4738baf3f276ef3600d413487caa70c8ed1427e75e03922b9f9210f
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 12:04:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
709403
x-cache
Hit from cloudfront
status
200
content-length
1311
last-modified
Thu, 04 Jun 2020 03:47:14 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"51f-5a73a00163758"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
SYx3geqr_pJ42zlzuqTBIoZ95b2lP5vn9v2zPPX6K_bMlHVPliqupA==
expires
Thu, 18 Jun 2020 12:04:43 GMT
embed.js
s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/
Redirect Chain
  • https://video.limelight.com/player/embed.js
  • https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js
18 KB
19 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
178.79.227.128 , Italy, ASN22822 (LLNW, US),
Reverse DNS
https-178-79-227-128.vie.llnw.net
Software
AmazonS3 /
Resource Hash
29ca0635f3a13ba2340907510cd06b2d26e9fd4abf88295914626c2096ac8924

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 12 Jun 2020 17:08:05 GMT
Last-Modified
Tue, 28 May 2019 17:21:09 GMT
Server
AmazonS3
Age
8789433
x-amz-id-2
fxq7uXglQSoEWqulSXHOZGF1Q0ZctK4ypgvzc2pkOm+wX36AkVl/dRpqnp6niqgDxk+rZrPABh4=
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=31536000
Content-Length
18768
Connection
keep-alive
Accept-Ranges
bytes
x-amz-request-id
51874FA8EFF7D424
X-LLID
e8fb24cfb64f977776af232fd18a1447
Expires
Tue, 02 Mar 2021 23:37:32 GMT

Redirect headers

Location
https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js
Date
Fri, 12 Jun 2020 17:08:05 GMT
Server
Apache
Connection
Keep-Alive
Keep-Alive
timeout=2, max=100
Content-Length
330
Content-Type
text/html; charset=iso-8859-1
js_jm3tTtzLZz9ztr1QmbjNUQg7CXVPQ0KIq1izyBk1azg.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		278 KB
67 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_jm3tTtzLZz9ztr1QmbjNUQg7CXVPQ0KIq1izyBk1azg.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
8e6ded4edccb673f73b6bd5099b8cd51083b09754f434288ab58b3c819356b38
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 12:04:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
709401
x-cache
Hit from cloudfront
status
200
content-length
67949
last-modified
Thu, 04 Jun 2020 03:47:15 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"1096d-5a73a0017d950"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
28SbwXG-GsGGBqv4A8Yhb-26n3okF1aGakr0opVJ9XrU0szmMArLqg==
expires
Thu, 18 Jun 2020 12:04:44 GMT
js_L6OZG5KXpK9TmHNSbl24vOE0yJf48VytacfkHRBNEVc.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		10 KB
3 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_L6OZG5KXpK9TmHNSbl24vOE0yJf48VytacfkHRBNEVc.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
2fa3991b9297a4af539873526e5db8bce134c897f8f15cad69c7e41d104d1157
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112090
x-cache
Hit from cloudfront
status
200
content-length
2833
last-modified
Wed, 10 Jun 2020 03:24:35 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"b11-5a7b262197c80"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
ZMJuCIpmMoBajjnpzLPhWvYrLa3s1gLlLmuxpWMrGzeFeFQBDFIVKg==
expires
Thu, 25 Jun 2020 09:59:55 GMT
js_bPh3Q6AKPB-AdasJkcfWUQYxe6rsN1QNiUqwOfElCSA.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		48 KB
13 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_bPh3Q6AKPB-AdasJkcfWUQYxe6rsN1QNiUqwOfElCSA.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
6cf87743a00a3c1f8075ab0991c7d65106317baaec37540d894ab039f1250920
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 12:40:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
102474
x-cache
Hit from cloudfront
status
200
content-length
12544
last-modified
Thu, 04 Jun 2020 03:47:15 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"3100-5a73a0018fa60"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
X-GiDewOI2CTupPI10zgjIR4VP9vs9D1bIvJkkkMTPrumrfoxx9cEg==
expires
Thu, 25 Jun 2020 12:40:11 GMT
js_yIkX_vb0Dxng7O5aNwkJ-nqApJpaPl61cDQzkBEByaA.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		94 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_yIkX_vb0Dxng7O5aNwkJ-nqApJpaPl61cDQzkBEByaA.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
c88917fef6f40f19e0ecee5a370909fa7a80a49a5a3e5eb5703433901101c9a0
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112090
x-cache
Hit from cloudfront
status
200
content-length
28579
last-modified
Thu, 04 Jun 2020 03:46:26 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"6fa3-5a739fd360e50"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
MW-Lg_AVxDoMIOfW-kFzihblL0yptBe80anC-vSP-CSVAchFpuaDsg==
expires
Thu, 25 Jun 2020 09:59:55 GMT
js_5mkVQduSavhPSKtIg-VBkjsgMwuU68PrQhH9Ye0ODvs.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		11 KB
3 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_5mkVQduSavhPSKtIg-VBkjsgMwuU68PrQhH9Ye0ODvs.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
e6691541db926af84f48ab4883e541923b20330b94ebc3eb4211fd61ed0e0efb
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112090
x-cache
Hit from cloudfront
status
200
content-length
2186
last-modified
Wed, 10 Jun 2020 03:26:19 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"88a-5a7b2685353f0"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
oLSgJdX7_8wQCTpN9psULe9vaui-lhALbRhgRXDg60OR7hwHbEY2fA==
expires
Thu, 25 Jun 2020 09:59:55 GMT
js_39wR4vuLCUZcIK_NsEhVLhl6834Dd3heLLFQ5DLVNsc.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		14 KB
4 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_39wR4vuLCUZcIK_NsEhVLhl6834Dd3heLLFQ5DLVNsc.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
dfdc11e2fb8b09465c20afcdb048552e197af37e0377785e2cb150e432d536c7
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 12:40:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
102474
x-cache
Hit from cloudfront
status
200
content-length
3655
last-modified
Tue, 12 May 2020 03:03:22 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"e47-5a56ab4d71440"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
rqEhrukidsAhkgwoZfjgKV8ZB0pFQ5zffA29gmucFShX4mSVBzqKjg==
expires
Thu, 25 Jun 2020 12:40:11 GMT
ckeditor.js
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ 		674 KB
203 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
945fe441f86cf714fbe8313e5a79d879d27f3c3fd542246715655c0e93dc0c5c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:06 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 14:48:55 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5578
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
Dak5DK5crUFALzShJP5ifX04y1ggKAquUHlmnBuuuNPiuw_Rfab48Q==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:06 GMT
js_ZrciCJCAxDyewaqeqgUiHehSzeEalZRdqNrEoAN5Q5c.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_ZrciCJCAxDyewaqeqgUiHehSzeEalZRdqNrEoAN5Q5c.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
66b722089080c43c9ec1aa9eaa05221de852cde11a95945da8dac4a003794397
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112090
x-cache
Hit from cloudfront
status
200
content-length
1209
last-modified
Wed, 10 Jun 2020 03:26:19 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"4b9-5a7b2684d58b0"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
naYohqOpN62PUB8050S2qBaOxgEJ4hY04iH1FzKujkxAmEUSGMcNFA==
expires
Thu, 25 Jun 2020 09:59:55 GMT
fa-brands-400.woff2
www.globalpharmainsights.com/sites/all/themes/shared_fonts/ 		75 KB
75 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/themes/shared_fonts/fa-brands-400.woff2
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
089630244600f33230010f5e04c67419ec642c5228540adb42e3fe92c631e6bf
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
Origin
https://www.globalpharmainsights.com

Response headers

date
Thu, 04 Jun 2020 03:37:26 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
last-modified
Thu, 04 Jun 2020 02:32:03 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
age
739840
etag
"12b04-5a738f33322a2"
x-cache
Hit from cloudfront
status
200
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
76548
x-amz-cf-id
UCOQDVOWBbfXOT6ZWZiW35PkdWVmVP7VtM21Yz93iCGD1fzW3Lsfbg==
expires
Thu, 18 Jun 2020 03:37:26 GMT
fa-solid-900.woff2
www.globalpharmainsights.com/sites/all/themes/shared_fonts/ 		74 KB
75 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/themes/shared_fonts/fa-solid-900.woff2
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
2c3097237d60f42e800ebe4009c9af144bb19e5581e1c0501c7b259eee7e210c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
Origin
https://www.globalpharmainsights.com

Response headers

date
Thu, 04 Jun 2020 03:37:26 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
last-modified
Thu, 04 Jun 2020 02:32:03 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
age
739838
etag
"12958-5a738f32a1dfe"
x-cache
Hit from cloudfront
status
200
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
76120
x-amz-cf-id
RKc8ay_jDOurdjHnI9nOkOCe5T1h85ZqAkdiL24UomeyPtSVgB-FNw==
expires
Thu, 18 Jun 2020 03:37:26 GMT
fa-regular-400.woff2
www.globalpharmainsights.com/sites/all/themes/shared_fonts/ 		13 KB
14 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/themes/shared_fonts/fa-regular-400.woff2
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
093f782260d70f914e7e591eba1502d3e992e9f7a69a17d1df6c32bcddd6f06a
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
Origin
https://www.globalpharmainsights.com

Response headers

date
Mon, 08 Jun 2020 10:54:19 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
last-modified
Mon, 08 Jun 2020 10:42:22 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
age
368026
etag
"3520-5a79044072182"
x-cache
Hit from cloudfront
status
200
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
13600
x-amz-cf-id
4ywFkeZLg-YMdwA5yaqmIpGk6kcHRQpOJzDkOOTGP0J1nnYX_iE3bg==
expires
Mon, 22 Jun 2020 10:54:19 GMT
pubads_impl_2020060103.js
securepubads.g.doubleclick.net/gpt/ 		246 KB
88 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
sffe /
Resource Hash
7281df0fc37f02952ecbff4b9f47640a7f193aac19c97f89e3e276b20d47e454
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Intervention
<https://www.chromestatus.com/feature/5718547946799104>; level="warning"

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 01 Jun 2020 18:46:06 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
90085
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:05 GMT
integrator.sync.js
adservice.google.de/adsid/ 		113 B
175 B 		Script
General
Check archive.org
Download Go to
Full URL
https://adservice.google.de/adsid/integrator.sync.js?domain=www.globalpharmainsights.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ea03bfd7fdda1eac185ebc3e8e74b33065b04c8e0adc48cbbd4136748dbd2742
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
108
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/ 		483 B
766 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2286349668923420&correlator=902020814646270&output=ldjh&impl=fif&eid=21065139%2C21066300&vrg=2020060103&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dinterstitial_a%26gdpr_banner%3Don%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie_enabled=1&bc=31&abxe=1&lmt=1591981633&dt=1591981685620&dlt=1591981685191&idt=386&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=0&adks=1971742020&ucis=1&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=11&icsg=186&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1600x3114&msz=1600x0&ga_vid=1332624323.1591981686&ga_sid=1591981686&ga_hid=1154489031&fws=0&ohw=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
5606b6ef1a229c2f2b078bbfffd54f70acbc305308ba0a55cf362bd09ccadc8d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
256
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
b1ff9ba2a5a6fa8f594604dadd847edf.safeframe.googlesyndication.com/safeframe/1-0-37/html/ 		0
0 		Other
General
Check archive.org
Download Go to
Full URL
https://b1ff9ba2a5a6fa8f594604dadd847edf.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers
container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/ 		0
0 		Other
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers
id
dpm.demdex.net/ 		383 B
1 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://dpm.demdex.net/id?d_visid_ver=4.5.2&d_fieldgroup=MC&d_rtbd=json&d_ver=2&d_orgid=DD4C6A00570E3C0F7F000101%40AdobeOrg&d_nsid=0&ts=1591981685676
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.202.93.59 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-202-93-59.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
d711f851965e7cb38b6e43dddf7d88d16c4859d40f4bfb93a0786045c1dae31a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

DCS
dcs-prod-irl1-v072-063831ec4.edge-irl1.demdex.com 5.73.2.20200611122118 3ms (+0ms)
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
Content-Encoding
gzip
X-TID
1nqPJWawQ4k=
Vary
Origin, Accept-Encoding, User-Agent
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Access-Control-Allow-Origin
https://www.globalpharmainsights.com
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json;charset=utf-8
Content-Length
315
Expires
Thu, 01 Jan 1970 00:00:00 GMT
AppMeasurement.min.js
assets.adobedtm.com/extensions/EP308220a2a4c4403f97fc1960100db40f/ 		36 KB
13 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.adobedtm.com/extensions/EP308220a2a4c4403f97fc1960100db40f/AppMeasurement.min.js
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:10c:382::1e80 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
adfcb165c69213b0aba3c64bc549f7ff156ec82110fb8ef144b1d16ebc13b04a

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
gzip
last-modified
Tue, 10 Mar 2020 22:29:22 GMT
server
AkamaiNetStorage
etag
"42fa244f36955eedb3cd8ade6f492bf6:1583879362.816163"
vary
Accept-Encoding
content-type
application/x-javascript
status
200
cache-control
no-cache
accept-ranges
bytes
timing-allow-origin
*
content-length
13342
expires
Fri, 12 Jun 2020 18:08:05 GMT
cc_af.js
tags.crwdcntrl.net/c/7499/ 		64 KB
15 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tags.crwdcntrl.net/c/7499/cc_af.js
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.116 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-116.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
3517e49035216248756bd8d6babd7e024b944f85eed8bc430ffdd509e593ba52

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 21:12:06 GMT
content-encoding
gzip
last-modified
Wed, 27 May 2020 14:23:57 GMT
server
AmazonS3
age
71761
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/json
status
200
cache-control
max-age: 86400
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
2criz4JihnG34cvXwvBiryE_bDEbqiiCQbkuNEqpTiAuNgU09zpE5A==
via
1.1 1d87c34bb2f20fda8e0841bc33179769.cloudfront.net (CloudFront)
js
www.googletagmanager.com/gtag/ 		83 KB
33 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagmanager.com/gtag/js?id=AW-998237655&l=dataLayer
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
a06e56a8c960b020069ccd0444e9007101811003816ca68886c76ea91724e1eb
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
br
vary
Accept-Encoding
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
33228
x-xss-protection
0
last-modified
Fri, 12 Jun 2020 15:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Fri, 12 Jun 2020 17:08:05 GMT
News
www.globalpharmainsights.com/no_cache/feeds/ajax/rss/ 		0
0
Products
www.globalpharmainsights.com/no_cache/feeds/ajax/rss/ 		9 KB
9 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/no_cache/feeds/ajax/rss/Products?fromPath=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
a94a963dcd2e927863ee4d8da81b6c0ae6461dc05a5061f825c91d9b0eda8c44
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff, nosniff
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-drupal-ajax-token
1
x-cache
Miss from cloudfront
content-type
application/json; charset=utf-8
status
200
expires
Sun, 19 Nov 1978 05:00:00 GMT
cache-control
no-cache, must-revalidate
x-amz-cf-id
J93s4vKCf3n1wmmfkC-7c06F6oy75JVNj-ENJSKVDSnshdB1vzRkNQ==
x-ua-compatible
IE=edge,chrome=1
Suppliers
www.globalpharmainsights.com/no_cache/feeds/ajax/rss/ 		9 KB
9 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/no_cache/feeds/ajax/rss/Suppliers?fromPath=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
080ef4bcdd505cac3c920d1b3b6021794792d4ff35ede61185d8922ad23c832d
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff, nosniff
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-drupal-ajax-token
1
x-cache
Miss from cloudfront
content-type
application/json; charset=utf-8
status
200
expires
Sun, 19 Nov 1978 05:00:00 GMT
cache-control
no-cache, must-revalidate
x-amz-cf-id
Fhfr7xqaIbbHTOydMHDeJIJvetVZ4_ijGnRT2SEPd0cmKjo5KYkbrw==
x-ua-compatible
IE=edge,chrome=1
ui-bg_flat_75_ffffff_40x100.png
www.globalpharmainsights.com/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/images/ 		178 B
604 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/images/ui-bg_flat_75_ffffff_40x100.png
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
39ab7ccd9f4e82579da78a9241265df288d8eb65dbbd7cf48aed2d0129887df5
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_b2lxsoMjuDz1VEsoXFy0Cgo8pcav1Ny1N-EHn8knPc0.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 03:37:31 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
739834
x-cache
Hit from cloudfront
status
200
content-length
178
last-modified
Thu, 04 Jun 2020 02:32:15 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"b2-5a738f3e757d5"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
dnMjiL0GEN1eEl_aqi_TPWAIYuAGsiyxZJyHwqiatmBo-2E2-kBU5w==
expires
Thu, 18 Jun 2020 03:37:31 GMT
backtotop.png
www.globalpharmainsights.com/sites/all/modules/contrib/back_to_top/ 		1 KB
2 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/back_to_top/backtotop.png
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
b40e0334f469c4b2508b88c82d19923ecc01ac6be08b81550b1d6da930480e4f
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_EMysOwdNz4P_aEBvy91ee-H45803PIdurHGMjmMp-B4.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 03:37:31 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
739834
x-cache
Hit from cloudfront
status
200
content-length
1219
last-modified
Thu, 04 Jun 2020 02:32:16 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"4c3-5a738f3f1d412"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
2JbIC-vPGlZYK65N-4Q1HJhZj96FpYZgqQP2ryiq0n3wCCVbfTwlCw==
expires
Thu, 18 Jun 2020 03:37:31 GMT
pinit.js
assets.pinterest.com/js/ 		361 B
673 B 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.pinterest.com/js/pinit.js?_=1591981685468
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:fb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3faadebc89cdb21d11634a032816f152462d1cb8903eb21d0642501fcad065de

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
br
x-cdn
cloudflare
status
200
etag
W/"82bfd941d2c9b3b9e0650a27c9d11737"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
x-cdn
cache-control
max-age=300
cf-ray
5a252c001823073e-FRA
cf-request-id
034b19d4130000073eddac5200000001
server
cloudflare
get_poll
www.globalpharmainsights.com/ 		4 KB
1 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/get_poll
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
ba2d62044fae5a47814e5c13dd217c5b12e6c3af4289cfa9aaf962f0a8b156e6
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept
*/*
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
gzip
x-content-type-options
nosniff, nosniff
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-cache
Miss from cloudfront
status
200
x-ua-compatible
IE=edge,chrome=1
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options
SAMEORIGIN
vary
Accept-Encoding,Cookie
content-language
en
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
cache-control
no-cache, must-revalidate
x-drupal-cache
MISS
content-type
application/json
x-amz-cf-id
BRRkJHkacv8d9Ggo4DpgbhkA0xtNZeiFh3C3rauRWQ5phD18bntq4w==
expires
Sun, 19 Nov 1978 05:00:00 GMT
emit.php
www.globalpharmainsights.com/sites/all/modules/contrib/radioactivity/ 		0
423 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/radioactivity/emit.php
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff

Request headers

Accept
text/html, */*; q=0.01
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff, nosniff
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-cache
Miss from cloudfront
content-type
text/html; charset=UTF-8
status
200
expires
Sun, 19 Nov 1978 05:00:00 GMT
cache-control
no-cache, must-revalidate
content-length
0
x-amz-cf-id
lh_mabO0gubKT6IddGAYrt1KMJ3Yx2ruP6OEmA-wa2u5tA6GdQ2AwQ==
x-ua-compatible
IE=edge,chrome=1
191
www.globalpharmainsights.com/ajax/get-comments-count/ 		3 B
497 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/ajax/get-comments-count/191
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
98089e6d36f78e9766c9ea34d5acb3611f3a92cd81c5eb102095d924ffc7d08b
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept
*/*
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff, nosniff
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-cache
Miss from cloudfront
status
200
content-length
3
x-ua-compatible
IE=edge,chrome=1
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options
SAMEORIGIN
vary
Cookie
content-language
en
cache-control
no-cache, must-revalidate
x-drupal-cache
MISS
content-type
application/json
x-amz-cf-id
dPFwyYrkP5mmeiYv16wLrBXhAF10FreaTr01WLMbOYPFCmWxIK947A==
expires
Sun, 19 Nov 1978 05:00:00 GMT
ntl8rdl.js
use.typekit.net/ 		20 KB
8 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/ntl8rdl.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_yIkX_vb0Dxng7O5aNwkJ-nqApJpaPl61cDQzkBEByaA.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
a3766442ecfc3a0e93a8e7c864fee2700c9220422bcc14016181c986b2f6744d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains;

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains;
content-encoding
gzip
server
nginx
status
200
date
Fri, 12 Jun 2020 17:08:05 GMT
vary
Accept-Encoding
content-type
text/javascript;charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=600, stale-while-revalidate=604800
timing-allow-origin
*
content-length
7560
ads
securepubads.g.doubleclick.net/gampad/ 		466 B
537 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2286349668923420&correlator=902020814646270&output=ldjh&impl=fif&adsid=NT&eid=21065139%2C21066300&vrg=2020060103&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dadhesion%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a-22ef1fb776b600fe%3AT%3D1591981685%3AS%3DALNI_Mahe9zClyuUay6JCAm2XlCqOdvBuA&bc=31&abxe=1&lmt=1591981633&dt=1591981685821&dlt=1591981685191&idt=386&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3064&adks=1268408308&ucis=2&ifi=2&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1332624323.1591981686&ga_sid=1591981686&ga_hid=1154489031&fws=4&ohw=0&btvi=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
bc36d84aa848bd549b4bf69a189996aa9fbe4672f33b8a4ac72d7ab0644a8eee
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
244
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		472 B
542 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2286349668923420&correlator=902020814646270&output=ldjh&impl=fif&adsid=NT&eid=21065139%2C21066300&vrg=2020060103&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dfootnote%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous%26gdpr_banner%3Don&cookie=ID%3D3f1a7122d508715a-22ef1fb776b600fe%3AT%3D1591981685%3AS%3DALNI_Mahe9zClyuUay6JCAm2XlCqOdvBuA&bc=31&abxe=1&lmt=1591981633&dt=1591981685828&dlt=1591981685191&idt=386&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3065&adks=1358323811&ucis=3&ifi=3&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1332624323.1591981686&ga_sid=1591981686&ga_hid=1154489031&fws=4&ohw=0&btvi=2
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
b41ca11a296536bfb19a33fbb48b0fc33a6de21a36e71cf58c55bffbc740da49
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
250
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		466 B
532 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2286349668923420&correlator=902020814646270&output=ldjh&impl=fif&adsid=NT&eid=21065139%2C21066300&vrg=2020060103&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&ists=1&prev_scp=pos%3Doop_a%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous%26gdpr_banner%3Don&cookie=ID%3D3f1a7122d508715a-22ef1fb776b600fe%3AT%3D1591981685%3AS%3DALNI_Mahe9zClyuUay6JCAm2XlCqOdvBuA&bc=31&abxe=1&lmt=1591981633&dt=1591981685834&dlt=1591981685191&idt=386&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3066&adks=2051226082&ucis=4&ifi=4&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1332624323.1591981686&ga_sid=1591981686&ga_hid=1154489031&fws=4&ohw=0&btvi=3
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
29e46146a785191e3bf4debb41415eef354c7cb74e26a8ac6620238415ab5dd5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
244
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		13 KB
6 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2286349668923420&correlator=902020814646270&output=ldjh&impl=fif&adsid=NT&eid=21065139%2C21066300&vrg=2020060103&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250&prev_scp=pos%3D300_1_lft%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a-22ef1fb776b600fe%3AT%3D1591981685%3AS%3DALNI_Mahe9zClyuUay6JCAm2XlCqOdvBuA&bc=31&abxe=1&lmt=1591981633&dt=1591981685840&dlt=1591981685191&idt=386&frm=20&biw=1600&bih=1200&oid=3&adxs=219&adys=548&adks=2518684364&ucis=5&ifi=5&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x250&msz=0x250&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1332624323.1591981686&ga_sid=1591981686&ga_hid=1154489031&fws=4&ohw=0&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
698f2c8970c6cc43f167830b1e84c180b8cfacd630a51f9885656538ea977916
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6218
x-xss-protection
0
google-lineitem-id
5374575282
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138312304633
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		466 B
537 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2286349668923420&correlator=902020814646270&output=ldjh&impl=fif&adsid=NT&eid=21065139%2C21066300&vrg=2020060103&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&ists=1&prev_scp=pos%3Dwrap%26combo%3Dwrap%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a-22ef1fb776b600fe%3AT%3D1591981685%3AS%3DALNI_Mahe9zClyuUay6JCAm2XlCqOdvBuA&bc=31&abxe=1&lmt=1591981633&dt=1591981685847&dlt=1591981685191&idt=386&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3067&adks=2351607552&ucis=6&ifi=6&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1332624323.1591981686&ga_sid=1591981686&ga_hid=1154489031&fws=4&ohw=0&btvi=4
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
03cd0425f1dfbf94d46145545ba4c40685560ed8a2a19ce5683006cf8771457d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
243
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
penton-legal-comm-get-message
www.globalpharmainsights.com/ajax/ 		821 B
2 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/ajax/penton-legal-comm-get-message
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
8b9aec49be5d5cc900eec1c08755f843459d9995a7bae3f6375037da6c01c487
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept
*/*
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff, nosniff
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-cache
Miss from cloudfront
status
200
content-length
821
x-ua-compatible
IE=edge,chrome=1
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options
SAMEORIGIN
content-language
en
cache-control
no-cache, must-revalidate
content-type
text/html; charset=UTF-8
x-amz-cf-id
Sk7p68pgmt2-paSmVTCQigVYEt3ph1tqQnNsy3bky1eTsHKSLa4jTA==
expires
Sun, 19 Nov 1978 05:00:00 GMT
RC4488730ca17f46b783d3193a682c14ba-source.min.js
assets.adobedtm.com/100e8b570010/c89496dc0f21/0eadc58b531c/ 		994 B
838 B 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.adobedtm.com/100e8b570010/c89496dc0f21/0eadc58b531c/RC4488730ca17f46b783d3193a682c14ba-source.min.js
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:10c:382::1e80 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
4b2699af5cddfe0118e20f883a6f4993c3482a7160e35bd1b8f609f45b89589d

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
gzip
last-modified
Wed, 27 May 2020 12:11:51 GMT
server
AkamaiNetStorage
etag
"e296c46fda28eead0a6917455448db77:1590581511.027982"
vary
Accept-Encoding
content-type
application/x-javascript
status
200
cache-control
max-age=3600
accept-ranges
bytes
timing-allow-origin
*
content-length
593
expires
Fri, 12 Jun 2020 18:08:05 GMT
Cookie set dest5.html
informaglobalexhibitions.demdex.net/ Frame E684 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://informaglobalexhibitions.demdex.net/dest5.html?d_nsid=0
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.202.138.86 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-202-138-86.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Host
informaglobalexhibitions.demdex.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Cookie
demdex=86620746516060112861991697106368209225
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Response headers

Accept-Ranges
bytes
Cache-Control
max-age=21600
Content-Encoding
gzip
Content-Type
text/html
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Thu, 11 Jun 2020 14:09:16 GMT
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Pragma
no-cache
Set-Cookie
demdex=86620746516060112861991697106368209225;Path=/;Domain=.demdex.net;Expires=Wed, 09-Dec-2020 17:08:06 GMT;Max-Age=15552000;Secure;SameSite=None
Strict-Transport-Security
max-age=31536000; includeSubDomains
Vary
Accept-Encoding, User-Agent
X-TID
3XzffagRS64=
Content-Length
2785
Connection
keep-alive
ibs:dpid=411&dpuuid=XuO2dQAAA1LNClL0
dpm.demdex.net/
Redirect Chain
  • https://cm.everesttech.net/cm/dd?d_uuid=86620746516060112861991697106368209225
  • https://dpm.demdex.net/ibs:dpid=411&dpuuid=XuO2dQAAA1LNClL0
42 B
915 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://dpm.demdex.net/ibs:dpid=411&dpuuid=XuO2dQAAA1LNClL0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.202.93.59 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-202-93-59.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

DCS
dcs-prod-irl1-v072-023033253.edge-irl1.demdex.com 5.73.2.20200611122118 0ms (+1ms)
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
X-Content-Type-Options
nosniff
X-TID
hDrgPOFfRWI=
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Connection
keep-alive
Content-Type
image/gif
Content-Length
42
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Date
Fri, 12 Jun 2020 17:08:05 GMT
Server
AMO-cookiemap/1.1
P3P
CP="NOI NID DEVa PSAa PSDa OUR IND PUR COM NAV INT DEM"
Location
https://dpm.demdex.net/ibs:dpid=411&dpuuid=XuO2dQAAA1LNClL0
Cache-Control
no-cache
Connection
Keep-Alive
Keep-Alive
timeout=15,max=100
Content-Length
0
ckeditor.config.js
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor.config.js?&t=I3I8
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
fd21533b25982658fb3d45f7e662bfa071b0e58204e5b44587b955d46f4fe203
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:19 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 09:29:07 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5566
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
NTourePPHS_cIC-dqMrSBsuTWiT91i_67cgbzdmyAyrg0P9bn1puQw==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:19 GMT
l
use.typekit.net/af/f80f1d/00000000000000003b9aefb8/27/ 		32 KB
32 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/af/f80f1d/00000000000000003b9aefb8/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n7&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
4a85a057330bbc6272c3dd4c02a15317b08a92b4de7514d9fda7d8cbf82a3cac

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin
https://www.globalpharmainsights.com

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
server
nginx
etag
"5b1424bf708a1baf048831772af7891cda52e1e0"
status
200
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
timing-allow-origin
*
content-length
32980
l
use.typekit.net/af/29352b/00000000000000003b9aefb9/27/ 		33 KB
33 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/af/29352b/00000000000000003b9aefb9/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=i7&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
39492f3c9f87d34d4d53b7fa1fc66d5003f986552288bb55ac10e7507d4c69dd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin
https://www.globalpharmainsights.com

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
server
nginx
etag
"41bd63e072fcddb931e4f5c670a122a6ae75b1a8"
status
200
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
timing-allow-origin
*
content-length
34024
l
use.typekit.net/af/af96c8/00000000000000003b9aefc0/27/ 		31 KB
31 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/af/af96c8/00000000000000003b9aefc0/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n4&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
1e71dfd2075bdd8ab13805b0c9bc396c00c1a3d982d3e9ddde63ccfaf4f2eaaf

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin
https://www.globalpharmainsights.com

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
server
nginx
etag
"625d31c6ff36363142e14c9d9cf9f2747ce3803a"
status
200
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
timing-allow-origin
*
content-length
31984
l
use.typekit.net/af/20aa1e/00000000000000003b9aefc1/27/ 		33 KB
33 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/af/20aa1e/00000000000000003b9aefc1/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=i4&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
1ccdbe5fba95906eb04fed55b6d5fe05d4130f09d1ef62a2a195b07bfcd20d98

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin
https://www.globalpharmainsights.com

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
server
nginx
etag
"0a37e0f13f84c73347be23130bb6d2063bc1d8a8"
status
200
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
timing-allow-origin
*
content-length
33796
l
use.typekit.net/af/13a799/00000000000000003b9adee3/27/ 		18 KB
18 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/af/13a799/00000000000000003b9adee3/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n6&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
f7d3a5e83ab0db74bd9ce3800f7e2b57083a45d72048eb0a1ec59ea71d5d1c7d

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin
https://www.globalpharmainsights.com

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
server
nginx
etag
"92db5ca13edfead8cacb9b7663621adc030e2d76"
status
200
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
timing-allow-origin
*
content-length
18560
hotjar-1097635.js
static.hotjar.com/c/ 		3 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://static.hotjar.com/c/hotjar-1097635.js?sv=6
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.102.199 Central, Hong Kong, ASN54825 (PACKET, US),
Reverse DNS
pkt-ams-k2-shared-ingress10
Software
/
Resource Hash
2ced372d0326cb47b7a8875d8077311fe3e5ad10a87c8d272f2debfa30defcbf
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
br
x-content-type-options
nosniff
content-type
application/javascript
section-io-tag
hotjarjs
age
321
status
200
section-io-cache
Hit
vary
Accept-Encoding
content-length
1533
cache-control
max-age=60
etag
W/2e276bb21ed5ba0e34aeb92993260e12
access-control-max-age
600
section-io-origin-status
304
access-control-allow-origin
*
x-cache-hit
1
section-io-origin-time-seconds
0.088
accept-ranges
bytes
section-io-id
4e5ee8235f8980aaffa57e35e0fdcdbd
section-origin-responded
true
dpm_8effee409c625e1a2d8f5033631840e6ce1dcb64.min.js
s.dpmsrv.com/ 		743 KB
85 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s.dpmsrv.com/dpm_8effee409c625e1a2d8f5033631840e6ce1dcb64.min.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.107 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-107.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
74445353848aede9be7ebc099b2865512031747c9d487c53a5e0d8bbb6b3da13

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Thu, 11 Jun 2020 21:00:34 GMT
Content-Encoding
gzip
Last-Modified
Thu, 11 Jun 2020 21:00:22 GMT
Server
AmazonS3
Age
72452
ETag
"d89e045af5d76c46f5a0fead6a4d9875"
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
Connection
keep-alive
X-Amz-Cf-Pop
FRA50-C1
Accept-Ranges
bytes
Content-Length
86057
X-Amz-Cf-Id
nTDRhohYEuhj3-dd72wzE-pn6C7vN7sMiFIWNbr1Y8mc8pLpvejgtQ==
fbevents.js
connect.facebook.net/en_US/ 		131 KB
31 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
4cb61e44bf63a9e090e666898cd04d382e4c33b55b62cc5e9ff7dab055fbf787
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-27=":443"; ma=3600
content-length
31766
x-xss-protection
0
pragma
public
x-fb-debug
ISNt8mPSXO1ABUhYV+jEgP51fIysqHopjZ596XNBNnRjPB5tSsv45Wnbp9KGm7mNFMyL1QKRHEPqkAYVqv68lQ==
x-fb-trip-id
664085054
x-frame-options
DENY
date
Fri, 12 Jun 2020 17:08:05 GMT, Fri, 12 Jun 2020 17:08:05 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 721B 		0
0 		Fetch
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssj5s6bFAJMpTdOmVJTDveAeOyRkLn_EmuYE9PEaojSFIOiTPvqnkPgN47D51TlQn375h1g3x2xK-ljVcogtAgZuUo229uXEHHqK8IWOCrGUwmt949KlgtUWB3cGcVkjYzsUq3truhOAo4lLnPsXq67EWSDXYv64luZivaFfS9b5pH319LMtfUwcLfP1JT-pBI--nF3E95YlRc6_MaubcUPrvAbkWow54b3vH6A6pQpCZ7cHNMK1_tKfvHlLZVlR2e9DktKkoEesGvfT8ALJ4WotEI1sYFhRzlnQZ5_8jZLdLpy7cZJld7J2joNAM0bih2YpvVRVakMZrwG90Sd-Set_emHzGg&sig=Cg0ArKJSzPGY3441re4hEAE&adurl=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 12 Jun 2020 17:08:05 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/ Frame 721B 		3 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7d2d1f9c78d8c0755bb8830fd20121d6d05c949c89b20536a89b6643f748c600
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Wed, 10 Jun 2020 00:53:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
231265
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1479
x-xss-protection
0
server
cafe
etag
9751230926324105381
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 24 Jun 2020 00:53:40 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 721B 		73 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
84058f4935f4a903f78426d22151ce5ca07e601bcf127fdc75f316b725be4c40
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1591788966119694"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
28177
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:05 GMT
l
www.google.com/ads/measurement/ Frame 721B 		0
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQB3aup_UG_Qiv6bvED2PF-qgTrfOPg23KXcVMa34GWqdYiJd9vHp0ftdaWv9JBjeKC_pJe
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers
moatad.js
z.moatads.com/pentonmedia53440730609/ Frame 721B 		290 KB
98 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://z.moatads.com/pentonmedia53440730609/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
7c86268aee3ee868908336bbb2a43d11dd200942de23762f1851e54c25233441

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
gzip
last-modified
Tue, 09 Jun 2020 16:53:21 GMT
server
AmazonS3
x-amz-request-id
C0C4DCF45926DF98
etag
"635e31427ca583c8b5d9961b3e554e44"
vary
Accept-Encoding
content-type
application/x-javascript
status
200
cache-control
max-age=62255
accept-ranges
bytes
content-length
100310
x-amz-id-2
NqI9NXdScjp197aIuegCvGSlq0kJgeA7k2ifOBN4VZJnV1HfPzlJeqBCKNUtOZ+vokwIEPWfQ78=
8783790369963399186
tpc.googlesyndication.com/simgad/ Frame 721B 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://tpc.googlesyndication.com/simgad/8783790369963399186
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
348ca2d79ab4ee80d72d725484651deb121af2c6ea349e6c18eef7ca833fae74
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 09:13:15 GMT
x-content-type-options
nosniff
age
28490
x-dns-prefetch-control
off
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
16265
x-xss-protection
0
last-modified
Tue, 19 May 2020 07:50:29 GMT
server
sffe
content-type
image/gif
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 12 Jun 2021 09:13:15 GMT
osd.js
www.googletagservices.com/activeview/js/current/ 		73 KB
27 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
2d233c1838084b7e804e0e7a887190eeeb356132b1f625c7fa96ed3efd61e8b2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1591788966119694"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
27882
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:06 GMT
pinit_main.js
assets.pinterest.com/js/ 		69 KB
21 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.pinterest.com/js/pinit_main.js?0.3779795792417231
Requested by
Host: assets.pinterest.com
URL: https://assets.pinterest.com/js/pinit.js?_=1591981685468
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:fb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
fb3c1eca6871a3f5a4504450ce3723ebca58e2d62dc113011e31eb4be36c94a6

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
br
x-cdn
cloudflare
status
200
etag
W/"e8887b4f8f70f289103ee0c74e6b81d6"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
x-cdn
cache-control
max-age=300
cf-ray
5a252c015b3e073e-FRA
cf-request-id
034b19d4d70000073eddad5200000001
server
cloudflare
ads
securepubads.g.doubleclick.net/gampad/ 		356 B
234 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2286349668923420&correlator=902020814646270&output=ldjh&impl=fif&adsid=NT&eid=21065139%2C21066300&vrg=2020060103&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=970x90%7C970x250%7C728x90&prev_scp=pos%3D728_1_a%26combo%3Dwrap%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981633&dt=1591981685979&dlt=1591981685191&idt=386&frm=20&biw=1600&bih=1200&oid=3&adxs=800&adys=36&adks=333558971&ucis=7&ifi=7&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=52&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x90&msz=0x90&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8HIRRMiSxw_plRfe28eorm4B1hCXJ4bEdyZluoaC5rRinRRwI09FuK-qGLymSSHBRdDpIRmTzcDNZ3XPaUDB1LBsY4VVipLWPgog%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1332624323.1591981686&ga_sid=1591981686&ga_hid=1154489031&fws=4&ohw=0&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
45c73b48ac09963dfa1fbf1e64fdd29ec341f09a75d0ae638dd06464c1e76723
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
159
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		356 B
236 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2286349668923420&correlator=902020814646270&output=ldjh&impl=fif&adsid=NT&eid=21065139%2C21066300&vrg=2020060103&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=320x50&fluid=height&prev_scp=pos%3Dnativekey_1_lft%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981633&dt=1591981685985&dlt=1591981685191&idt=386&frm=20&biw=1600&bih=1200&oid=3&adxs=209&adys=490&adks=2802005418&ucis=8&ifi=8&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=52&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x0&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8HIRRMiSxw_plRfe28eorm4B1hCXJ4bEdyZluoaC5rRinRRwI09FuK-qGLymSSHBRdDpIRmTzcDNZ3XPaUDB1LBsY4VVipLWPgog%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1332624323.1591981686&ga_sid=1591981686&ga_hid=1154489031&fws=4&ohw=0&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
a8ae647f1bb195ba46c327af051bfa8c558fd493b553260cb85d70fa07d55a93
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
162
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		356 B
233 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2286349668923420&correlator=902020814646270&output=ldjh&impl=fif&adsid=NT&eid=21065139%2C21066300&vrg=2020060103&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=320x50&fluid=height&prev_scp=pos%3Dnativekey_2_lft%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981633&dt=1591981685991&dlt=1591981685191&idt=386&frm=20&biw=1600&bih=1200&oid=3&adxs=209&adys=936&adks=3456737692&ucis=9&ifi=9&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=52&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x0&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8HIRRMiSxw_plRfe28eorm4B1hCXJ4bEdyZluoaC5rRinRRwI09FuK-qGLymSSHBRdDpIRmTzcDNZ3XPaUDB1LBsY4VVipLWPgog%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1332624323.1591981686&ga_sid=1591981686&ga_hid=1154489031&fws=4&ohw=0&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
63920855c5c5dc5fa1308031057d5067404bf5c1db19b596bf3cc038d73b3c6c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
162
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		13 KB
6 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2286349668923420&correlator=902020814646270&output=ldjh&impl=fif&adsid=NT&eid=21065139%2C21066300&vrg=2020060103&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250%7C300x600&prev_scp=pos%3D300_1_rht%26article_number%3D1%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981633&dt=1591981685999&dlt=1591981685191&idt=386&frm=20&biw=1600&bih=1200&oid=3&adxs=1355&adys=1180&adks=556191258&ucis=a&ifi=10&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=52&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x250&msz=0x250&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8HIRRMiSxw_plRfe28eorm4B1hCXJ4bEdyZluoaC5rRinRRwI09FuK-qGLymSSHBRdDpIRmTzcDNZ3XPaUDB1LBsY4VVipLWPgog%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1332624323.1591981686&ga_sid=1591981686&ga_hid=1154489031&fws=4&ohw=0&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
518b0b1016fba014ad3f53fa419a4a024275e5601c6d428fae585351a6d166ff
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6136
x-xss-protection
0
google-lineitem-id
5374575282
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138312272443
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		353 B
233 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2286349668923420&correlator=902020814646270&output=ldjh&impl=fif&adsid=NT&eid=21065139%2C21066300&vrg=2020060103&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dinarticlevideo_1_a%26article_number%3D1%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981633&dt=1591981686005&dlt=1591981685191&idt=386&frm=20&biw=1600&bih=1200&oid=3&adxs=-12245933&adys=-12245933&adks=2532612962&ucis=b&ifi=11&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=52&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x0&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H8HIRRMiSxw_plRfe28eorm4B1hCXJ4bEdyZluoaC5rRinRRwI09FuK-qGLymSSHBRdDpIRmTzcDNZ3XPaUDB1LBsY4VVipLWPgog%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1332624323.1591981686&ga_sid=1591981686&ga_hid=1154489031&fws=132&ohw=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
23d478fef140a56806986c6a092aa52a845fa2965780c37d0f59adc4477df0de
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
158
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
conversion_async.js
www.googleadservices.com/pagead/ 		29 KB
11 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googleadservices.com/pagead/conversion_async.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=AW-998237655&l=dataLayer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s28-in-f2.1e100.net
Software
cafe /
Resource Hash
760eb9892eb9014f738852a504554e1a90d5e06e2e3adb4e848323eb745d5c78
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
11025
x-xss-protection
0
server
cafe
etag
15479961422638236731
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Fri, 12 Jun 2020 17:08:06 GMT
s56478911649576
informaglobalexhibitions.d3.sc.omtrdc.net/b/ss/,informaglobalprod/1/JS-2.20.0-LATI/ 		43 B
448 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://informaglobalexhibitions.d3.sc.omtrdc.net/b/ss/,informaglobalprod/1/JS-2.20.0-LATI/s56478911649576
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/extensions/EP308220a2a4c4403f97fc1960100db40f/AppMeasurement.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
15.236.175.233 Paris, France, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-15-236-175-233.eu-west-3.compute.amazonaws.com
Software
jag /
Resource Hash
55c9d2f019f9d7ddfd69b2ad0351c5617338a222362aebb02b3b98a4dbc18486
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
x-content-type-options
nosniff
x-c
master-1308.I3d0a82.M0-421
p3p
CP="This is not a P3P policy"
status
200
content-length
43
x-xss-protection
1; mode=block
pragma
no-cache
last-modified
Sat, 13 Jun 2020 17:08:06 GMT
server
jag
xserver
anedge-6f7565dc8b-r9jwn
etag
3418754638685765632-4614228701585288092
vary
*
content-type
image/gif;charset=utf-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, no-store, max-age=0, no-transform, private
access-control-allow-credentials
true
expires
Thu, 11 Jun 2020 17:08:06 GMT
p.gif
p.typekit.net/ 		35 B
201 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://p.typekit.net/p.gif?s=1&k=ntl8rdl&ht=tk&h=www.globalpharmainsights.com&f=139.140.175.176.17391&a=4139614&js=1.19.2&app=typekit&e=js&_=1591981686072
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:10c:28a::19fd , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
nginx /
Resource Hash
9b9265c69a5cc295d1ab0d04e0273b3677db1a6216ce2ccf4efc8c277ed84b39

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
last-modified
Fri, 15 Feb 2019 23:43:47 GMT
server
nginx
etag
"5c674eb3-23"
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
max-age=604800
accept-ranges
bytes
content-length
35
expires
Mon, 26 Aug 2019 13:32:57 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 721B 		0
54 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstFasNbn4snNBhGMpBEDkfNq-CkzZ84ykm6KrNgFLALCYUNhPTCcEIYp-LJ8g60PbFNDZqdeEbuFirxWvGtcau3B8K7qpdetkf5EW35EngsTYK31fRJdHnjxU86GSJVJK-ZtRuAP2Y4XTth46DkMKKI5w1dZnskB-WW5C5rslIxhkika4mr-gIw_2ly9vldLCNEpifFcNnFz963X2fyNjv1aGOYFE2WcYVbnM6QtJSt-5GOzkUntClLtY-3hmIUa-AqtlSPJ2BgdwA-i1wd0ERzQslk8UDouFSXmpH9KU98VBMR5x_dEf9ycueSxWMhmDBcQefFvfIyc6tbntwIvTnH62wPm-JxrA&sig=Cg0ArKJSzFcmXVqGU4BVEAE&adurl=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 12 Jun 2020 17:08:06 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
view
securepubads.g.doubleclick.net/pcs/ Frame D0C4 		0
0 		Fetch
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstlrfYpBAiLtqx6wnHkZ-ekwTKOdHSo8ahZY91DeR2_T-V2YoJUpSB7PHYbwn-WeF4vSUIW-Jd5U_2QmZJ4ZkS-2zULBWADfC5gBBfeqqp3Bt1Ecs0EWWQb6Qr3lc39JXnWYV_jn-5PtbPGhnNNxMyxcTSG9g6ypI4pFokjtEaYOFEN_MxYtpjZR7du2kg2-qKtf4oWYoiklfyfJ0Il7u6InCR8jU7UGFo5_Q-IEXrvY685Lelt6DAAYpX0-QnaTFa2Tglv7YkWs_dTCsi7xBE3pW6-VirICCwZDCeiSHxWNlYQppRtGckADAzU08EV2K4FQLjMWBWOCbxSer_nY1vVLug1REs&sig=Cg0ArKJSzGgWChOG3IuNEAE&adurl=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 12 Jun 2020 17:08:06 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
8783790369963399186
tpc.googlesyndication.com/simgad/ Frame D0C4 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://tpc.googlesyndication.com/simgad/8783790369963399186
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
348ca2d79ab4ee80d72d725484651deb121af2c6ea349e6c18eef7ca833fae74
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 09:13:15 GMT
x-content-type-options
nosniff
age
28491
x-dns-prefetch-control
off
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
16265
x-xss-protection
0
last-modified
Tue, 19 May 2020 07:50:29 GMT
server
sffe
content-type
image/gif
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 12 Jun 2021 09:13:15 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/ Frame D0C4 		3 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7d2d1f9c78d8c0755bb8830fd20121d6d05c949c89b20536a89b6643f748c600
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Wed, 10 Jun 2020 00:53:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
231266
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1479
x-xss-protection
0
server
cafe
etag
9751230926324105381
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 24 Jun 2020 00:53:40 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame D0C4 		73 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
84058f4935f4a903f78426d22151ce5ca07e601bcf127fdc75f316b725be4c40
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1591788966119694"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
28177
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:06 GMT
l
www.google.com/ads/measurement/ Frame D0C4 		0
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaT2gUTMJsGAnBOdSxGjOFSgWHTE0npOxG7o6FH6jNhYwVa1LYA0SCgzOl7IpO_JOPA1Kmpq
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers
moatad.js
z.moatads.com/pentonmedia53440730609/ Frame D0C4 		290 KB
98 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://z.moatads.com/pentonmedia53440730609/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
7c86268aee3ee868908336bbb2a43d11dd200942de23762f1851e54c25233441

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
gzip
last-modified
Tue, 09 Jun 2020 16:53:21 GMT
server
AmazonS3
x-amz-request-id
C0C4DCF45926DF98
etag
"635e31427ca583c8b5d9961b3e554e44"
vary
Accept-Encoding
content-type
application/x-javascript
status
200
cache-control
max-age=62255
accept-ranges
bytes
content-length
100310
x-amz-id-2
NqI9NXdScjp197aIuegCvGSlq0kJgeA7k2ifOBN4VZJnV1HfPzlJeqBCKNUtOZ+vokwIEPWfQ78=
editor.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/skins/moono-lisa/ 		46 KB
6 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/skins/moono-lisa/editor.css?t=I3I8
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
f6cd5dec07fd04b7db1a02aa063ff9550f6f595f7902a23bf466a6044bde796e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:06:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 14:50:39 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
116
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
Y5RbOO9vY59YonnSV5Fx8BF_BsBinKCrh7HXwQIeG47WWg0UlnU1EQ==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 20:06:10 GMT
en.js
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/lang/ 		19 KB
7 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/lang/en.js?t=I3I8
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
69a9941f0ab4a5c4851d9286d9aaf981f7b6c8f1b716c057e77102a2759dc9e7
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:06:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 14:48:44 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
116
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
Vv5M2f_-H3x8tJnXI0tC97cZC1y1Zhr9O1xEv4Twq-RkbeD0jsCPUw==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 20:06:10 GMT
1026610140874609
connect.facebook.net/signals/config/ 		147 KB
37 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/signals/config/1026610140874609?v=2.9.18&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
2d0f94a6c3feaec5930c8a7bc2b5e5b5350f416a89a1496d7032ff2039278064
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-27=":443"; ma=3600
content-length
37522
x-xss-protection
0
pragma
public
x-fb-debug
fVnTcrk5lTYi8r0PKvCH7tqwRR7vL+dkAE7GhgqofgL+M3kXNeVkxu9xIXhtzpaiXWTup5c2hLJlG6Eh3TuW7w==
x-fb-trip-id
664085054
x-frame-options
DENY
date
Fri, 12 Jun 2020 17:08:06 GMT, Fri, 12 Jun 2020 17:08:06 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
modules.5cd4945c79de888b7e62.js
script.hotjar.com/ 		369 KB
70 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://script.hotjar.com/modules.5cd4945c79de888b7e62.js
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-1097635.js?sv=6
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.102.199 Central, Hong Kong, ASN54825 (PACKET, US),
Reverse DNS
pkt-ams-k2-shared-ingress10
Software
/
Resource Hash
998dddc13ee0857954656d34d9546ff47b99f6daea732de0dd99d17f5d5db79f

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:05 GMT
content-encoding
br
age
40762
status
200
section-io-cache
Hit
content-length
71510
last-modified
Thu, 11 Jun 2020 15:36:15 GMT
etag
"5fe7ffce3019c5c5010d946c7e87cef9"
vary
Accept-Encoding
section-io-origin-status
200
access-control-allow-origin
*
cache-control
max-age=31536000
section-io-origin-time-seconds
0.033
section-io-id
7d64e60e3c5c2cbb8a63042343d2cea4
accept-ranges
bytes
content-type
application/javascript
section-origin-responded
true
truncated
/ Frame 721B 		210 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9cf66ec0ad6e7befe5d5f7cc7a7d6329af65acdeced3e56fa3d49ba6a42213db

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
truncated
/ 		1 KB
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
e6119ad52adef631ee4fb2539d02ed906dee8f8f3e64b4d8a091ea0fb864b9f4

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
tag.aspx
ml314.com/ Frame 721B 		26 KB
12 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ml314.com/tag.aspx?1252020
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/pentonmedia53440730609/moatad.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.251.220.194 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-251-220-194.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
c293a28e23c66b27bd04bc1742f3aab0ebf6c382961c1e83140f035a08ea5e5d

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 12 Jun 2020 17:08:06 GMT
Content-Encoding
gzip
Last-Modified
Fri, 12 Jun 2020 06:00:32 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, max-age=46346
Connection
keep-alive
Content-Length
11932
Expires
Sat, 13 Jun 2020 06:00:32 GMT
n.js
geo.moatads.com/ 		99 B
272 B 		Script
General
Check archive.org
Download Go to
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&i=PENTONMEDIA1&hp=1&wf=1&vb=11&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1591981686180&de=551100499099&m=0&ar=c34ad4f880-clean&iw=821c7c5&q=2&cb=0&ym=0&cu=1591981686180&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&zMoatPS=300_1_lft&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&gw=pentonmedia53440730609&fd=1&ac=1&it=500&ti=0&ih=1&pe=1%3A1135%3A1135%3A0%3A976&fs=181543&na=305298099&cs=0&callback=MoatDataJsonpRequest_70550443
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/pentonmedia53440730609/moatad.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.178.2.28 London, United Kingdom, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-35-178-2-28.eu-west-2.compute.amazonaws.com
Software
TornadoServer/4.5.3 /
Resource Hash
614f47a3c0ab907aa9447c32eb830849c150b48a768236bd616b9c20574820db

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
server
TornadoServer/4.5.3
etag
"4f1817103114ccec3bf7657306c042218a5e6887"
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=900
timing-allow-origin
*
content-length
99
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=17&i=PENTONMEDIA1&hp=1&wf=1&vb=11&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1591981686180&de=551100499099&m=0&ar=c34ad4f880-clean&iw=821c7c5&q=3&cb=0&ym=0&cu=1591981686180&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&zMoatPS=300_1_lft&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&gw=pentonmedia53440730609&fd=1&ac=1&it=500&ti=0&ih=1&pe=1%3A1135%3A1135%3A0%3A976&fs=181543&na=1373615912&cs=0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:06 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:06 GMT
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D55%26pixelIndex%3D0%26r%3D817261%26tzOffset%3D-120%26url%3Dhttps%253A%252F%252Fwww.globalpharmain...
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D55%2526pixelIndex%253D0%2526r%253D817261%2526tzOffset%253...
  • https://a.dpmsrv.com/dpmpxl/index.php?id=453945625446112413&q=xImp&v=1.x&cl=55&pixelIndex=0&r=817261&tzOffset=-120&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilea...
0
0
/
googleads.g.doubleclick.net/pagead/viewthroughconversion/998237655/ 		3 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://googleads.g.doubleclick.net/pagead/viewthroughconversion/998237655/?random=1591981686342&cv=9&fst=1591981686342&num=1&bg=ffffff&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa640&sendb=1&ig=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&tiba=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20remdesivir%20%7C%20Global%20Pharma%20Insights&hn=www.googleadservices.com&async=1&rfmt=3&fmt=4
Requested by
Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion_async.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f0bc82a5c321e66c3a5bb23ea7056f58f90c89a974c853880483854c01b90a59
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
cache-control
no-cache, must-revalidate
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
1385
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
box-469cf41adb11dc78be68c1ae7f9457a4.html
vars.hotjar.com/ Frame 51E0 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://vars.hotjar.com/box-469cf41adb11dc78be68c1ae7f9457a4.html
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-1097635.js?sv=6
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.102.199 Central, Hong Kong, ASN54825 (PACKET, US),
Reverse DNS
pkt-ams-k2-shared-ingress10
Software
/
Resource Hash

Request headers

:method
GET
:authority
vars.hotjar.com
:scheme
https
:path
/box-469cf41adb11dc78be68c1ae7f9457a4.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Response headers

status
200
date
Fri, 12 Jun 2020 17:08:06 GMT
content-type
text/html
content-length
851
last-modified
Wed, 03 Jun 2020 11:24:24 GMT
etag
"d594f1d4c3e5dbd6b556c60d34e0daea"
cache-control
max-age=31536000
content-encoding
br
section-io-origin-status
200
section-io-origin-time-seconds
0.057
section-origin-responded
true
age
739688
vary
Accept-Encoding
section-io-cache
Hit
accept-ranges
bytes
section-io-id
2a4e4dfc94c2cd131c7b94b5449cdcdc
pinit.js
assets.pinterest.com/js/ 		361 B
408 B 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.pinterest.com/js/pinit.js?_=1591981685469
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:fb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3faadebc89cdb21d11634a032816f152462d1cb8903eb21d0642501fcad065de

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
br
x-cdn
cloudflare
status
200
etag
W/"82bfd941d2c9b3b9e0650a27c9d11737"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
x-cdn
cache-control
max-age=300
cf-ray
5a252c03da18073e-FRA
cf-request-id
034b19d66a0000073eddafc200000001
server
cloudflare
get_poll
www.globalpharmainsights.com/ 		0
0
/
www.facebook.com/tr/ 		44 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.facebook.com/tr/?id=1026610140874609&ev=PageView&dl=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&rl=&if=false&ts=1591981686392&sw=1600&sh=1200&v=2.9.18&r=stable&ec=0&o=28&fbp=fb.1.1591981686391.812833065&it=1591981686141&coo=false&rqm=GET
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT, Fri, 12 Jun 2020 17:08:06 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-27=":443"; ma=3600
content-length
44
expires
Fri, 12 Jun 2020 17:08:06 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame D0C4 		0
54 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsv6_V6clr6c4zxTz7h6DsNLeG-9Q2ctrhtWfIROZvdt698DEtvb3huC83dkvqZFYSoojsjRcuu7wmU9X-QDmtQi5KGawVEQlXpDzHsDCzEz2yr5xnN9zkLPHYndtGTyqjl1ib_qEFOYphECSEXChhHqHKqxWd7Sak-ch-9zqg5aMo8nLG6SggwoME9SmXg6VL9OXui01--lan2QU5W6avLlfzp7DitQBPd51HHQQp6r-fUI7HPt43vcoKIsqLohjDIDhkgfzch5N3xHh0bjYwetgcrzxbTO5P6vdkvJnyw8R9cClVCAx2x_VNhcFHFhvWOSIL2kFwZ0Mccw0xq2RGQlLRrfahqxrQ&sig=Cg0ArKJSzCF8FO5D9Eg5EAE&adurl=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s07-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 12 Jun 2020 17:08:06 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
truncated
/ Frame D0C4 		216 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
7cbf545ad9a6d65dc6c72560f71245179f8c3230eae407a63c46780292e9f928

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=0&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=https%3A%2F%2Ftpc.googlesyndication.com%2Fsimgad%2F8783790369963399186&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&bq=0&g=0&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591981686180&de=551100499099&cu=1591981686180&m=82&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=2919&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A-%3A-&pe=1%3A1135%3A1135%3A0%3A976&as=0&ag=30&an=0&gf=30&gg=0&ix=30&ic=30&ez=1&aj=1&pg=100&pf=0&ib=0&cc=0&bw=30&bx=0&dj=1&aa=0&ad=0&cn=0&gk=0&gl=0&ik=0&im=0&in=0&pd=0&em=0&en=0&st=1&su=1&of=1&oz=1&oe=0%3A0%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=60&cd=0&ah=60&am=0&rf=0&re=0&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=637941285&cs=0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:06 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:06 GMT
ckeditor.styles.js
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor.styles.js?t=I3I8
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
b937394951285201e18e193006731ebafcc0336f1249c737f74a4df37c8f5f7b
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 14:50:39 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5565
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
PhQeQOe9CG2cFxeDlpsmn65nDNqjlC4w8QlLKaK6TEnDl4VMk4qLSA==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:21 GMT
/
www.google.com/pagead/1p-user-list/998237655/ 		42 B
107 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.com/pagead/1p-user-list/998237655/?random=1591981686342&cv=9&fst=1591981200000&num=1&bg=ffffff&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa640&sendb=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&tiba=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20remdesivir%20%7C%20Global%20Pharma%20Insights&async=1&fmt=3&is_vtc=1&random=2631485767&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:06 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.de/pagead/1p-user-list/998237655/ 		42 B
107 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.de/pagead/1p-user-list/998237655/?random=1591981686342&cv=9&fst=1591981200000&num=1&bg=ffffff&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa640&sendb=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&tiba=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20remdesivir%20%7C%20Global%20Pharma%20Insights&async=1&fmt=3&is_vtc=1&random=2631485767&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:824::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:06 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=17&i=PENTONMEDIA1&hp=1&wf=1&vb=11&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1591981686410&de=543391131609&m=0&ar=c34ad4f880-clean&iw=821c7c5&q=7&cb=0&ym=0&cu=1591981686410&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4874126281%3A2696286467%3A5374575282%3A138312272443&zMoatPS=300_1_rht&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&bo=21946295198&bp=21988232143&bd=300_1_rht&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&gw=pentonmedia53440730609&fd=1&ac=1&it=500&ti=0&ih=1&pe=1%3A1135%3A1135%3A0%3A976&fs=181543&na=1812886060&cs=0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:06 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:06 GMT
visit-data
in.hotjar.com/api/v2/client/sites/1097635/ 		178 B
320 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://in.hotjar.com/api/v2/client/sites/1097635/visit-data?sv=6
Requested by
Host: script.hotjar.com
URL: https://script.hotjar.com/modules.5cd4945c79de888b7e62.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.171.1.253 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-171-1-253.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
6154d5f7f6961e042d013bab33fd02b691970d873f44f3c32d8fcc6e79ef5bcd

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain; charset=UTF-8

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
br
status
200
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
access-control-max-age
86400
access-control-allow-credentials
true
1097635
vc.hotjar.io/sessions/ 		0
116 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://vc.hotjar.io/sessions/1097635?s=0.25
Requested by
Host: script.hotjar.com
URL: https://script.hotjar.com/modules.5cd4945c79de888b7e62.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.101.5 Central, Hong Kong, ASN54825 (PACKET, US),
Reverse DNS
pkt-ams-k2-shared-ingress16
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

status
204
date
Fri, 12 Jun 2020 17:08:06 GMT
access-control-allow-origin
*
section-io-id
c0453a9c35dbf6fbe5e7ceec6f532a23
section-origin-responded
true
plugin.js
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/plugins/drupalbreaks/ 		6 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/plugins/drupalbreaks/plugin.js?t=I3I8
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
293153343c929ef767fad32776072237665ed6286d473bfba46fcf3957e37754
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:22 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 14:48:44 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5564
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
ZN9Hfjz7oJAbUQUvJPrVhgeq6TvdFkNTZq4RAZlj2CcxCyW1CFG4tg==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:22 GMT
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=0&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=https%3A%2F%2Ftpc.googlesyndication.com%2Fsimgad%2F8783790369963399186&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&bq=0&g=0&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591981686410&de=543391131609&cu=1591981686410&m=16&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=2919&le=1&gm=1&io=1&vv=1&vw=1%3A3%3A0&vp=72&vx=72%3A-%3A-&pe=1%3A1135%3A1135%3A0%3A976&as=0&ag=2&an=0&gf=0&gg=0&ix=0&ic=0&ez=1&aj=1&pg=72&pf=0&ib=1&cc=0&bw=2&bx=0&dj=1&aa=0&ad=0&cn=0&gk=0&gl=0&ik=0&im=0&in=0&pd=0&em=0&en=0&st=1&su=1&of=1&oz=1&oe=0%3A0%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=4&cd=0&ah=4&am=0&rf=0&re=0&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312272443&bo=21946295198&bp=21988232143&bd=300_1_rht&zMoatPS=300_1_rht&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&oq=0&ot=cc&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=520194237&cs=0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:06 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:06 GMT
scayt.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/skins/moono-lisa/ 		356 B
777 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/skins/moono-lisa/scayt.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
94465f8a7abf4da8295e0fa93a60eba1287830dfc41e3698fb3d20091b95d58c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
5563
x-cache
Hit from cloudfront
status
200
content-length
356
last-modified
Fri, 12 Jun 2020 14:48:44 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"164-5a7e42c7be8e5"
content-type
text/css
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
6cBWgb12NqNB1lloxvwhI3md7ZAD2fw2lhtdASUuxolWPA_YEJiCwA==
expires
Fri, 12 Jun 2020 18:35:23 GMT
dialog.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/dialogs/ 		396 B
818 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/dialogs/dialog.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
75e0679953e586ffac55af12700c15b9a4b7d49765103c16fd8943c24162bf0c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
5563
x-cache
Hit from cloudfront
status
200
content-length
396
last-modified
Fri, 12 Jun 2020 14:50:39 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"18c-5a7e4335ab44f"
content-type
text/css
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
UaRGPW-ukBBWIcITfnb8l4zsk5l6LNUHcMDEOamyE-cW8EJyKP52TA==
expires
Fri, 12 Jun 2020 18:35:23 GMT
tableselection.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/ 		1 KB
851 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/tableselection.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
654307a47b37c66a953bb6a536cd2960a05b4e52140b2fd5e9da3a85b9a8f245
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 12:19:52 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5563
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
wskq3XaIM7VYwke43GRtvPiRbi9atRMMbv8OWzAKVg3E3zFn3rxp4w==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
wsc.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/wsc/skins/moono-lisa/ 		1 KB
740 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/wsc/skins/moono-lisa/wsc.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
a0fc7fe1ba275090a93038c52950ddb538963b336f0009f4c6efd1722717404f
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 01:48:43 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5563
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
w9E5GlJtZJhu0NZjTcYLIFhqx96Le9phM8oIFKssEg2Cc-XIvbwLXQ==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
copyformatting.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/ 		1 KB
1 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/copyformatting.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
7d39b20ee96b3b32389afdc846932865a236034fbabff52b230c7cb824a0f7f0
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 12:19:52 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5563
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
196WNdGsNPJ5MQty-ytvYor0ApECMiXRSV_SvleNz7VoZCG-_4qQnw==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
ckeditor.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/css/ Frame 49F5 		431 B
851 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/css/ckeditor.css?qbs4lh
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
f2470640af17a4eb9988eed14e1110ae897fc6314340d0df1bf050d2c8d38ea6
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
5563
x-cache
Hit from cloudfront
status
200
content-length
431
last-modified
Fri, 12 Jun 2020 01:48:43 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"1af-5a7d946f0c302"
content-type
text/css
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
pIQidhEat2-0j6aerdCJhuzd-yB0LMlo0ogQqiye74ufB1OJyaZGzQ==
expires
Fri, 12 Jun 2020 18:35:23 GMT
contents.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ Frame 49F5 		3 KB
2 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/contents.css?qbs4lh
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
09f958e32d737ce88d6be77af3e519297dd86db7847405c3c9f1a5a1da4a1609
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 11:06:57 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5563
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
Hd5c7O9afrjsXl-kFIusnwgoAFx2b1g_Eq0O3XSTBn0IFw_4IZOznA==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
copyformatting.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/ Frame 49F5 		1 KB
1 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/copyformatting.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
7d39b20ee96b3b32389afdc846932865a236034fbabff52b230c7cb824a0f7f0
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 12:19:52 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5563
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
Uymlta0-g-7fKpB3LpcypkFg95iXlU3Yptu2johYKf-8Q46Qx8Htzg==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
tableselection.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/ Frame 49F5 		1 KB
851 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/tableselection.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.70 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-70.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
654307a47b37c66a953bb6a536cd2960a05b4e52140b2fd5e9da3a85b9a8f245
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 13:40:29 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5563
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
bGA4NS0qfABlX_F5_Y2Mz9i0FGwO2WFOMycH8haUkY9Yfqgfr6cWVQ==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
pinit.js
assets.pinterest.com/js/ 		361 B
310 B 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.pinterest.com/js/pinit.js?_=1591981685470
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:fb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
br
x-cdn
cloudflare
status
200
etag
W/"82bfd941d2c9b3b9e0650a27c9d11737"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
x-cdn
cache-control
max-age=300
cf-ray
5a252c05bf1a073e-FRA
cf-request-id
034b19d7900000073eddb10200000001
server
cloudflare
get_poll
www.globalpharmainsights.com/ 		0
0
Primary Request gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir
www.globalpharmainsights.com/manufacturing-outsourcing/ 		113 KB
19 KB 		Document
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_yIkX_vb0Dxng7O5aNwkJ-nqApJpaPl61cDQzkBEByaA.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
836f3c883c16a11280d14c9bc18f6ea977aaa75ed1c1c49083811d9929c69c3d
Security Headers
Name Value
X-Content-Type-Options nosniff nosniff
X-Frame-Options SAMEORIGIN

Request headers

:method
GET
:authority
www.globalpharmainsights.com
:scheme
https
:path
/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
same-origin
sec-fetch-mode
navigate
sec-fetch-dest
document
referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
penton_gdpr_cookie=1; SSESSabb96de343dde80a1e2e8a1591776328=1V-ta355Fa76eVK6Gov1q2tK_cJ9IAd-EgRQtIJN6Cc; has_js=1; AMCVS_DD4C6A00570E3C0F7F000101%40AdobeOrg=1; __gads=ID=3f1a7122d508715a:T=1591981685:S=ALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA; s_campaign=email%3AEloqua%3A%3A%3A%3AHLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES%3Af3bea1f6-c791-47dc-8d2d-b71160403f3f%3AOthers%3AIntroducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights; utm_parameters=utm_source:Eloqua,utm_medium:email,utm_campaign:HLN00GPI-ES-AWARENESS-GENERAL1,utmMDMContactID:f3bea1f6-c791-47dc-8d2d-b71160403f3f,utm_content:undefined,utm_term:undefined,utm_refCode:undefined; s_lv=1591981686051; s_lv_s=First%20Visit; gpv_pn=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20and%20market%20remdesivir; s_tp=3006; s_ppv=Gilead%2520signs%2520agreements%2520with%2520generics%2520firms%2520to%2520manufacture%2520and%2520market%2520remdesivir%2C40%2C40%2C1200; s_cc=true; AMCV_DD4C6A00570E3C0F7F000101%40AdobeOrg=-432600572%7CMCIDTS%7C18426%7CMCMID%7C86883954222033562171947054144865683686%7CMCAAMLH-1592586485%7C6%7CMCAAMB-1592586485%7C6G1ynYcLPuiQxYZrsz_pkqfLG9yMXBpb2zX5dvJdYQJzPXImdj0y%7CMCOPTOUT-1591988885s%7CNONE%7CMCSYNCSOP%7C411-18433%7CvVersion%7C4.5.2; dpm_url_count=1; _fbp=fb.1.1591981686391.812833065; _hjid=aa9587b8-cfe6-4346-9ef0-511be20f896d; _hjIncludedInSample=1; _hjAbsoluteSessionInProgress=1; Drupal.legal[119][nid]=119; Drupal.legal[119][for_review]=0; Drupal.legal[119][confirm]=0; Drupal.legal[119][count]=1; aucp13n=d7wabu
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Response headers

status
200
content-type
text/html; charset=utf-8
date
Fri, 12 Jun 2020 17:08:07 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-content-type-options
nosniff nosniff
x-powered-by
PHP/7.2.31
x-drupal-cache
MISS
expires
Sun, 19 Nov 1978 05:00:00 GMT
cache-control
public, max-age=300
x-ua-compatible
IE=edge,chrome=1
content-language
en
x-frame-options
SAMEORIGIN
x-generator
Drupal 7 (http://drupal.org)
link
<https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir>; rel="canonical",<https://www.globalpharmainsights.com/node/191>; rel="shortlink"
etag
"1591981686-1-https://www.globalpharmainsights.com"
last-modified
Fri, 12 Jun 2020 17:08:06 GMT
content-encoding
gzip
vary
Cookie,Accept-Encoding
x-cache
Miss from cloudfront
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
d_30yqnW6Xd5aGU_AVDkmxf_goQ37-TDPFasQY0TqbdRKP6n9co0Sw==
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=21&q=0&yco=0&yt=0&xco=0&xt=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&bq=0&g=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591981686180&de=551100499099&cu=1591981686180&m=592&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1135%3A1135%3A0%3A976&as=0&ag=270&an=30&gf=270&gg=30&ix=270&ic=270&ez=1&aj=1&pg=100&pf=100&ib=0&cc=0&bw=270&bx=30&dj=1&aa=0&ad=120&cn=0&gk=120&gl=0&ik=120&cq=1&im=0&in=0&pd=0&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=300&cd=60&ah=300&am=60&rf=0&re=1&ft=120&fv=0&fw=120&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=1590480001&cs=0
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:06 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:06 GMT
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=21&q=0&yco=0&yt=0&xco=0&xt=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&bq=0&g=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591981686410&de=543391131609&cu=1591981686410&m=367&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&vv=1&vw=1%3A3%3A0&vp=72&vx=72%3A72%3A-&pe=1%3A1135%3A1135%3A0%3A976&as=0&ag=259&an=2&gf=0&gg=0&ix=0&ic=0&ez=1&aj=1&pg=72&pf=72&ib=1&cc=0&bw=259&bx=2&dj=1&aa=0&ad=129&cn=0&gk=0&gl=0&ik=0&cq=1&im=0&in=0&pd=0&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=261&cd=4&ah=261&am=4&rf=0&re=0&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312272443&bo=21946295198&bp=21988232143&bd=300_1_rht&zMoatPS=300_1_rht&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&oq=0&ot=cc&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=1269803267&cs=0
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:06 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:06 GMT
/
log.pinterest.com/ 		0
434 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://log.pinterest.com/?type=pidget&guid=wprx6jtWX_nn&tv=2020060301&event=init&sub=www&button_count=1&follow_count=0&pin_count=0&profile_count=0&board_count=0&section_count=0&lang=en&nvl=en-US&via=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.36.84 Amsterdam, Netherlands, ASN54113 (FASTLY, US),
Reverse DNS
Software
envoy /
Resource Hash

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:07 GMT
via
1.1 varnish
server
envoy
x-timer
S1591981687.225388,VS0,VE100
x-served-by
cache-ams21052-AMS
x-cache
MISS
status
200
x-envoy-upstream-service-time
4
x-pinterest-rid
9210278645753836
accept-ranges
bytes
content-length
0
x-cache-hits
0
activeview
pagead2.googlesyndication.com/pcs/ Frame 721B 		0
0
activeview
pagead2.googlesyndication.com/pcs/ Frame D0C4 		0
0
css_PpiQEI-azlEmknynFVbTW6pWwXhVPT_fbABYbBL6JWQ.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 		2 KB
1 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_PpiQEI-azlEmknynFVbTW6pWwXhVPT_fbABYbBL6JWQ.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /
Resource Hash
3e9890108f9ace5126927ca71556d35baa56c178553d3fdf6c00586c12fa2564
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 29 May 2020 22:06:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1191695
x-cache
Hit from cloudfront
status
200
content-length
922
last-modified
Thu, 07 May 2020 03:02:16 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag
"39a-5a5061bb444b8"
vary
Accept-Encoding
content-type
text/css
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
YTnZ_8daccKf6WWb0uks3y0QVKOWiUWl4XMqIoKHr1pfsOF-21J_Ng==
expires
Fri, 12 Jun 2020 22:06:32 GMT
css_b2lxsoMjuDz1VEsoXFy0Cgo8pcav1Ny1N-EHn8knPc0.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 		19 KB
4 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_b2lxsoMjuDz1VEsoXFy0Cgo8pcav1Ny1N-EHn8knPc0.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
6f6971b28323b83cf5544b285c5cb40a0a3ca5c6afd4dcb537e1079fc9273dcd
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 12:04:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
709403
x-cache
Hit from cloudfront
status
200
content-length
3400
last-modified
Thu, 04 Jun 2020 03:46:25 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"d48-5a739fd2ae2f0"
vary
Accept-Encoding
content-type
text/css
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
l23JNoWYpYnsjpAmiX8ii-mZZJeIqS1WN8B1lmqKVY9BkVOvBhhOkQ==
expires
Thu, 18 Jun 2020 12:04:44 GMT
css_EMysOwdNz4P_aEBvy91ee-H45803PIdurHGMjmMp-B4.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 		17 KB
4 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_EMysOwdNz4P_aEBvy91ee-H45803PIdurHGMjmMp-B4.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
10ccac3b074dcf83ff68406fcbdd5e7be1f8e7cd373c876eac718c8e6329f81e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 02 Jun 2020 00:37:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
923409
x-cache
Hit from cloudfront
status
200
content-length
3876
last-modified
Tue, 28 Apr 2020 23:04:16 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"f24-5a461d9cdee40"
vary
Accept-Encoding
content-type
text/css
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
PqXUCuagjJ0KU0YLLTjy35MAVa2zNDykpJ9Ewo3Rbx5em-LsVa0oNA==
expires
Tue, 16 Jun 2020 00:37:59 GMT
css_fIVgxWnE83pCcIB_bpOeDbuIS61SfKIUkuXnxkQZul4.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 		36 KB
6 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_fIVgxWnE83pCcIB_bpOeDbuIS61SfKIUkuXnxkQZul4.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
7c8560c569c4f37a4270807f6e939e0dbb884bad527ca21492e5e7c64419ba5e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 12:40:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
102476
x-cache
Hit from cloudfront
status
200
content-length
5883
last-modified
Thu, 04 Jun 2020 03:47:14 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"16fb-5a73a0013d5f8"
vary
Accept-Encoding
content-type
text/css
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
1EXsR1AqPXq4CXDXXB9R8GlOX25Ts6MVEjttHoueNUwJyHJJkfT_ow==
expires
Thu, 25 Jun 2020 12:40:11 GMT
css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 		771 KB
103 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
0fb3fd54954e792633886c230ead89609bc9799ba792ba1c38b9fa905595caae
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112093
x-cache
Hit from cloudfront
status
200
content-length
105279
last-modified
Wed, 10 Jun 2020 03:24:35 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"19b3f-5a7b262142168"
vary
Accept-Encoding
content-type
text/css
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
A9roybWXQrxqd__4u6PBIAQWCXCwRIKemVYjKdZGmmGS19k6xXFShw==
expires
Thu, 25 Jun 2020 09:59:54 GMT
gpt.js
www.googletagservices.com/tag/js/ 		43 KB
14 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
7848437d39e9a43e7c809b181413a624a1563db3e24439c03115a8fea68fcc57
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:07 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"540 / 354 of 1000 / last-modified: 1591967721"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
14524
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:07 GMT
header.png
www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/ 		12 KB
13 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/header.png
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
f3398fb55770fb83d26d8537073b425b2b9c64f8652a74a0a17a17d35c8cd834
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 03:37:26 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
739842
x-cache
Hit from cloudfront
status
200
content-length
12472
last-modified
Thu, 04 Jun 2020 02:32:06 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"30b8-5a738f35f8c84"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
jeMh0cJPpISJgUWjYJGWKOROQePOy08XFMRGstsoPtfooxB0ux1jcQ==
expires
Thu, 18 Jun 2020 03:37:26 GMT
CPHI%20Online%20TEAL%20LOGO%20no%20border.png
www.globalpharmainsights.com/sites/cphi.com/files/styles/hp_widget_program_standard/public/ 		14 KB
14 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/hp_widget_program_standard/public/CPHI%20Online%20TEAL%20LOGO%20no%20border.png?itok=WDbHTO0d
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
6228e9180404b87bdd1d53f6d32ceecd1e73407ae40c6d5851a12fa0caba889d
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 05 Jun 2020 12:34:31 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
621216
x-cache
Hit from cloudfront
status
200
content-length
14117
last-modified
Fri, 17 Apr 2020 14:46:33 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"3725-5a37d9d975f40"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
Sl757jAW3Dn7ckYbGW86qJYDV3ORplCY7F2kBlbMOT8PwY7Ual-KQg==
expires
Fri, 19 Jun 2020 12:34:31 GMT
HLN00CPO-Gilead-distribution.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_featured_standard/public/ 		57 KB
57 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_featured_standard/public/HLN00CPO-Gilead-distribution.jpg?itok=uJBDDbK5
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
32565490c2301442c897cf7c812b98f4543036571824c424e123735ccbd19137
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 08:34:21 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
30827
x-cache
Hit from cloudfront
status
200
content-length
58070
last-modified
Wed, 13 May 2020 08:45:23 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"e2d6-5a58399d31e50"
content-type
image/jpeg
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
tXhPcSh3eHtI4L50NfECqDkx7_qFGZs1hZ_0Z0KVbcBsFOvo4RtUvg==
expires
Fri, 26 Jun 2020 08:34:21 GMT
account-default-image.png
www.globalpharmainsights.com/sites/all/themes/penton_core_theme/images/ 		5 KB
5 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/all/themes/penton_core_theme/images/account-default-image.png
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
12260d8e3e5f7c60dfda5731f3b77e1748c45fe480bec2d0cee49616dd48ae04
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 16:01:23 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
4005
x-cache
Hit from cloudfront
status
200
content-length
5140
last-modified
Fri, 12 Jun 2020 11:06:47 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"1414-5a7e112b78fcc"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
rWYlQ-SjXgrwm1jBwD_BBAvzbx6V0Nx_r1IH5UEZesww9KGI65e5Kg==
expires
Fri, 26 Jun 2020 16:01:23 GMT
CPhI%20India_CoT.png
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 		2 KB
2 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/CPhI%20India_CoT.png?itok=FLPd7SgR
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /
Resource Hash
0444c8c10665ee4ae69b68f021bf722af7e87b5bb2e52ba9bcb9d8b741e98ae1
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 04:54:16 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
44031
x-cache
Hit from cloudfront
status
200
content-length
1691
last-modified
Thu, 16 Apr 2020 08:52:03 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag
"69b-5a3648bf85c80"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
RyILhFidlqQUM2YyAEOSPsa0MlQGCmOgmmTbSbvGJejbie4cH2I1ng==
expires
Fri, 26 Jun 2020 04:54:16 GMT
HLN00CPO-Remdesivir-Gilead.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 		2 KB
2 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/HLN00CPO-Remdesivir-Gilead.jpg?itok=2ZaOW6BX
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
1a57e0006d9f342948a1fe2394bc31e62f529a5394c037ce0efcd92d0bd1da55
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 09 Jun 2020 09:11:28 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
287799
x-cache
Hit from cloudfront
status
200
content-length
1842
last-modified
Wed, 06 May 2020 10:00:41 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"732-5a4f7d636cbd0"
content-type
image/jpeg
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
VCY1vOHFl5u1zrhorvDJ87mLfaEE9MJUj3GWa9B48Bl7YUv9wHiihA==
expires
Tue, 23 Jun 2020 09:11:28 GMT
HLN00CPO-Continuous-manufacturing-cogs.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 		2 KB
3 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/HLN00CPO-Continuous-manufacturing-cogs.jpg?itok=YD6TVkcM
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
240d40d23dcebd0e448df4c2b45863b27c86f706f8a53a79c3b4b98ce193b67b
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 08:36:45 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
30682
x-cache
Hit from cloudfront
status
200
content-length
2307
last-modified
Fri, 12 Jun 2020 08:34:21 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"903-5a7def19fb820"
content-type
image/jpeg
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
qXcOoUpHjCi8qHtldAbf4HMUGqtZkKVchcxeJdoqQu78-LesGDdEjA==
expires
Fri, 26 Jun 2020 08:36:45 GMT
HLN00COP-COVID-19-weekly-tracker.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 		2 KB
2 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/HLN00COP-COVID-19-weekly-tracker.jpg?itok=o-1CYn9m
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /
Resource Hash
e4dff53a6d9d1b0557739d82c88285e80935eb9fa580043136af323748cab6ee
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 30 May 2020 10:33:15 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
1146892
x-cache
Hit from cloudfront
status
200
content-length
1683
last-modified
Thu, 16 Apr 2020 08:16:22 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag
"693-5a3640c57d488"
content-type
image/jpeg
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
p4iorvQmy5WHiqDj_HhXrmFKoTMY6pl6-Zdbz4qbc_cobDlzUL4pWQ==
expires
Sat, 13 Jun 2020 10:33:15 GMT
footer.png
www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/ 		11 KB
12 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/footer.png
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
e46041e34d5f1093b7b2c0858814e0e6468b9b6a80426a23d54230239ed92026
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 03:37:27 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
739841
x-cache
Hit from cloudfront
status
200
content-length
11655
last-modified
Thu, 04 Jun 2020 02:22:15 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"2d87-5a738d02a09ca"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
WDkcqmaqQgpak-CVv-wyr619j1wNKK-Uq1PLPXR7B54EpWWGJx9Djg==
expires
Thu, 18 Jun 2020 03:37:27 GMT
js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		97 KB
35 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /
Resource Hash
fcf899b8ada8e170270c258e868822185d358321f37aeed0c6f3b27d37be6323
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 29 May 2020 22:06:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1191695
x-cache
Hit from cloudfront
status
200
content-length
34910
last-modified
Thu, 07 May 2020 03:06:03 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag
"885e-5a50629326688"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
GkosevcBAEvKkWPO8F5fGxJkgLVC4xxr4JALFOxL9Dlit-t5QC647A==
expires
Fri, 12 Jun 2020 22:06:32 GMT
js_s3L_uC35AiN5EGYY533su-jccnLRp2aKpOnjgPLbo34.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		20 KB
7 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_s3L_uC35AiN5EGYY533su-jccnLRp2aKpOnjgPLbo34.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
b372ffb82df9022379106618e77decbbe8dc7272d1a7668aa4e9e380f2dba37e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112092
x-cache
Hit from cloudfront
status
200
content-length
6931
last-modified
Wed, 10 Jun 2020 03:26:19 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"1b13-5a7b26851d908"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
nbNG-DucRq5pc-tD6OlXvCfKj_9_gMfC_nywuEgUTLsD1mF_lNkhTw==
expires
Thu, 25 Jun 2020 09:59:55 GMT
launch-560312491757.min.js
assets.adobedtm.com/100e8b570010/c89496dc0f21/ 		178 KB
50 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:10c:387::1e80 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
6ab81fba1ff6dbfb3aac51f5a2a8b1a5a4bc58cbeeac086de3f6e838cb3c93cf

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:07 GMT
content-encoding
gzip
last-modified
Wed, 27 May 2020 12:11:50 GMT
server
AkamaiNetStorage
etag
"1dd9abe35bae1a8805e8349a0bd9dfcb:1590581510.227931"
vary
Accept-Encoding
content-type
application/x-javascript
status
200
cache-control
max-age=3600
accept-ranges
bytes
timing-allow-origin
*
content-length
51138
expires
Fri, 12 Jun 2020 18:08:07 GMT
js_I-uzEZ6lB_oNELbin5YHol-LXruj-gjGpig7o5Yiy3g.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		166 KB
48 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_I-uzEZ6lB_oNELbin5YHol-LXruj-gjGpig7o5Yiy3g.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
23ebb3119ea507fa0d10b6e29f9607a25f8b5ebba3fa08c6a6283ba39622cb78
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 12:40:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
102477
x-cache
Hit from cloudfront
status
200
content-length
48418
last-modified
Thu, 04 Jun 2020 03:47:14 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"bd22-5a73a001558b0"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
f0-oSOhFM2nPIz4K90K_YZPOGVkcKK2LXk-7fz_jiWOnV3uj7fvIQA==
expires
Thu, 25 Jun 2020 12:40:11 GMT
js_13l6iCSWqEmXf4TMDp51TAkvk6FN2jCQAjkAuVSOeqo.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		15 KB
4 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_13l6iCSWqEmXf4TMDp51TAkvk6FN2jCQAjkAuVSOeqo.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
d7797a882496a849977f84cc0e9e754c092f93a14dda3090023900b9548e7aaa
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 12:04:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
709403
x-cache
Hit from cloudfront
status
200
content-length
3712
last-modified
Thu, 04 Jun 2020 03:46:26 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"e80-5a739fd32dde8"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
eosszD0kBeyMcNjYBSkVgL4e5lvAUxbCUZPe0RdbEeoaiWmKQNKivg==
expires
Thu, 18 Jun 2020 12:04:44 GMT
js_FoO86KRzi68_J27zYA1BNIfKpwyO0UJ-deA5Irn5IQ8.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		5 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_FoO86KRzi68_J27zYA1BNIfKpwyO0UJ-deA5Irn5IQ8.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
1683bce8a4738baf3f276ef3600d413487caa70c8ed1427e75e03922b9f9210f
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 12:04:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
709405
x-cache
Hit from cloudfront
status
200
content-length
1311
last-modified
Thu, 04 Jun 2020 03:47:14 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"51f-5a73a00163758"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
ko0nSB1VevPeczDuzDtbq34G89uybfalSt4gC7i8h-6qMsDgODQxaw==
expires
Thu, 18 Jun 2020 12:04:43 GMT
embed.js
s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/
Redirect Chain
  • https://video.limelight.com/player/embed.js
  • https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js
18 KB
19 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
178.79.227.0 , Italy, ASN22822 (LLNW, US),
Reverse DNS
https-178-79-227-0.vie.llnw.net
Software
AmazonS3 /
Resource Hash
29ca0635f3a13ba2340907510cd06b2d26e9fd4abf88295914626c2096ac8924

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 12 Jun 2020 17:08:07 GMT
Last-Modified
Tue, 28 May 2019 17:21:09 GMT
Server
AmazonS3
Age
31117449
x-amz-id-2
nBrkEsispEJFEwxK1nbKQJvArPuv+EoFoHVycloXjt5zu7JRw94kr1w86FaNNfoAsnwXWdIEadA=
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=31536000
Content-Length
18768
Connection
keep-alive
Accept-Ranges
bytes
x-amz-request-id
05B20CCF6EE1DF2D
X-LLID
9a24bf7de66f9ec47cb3794b37ff094c
Expires
Wed, 17 Jun 2020 13:23:58 GMT

Redirect headers

Location
https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js
Date
Fri, 12 Jun 2020 17:08:07 GMT
Server
Apache
Connection
Keep-Alive
Keep-Alive
timeout=2, max=100
Content-Length
330
Content-Type
text/html; charset=iso-8859-1
js_jm3tTtzLZz9ztr1QmbjNUQg7CXVPQ0KIq1izyBk1azg.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		278 KB
67 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_jm3tTtzLZz9ztr1QmbjNUQg7CXVPQ0KIq1izyBk1azg.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
8e6ded4edccb673f73b6bd5099b8cd51083b09754f434288ab58b3c819356b38
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 12:04:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
709404
x-cache
Hit from cloudfront
status
200
content-length
67949
last-modified
Thu, 04 Jun 2020 03:47:15 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"1096d-5a73a0017d950"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
wQA5QIcW6VyQ3OVmAqkHdqs1SGFRaUPU9vpC8oY09EyQ-y73oTSh0g==
expires
Thu, 18 Jun 2020 12:04:44 GMT
js_L6OZG5KXpK9TmHNSbl24vOE0yJf48VytacfkHRBNEVc.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		10 KB
3 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_L6OZG5KXpK9TmHNSbl24vOE0yJf48VytacfkHRBNEVc.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
2fa3991b9297a4af539873526e5db8bce134c897f8f15cad69c7e41d104d1157
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112092
x-cache
Hit from cloudfront
status
200
content-length
2833
last-modified
Wed, 10 Jun 2020 03:24:35 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"b11-5a7b262197c80"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
Th0ZJwDUTzr7xZd9IWMjPjIc9dH9gV8Int_6r0zCDkI_v-znhOWWfQ==
expires
Thu, 25 Jun 2020 09:59:55 GMT
js_bPh3Q6AKPB-AdasJkcfWUQYxe6rsN1QNiUqwOfElCSA.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		48 KB
13 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_bPh3Q6AKPB-AdasJkcfWUQYxe6rsN1QNiUqwOfElCSA.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
6cf87743a00a3c1f8075ab0991c7d65106317baaec37540d894ab039f1250920
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 12:40:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
102476
x-cache
Hit from cloudfront
status
200
content-length
12544
last-modified
Thu, 04 Jun 2020 03:47:15 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"3100-5a73a0018fa60"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
b6JcZvKkOHzYdmaAO3bYpjMtArN6P38ma57i53BWv56EQS1s_YsAgg==
expires
Thu, 25 Jun 2020 12:40:11 GMT
js_yIkX_vb0Dxng7O5aNwkJ-nqApJpaPl61cDQzkBEByaA.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		94 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_yIkX_vb0Dxng7O5aNwkJ-nqApJpaPl61cDQzkBEByaA.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
c88917fef6f40f19e0ecee5a370909fa7a80a49a5a3e5eb5703433901101c9a0
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112092
x-cache
Hit from cloudfront
status
200
content-length
28579
last-modified
Thu, 04 Jun 2020 03:46:26 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"6fa3-5a739fd360e50"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
VkD1Rez9yuFlnqooJQ_HcHA-YpF6mXnDNCBZcF1CfuU-F5IyzXV2VQ==
expires
Thu, 25 Jun 2020 09:59:55 GMT
js_5mkVQduSavhPSKtIg-VBkjsgMwuU68PrQhH9Ye0ODvs.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		11 KB
3 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_5mkVQduSavhPSKtIg-VBkjsgMwuU68PrQhH9Ye0ODvs.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
e6691541db926af84f48ab4883e541923b20330b94ebc3eb4211fd61ed0e0efb
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112092
x-cache
Hit from cloudfront
status
200
content-length
2186
last-modified
Wed, 10 Jun 2020 03:26:19 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"88a-5a7b2685353f0"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
b6eIL5wbphTPWEfFXt0TE3Dth9pxQCWTAaR6DWS2nT2XyFNl6m_LnA==
expires
Thu, 25 Jun 2020 09:59:55 GMT
js_39wR4vuLCUZcIK_NsEhVLhl6834Dd3heLLFQ5DLVNsc.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		14 KB
4 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_39wR4vuLCUZcIK_NsEhVLhl6834Dd3heLLFQ5DLVNsc.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
dfdc11e2fb8b09465c20afcdb048552e197af37e0377785e2cb150e432d536c7
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 12:40:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
102477
x-cache
Hit from cloudfront
status
200
content-length
3655
last-modified
Tue, 12 May 2020 03:03:22 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"e47-5a56ab4d71440"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
ye-OZP2OUtBw0Gc4InWO7UZ7D4O7U1ldK-on2pN1wOepHPlPN_aE5w==
expires
Thu, 25 Jun 2020 12:40:11 GMT
ckeditor.js
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ 		674 KB
203 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
945fe441f86cf714fbe8313e5a79d879d27f3c3fd542246715655c0e93dc0c5c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:06 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 14:48:55 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5581
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
6M_BPhHTVRfD0RWOG9tXUecj5alMTDmPxwoxR44OCj6rQxgq6KACBg==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:06 GMT
js_ZrciCJCAxDyewaqeqgUiHehSzeEalZRdqNrEoAN5Q5c.js
www.globalpharmainsights.com/sites/cphi.com/files/js/ 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_ZrciCJCAxDyewaqeqgUiHehSzeEalZRdqNrEoAN5Q5c.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
66b722089080c43c9ec1aa9eaa05221de852cde11a95945da8dac4a003794397
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 09:59:55 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
112092
x-cache
Hit from cloudfront
status
200
content-length
1209
last-modified
Wed, 10 Jun 2020 03:26:19 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"4b9-5a7b2684d58b0"
vary
Accept-Encoding
content-type
text/javascript
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
awDCUoGAlpiWhkOVdj4juEnl_QywOe789eKBYWE6t41021qhZVlRTA==
expires
Thu, 25 Jun 2020 09:59:55 GMT
fa-brands-400.woff2
www.globalpharmainsights.com/sites/all/themes/shared_fonts/ 		75 KB
75 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/themes/shared_fonts/fa-brands-400.woff2
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
089630244600f33230010f5e04c67419ec642c5228540adb42e3fe92c631e6bf
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
Origin
https://www.globalpharmainsights.com

Response headers

date
Thu, 04 Jun 2020 03:37:26 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
last-modified
Thu, 04 Jun 2020 02:32:03 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
age
739842
etag
"12b04-5a738f33322a2"
x-cache
Hit from cloudfront
status
200
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
76548
x-amz-cf-id
PhuqoOrGRa3s4TO8BmnOIPpE_hGAZPViN391vBTlGInp5M1ArwM7hA==
expires
Thu, 18 Jun 2020 03:37:26 GMT
fa-solid-900.woff2
www.globalpharmainsights.com/sites/all/themes/shared_fonts/ 		74 KB
75 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/themes/shared_fonts/fa-solid-900.woff2
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
2c3097237d60f42e800ebe4009c9af144bb19e5581e1c0501c7b259eee7e210c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
Origin
https://www.globalpharmainsights.com

Response headers

date
Thu, 04 Jun 2020 03:37:26 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
last-modified
Thu, 04 Jun 2020 02:32:03 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
age
739841
etag
"12958-5a738f32a1dfe"
x-cache
Hit from cloudfront
status
200
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
76120
x-amz-cf-id
cUIlGs-iy5JULS8NizEyNL3a3X48ILK3Im3gdS8yRi1SdrqxWCiYCA==
expires
Thu, 18 Jun 2020 03:37:26 GMT
fa-regular-400.woff2
www.globalpharmainsights.com/sites/all/themes/shared_fonts/ 		13 KB
14 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/themes/shared_fonts/fa-regular-400.woff2
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
093f782260d70f914e7e591eba1502d3e992e9f7a69a17d1df6c32bcddd6f06a
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
Origin
https://www.globalpharmainsights.com

Response headers

date
Mon, 08 Jun 2020 10:54:19 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
last-modified
Mon, 08 Jun 2020 10:42:22 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
age
368028
etag
"3520-5a79044072182"
x-cache
Hit from cloudfront
status
200
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
13600
x-amz-cf-id
kK-gkGE-Jv6xDLSWHRGmpaEqA3QJPBV4QidIWuP9RRLvtlqmZHP1og==
expires
Mon, 22 Jun 2020 10:54:19 GMT
pubads_impl_2020060103.js
securepubads.g.doubleclick.net/gpt/ 		246 KB
88 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
sffe /
Resource Hash
7281df0fc37f02952ecbff4b9f47640a7f193aac19c97f89e3e276b20d47e454
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Intervention
<https://www.chromestatus.com/feature/5718547946799104>; level="warning"

Response headers

date
Fri, 12 Jun 2020 17:08:07 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 01 Jun 2020 18:46:06 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
90085
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:07 GMT
integrator.sync.js
adservice.google.de/adsid/ 		113 B
956 B 		Script
General
Check archive.org
Download Go to
Full URL
https://adservice.google.de/adsid/integrator.sync.js?domain=www.globalpharmainsights.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ea03bfd7fdda1eac185ebc3e8e74b33065b04c8e0adc48cbbd4136748dbd2742
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 12 Jun 2020 17:08:07 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
108
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/ 		353 B
574 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=829988948577741&correlator=2338363894634368&output=ldjh&impl=fif&eid=21064366&vrg=2020060103&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dinterstitial_a%26gdpr_banner%3Doff%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981686&dt=1591981687885&dlt=1591981687596&idt=281&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=0&adks=1971742020&ucis=1&ifi=1&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=11&icsg=186&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1600x3114&msz=1600x0&ga_vid=1712637215.1591981688&ga_sid=1591981688&ga_hid=642320834&fws=0&ohw=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
b9754aa1856ffc1d9b663adb7113da71822b5641403a8a957cf4a2f62ecbeef2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:07 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
158
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
38683bacb692dc3ca6a4b9092b6a8b4e.safeframe.googlesyndication.com/safeframe/1-0-37/html/ 		0
0 		Other
General
Check archive.org
Download Go to
Full URL
https://38683bacb692dc3ca6a4b9092b6a8b4e.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers
container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/ 		0
0 		Other
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers
AppMeasurement.min.js
assets.adobedtm.com/extensions/EP308220a2a4c4403f97fc1960100db40f/ 		36 KB
13 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.adobedtm.com/extensions/EP308220a2a4c4403f97fc1960100db40f/AppMeasurement.min.js
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:10c:387::1e80 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
adfcb165c69213b0aba3c64bc549f7ff156ec82110fb8ef144b1d16ebc13b04a

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:07 GMT
content-encoding
gzip
last-modified
Tue, 10 Mar 2020 22:29:22 GMT
server
AkamaiNetStorage
etag
"42fa244f36955eedb3cd8ade6f492bf6:1583879362.816163"
vary
Accept-Encoding
content-type
application/x-javascript
status
200
cache-control
no-cache
accept-ranges
bytes
timing-allow-origin
*
content-length
13342
expires
Fri, 12 Jun 2020 18:08:07 GMT
cc_af.js
tags.crwdcntrl.net/c/7499/ 		64 KB
15 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tags.crwdcntrl.net/c/7499/cc_af.js
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.121 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-121.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
3517e49035216248756bd8d6babd7e024b944f85eed8bc430ffdd509e593ba52

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Jun 2020 21:12:06 GMT
content-encoding
gzip
last-modified
Wed, 27 May 2020 14:23:57 GMT
server
AmazonS3
age
71763
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/json
status
200
cache-control
max-age: 86400
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
7FZfNys9bKIL4_qDnP7XVZ9ilmgsIUojUBF3uVqXA2KzjNqPSkvleA==
via
1.1 d627b75d0c1aedd3691390ac8498d3b0.cloudfront.net (CloudFront)
js
www.googletagmanager.com/gtag/ 		83 KB
33 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagmanager.com/gtag/js?id=AW-998237655&l=dataLayer
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
a06e56a8c960b020069ccd0444e9007101811003816ca68886c76ea91724e1eb
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:07 GMT
content-encoding
br
vary
Accept-Encoding
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
33228
x-xss-protection
0
last-modified
Fri, 12 Jun 2020 15:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Fri, 12 Jun 2020 17:08:07 GMT
News
www.globalpharmainsights.com/no_cache/feeds/ajax/rss/ 		9 KB
10 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/no_cache/feeds/ajax/rss/News?fromPath=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
f1cadabd441bba3ee35c47cd6d029a4b8030cb22b99896932c385e30bb3110cc
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff, nosniff
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-drupal-ajax-token
1
x-cache
Miss from cloudfront
content-type
application/json; charset=utf-8
status
200
expires
Sun, 19 Nov 1978 05:00:00 GMT
cache-control
no-cache, must-revalidate
x-amz-cf-id
eXg9RxGQCZN9luk5x2KzmLUirQjEaPtj6cZvyGcOwLi5Wo7z1KvNQA==
x-ua-compatible
IE=edge,chrome=1
Products
www.globalpharmainsights.com/no_cache/feeds/ajax/rss/ 		9 KB
9 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/no_cache/feeds/ajax/rss/Products?fromPath=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
a94a963dcd2e927863ee4d8da81b6c0ae6461dc05a5061f825c91d9b0eda8c44
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

date
Fri, 12 Jun 2020 17:08:09 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff, nosniff
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-drupal-ajax-token
1
x-cache
Miss from cloudfront
content-type
application/json; charset=utf-8
status
200
expires
Sun, 19 Nov 1978 05:00:00 GMT
cache-control
no-cache, must-revalidate
x-amz-cf-id
rUPaGTxRdemgFMUl-TznWhwP5nVTUUgUWaCbwaabKwQkTgPkdL-POw==
x-ua-compatible
IE=edge,chrome=1
Suppliers
www.globalpharmainsights.com/no_cache/feeds/ajax/rss/ 		9 KB
9 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/no_cache/feeds/ajax/rss/Suppliers?fromPath=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
080ef4bcdd505cac3c920d1b3b6021794792d4ff35ede61185d8922ad23c832d
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

date
Fri, 12 Jun 2020 17:08:09 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff, nosniff
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-drupal-ajax-token
1
x-cache
Miss from cloudfront
content-type
application/json; charset=utf-8
status
200
expires
Sun, 19 Nov 1978 05:00:00 GMT
cache-control
no-cache, must-revalidate
x-amz-cf-id
eSYyTy_A62siZr9H-OUdk2uuCaz-LLx4emEzw5Jh2WnzexVHWfgAig==
x-ua-compatible
IE=edge,chrome=1
ui-bg_flat_75_ffffff_40x100.png
www.globalpharmainsights.com/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/images/ 		178 B
605 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/images/ui-bg_flat_75_ffffff_40x100.png
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
39ab7ccd9f4e82579da78a9241265df288d8eb65dbbd7cf48aed2d0129887df5
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_b2lxsoMjuDz1VEsoXFy0Cgo8pcav1Ny1N-EHn8knPc0.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 03:37:31 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
739836
x-cache
Hit from cloudfront
status
200
content-length
178
last-modified
Thu, 04 Jun 2020 02:32:15 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"b2-5a738f3e757d5"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
zh7D8ElpT4xMz0QbHzDLgmz1YI0qY7Z0oAGgDeQWvG6F8aIMfe3fxg==
expires
Thu, 18 Jun 2020 03:37:31 GMT
backtotop.png
www.globalpharmainsights.com/sites/all/modules/contrib/back_to_top/ 		1 KB
2 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/back_to_top/backtotop.png
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /
Resource Hash
b40e0334f469c4b2508b88c82d19923ecc01ac6be08b81550b1d6da930480e4f
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_EMysOwdNz4P_aEBvy91ee-H45803PIdurHGMjmMp-B4.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 04 Jun 2020 03:37:31 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
739836
x-cache
Hit from cloudfront
status
200
content-length
1219
last-modified
Thu, 04 Jun 2020 02:32:16 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag
"4c3-5a738f3f1d412"
content-type
image/png
cache-control
max-age=1209600
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
MGfb8EW2-V_T0XCFIstRxoawhdEAEUy9Xg9JPRaG1WftvwzR8FaKnw==
expires
Thu, 18 Jun 2020 03:37:31 GMT
pinit.js
assets.pinterest.com/js/ 		361 B
673 B 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.pinterest.com/js/pinit.js?_=1591981687714
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:eb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3faadebc89cdb21d11634a032816f152462d1cb8903eb21d0642501fcad065de

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-cdn
cloudflare
status
200
etag
W/"82bfd941d2c9b3b9e0650a27c9d11737"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
x-cdn
cache-control
max-age=300
cf-ray
5a252c0e0e9405c8-FRA
cf-request-id
034b19dcc3000005c8de168200000001
server
cloudflare
get_poll
www.globalpharmainsights.com/ 		4 KB
1 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/get_poll
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
f605f6020113e67e533c81e272181588b8b588283d8806d1a4719fb8ec66d649
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept
*/*
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:09 GMT
content-encoding
gzip
x-content-type-options
nosniff, nosniff
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-cache
Miss from cloudfront
status
200
x-ua-compatible
IE=edge,chrome=1
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options
SAMEORIGIN
vary
Accept-Encoding,Cookie
content-language
en
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
no-cache, must-revalidate
x-drupal-cache
MISS
content-type
application/json
x-amz-cf-id
Y8BK9T1XaJ7LiAJMiSiw1RfIJFMNVO_yR3XEvwNkaF2pEzPeObRr3A==
expires
Sun, 19 Nov 1978 05:00:00 GMT
emit.php
www.globalpharmainsights.com/sites/all/modules/contrib/radioactivity/ 		0
424 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/radioactivity/emit.php
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff

Request headers

Accept
text/html, */*; q=0.01
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff, nosniff
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-cache
Miss from cloudfront
content-type
text/html; charset=UTF-8
status
200
expires
Sun, 19 Nov 1978 05:00:00 GMT
cache-control
no-cache, must-revalidate
content-length
0
x-amz-cf-id
joEggGow01zx_MJp0Af4C09w9UH6GYCZpA0bE4lNFqOqrI-k0HhdHw==
x-ua-compatible
IE=edge,chrome=1
191
www.globalpharmainsights.com/ajax/get-comments-count/ 		3 B
497 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/ajax/get-comments-count/191
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
98089e6d36f78e9766c9ea34d5acb3611f3a92cd81c5eb102095d924ffc7d08b
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept
*/*
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff, nosniff
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-cache
Miss from cloudfront
status
200
content-length
3
x-ua-compatible
IE=edge,chrome=1
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options
SAMEORIGIN
vary
Cookie
content-language
en
cache-control
no-cache, must-revalidate
x-drupal-cache
MISS
content-type
application/json
x-amz-cf-id
kvCpFTvdnpa4SG72fSnY7az9Y6cOwu5JTyCR-Gu5cPbyzykVoVJS5w==
expires
Sun, 19 Nov 1978 05:00:00 GMT
ntl8rdl.js
use.typekit.net/ 		20 KB
8 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/ntl8rdl.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_yIkX_vb0Dxng7O5aNwkJ-nqApJpaPl61cDQzkBEByaA.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
a3766442ecfc3a0e93a8e7c864fee2700c9220422bcc14016181c986b2f6744d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains;

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains;
content-encoding
gzip
server
nginx
status
200
date
Fri, 12 Jun 2020 17:08:08 GMT
vary
Accept-Encoding
content-type
text/javascript;charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=600, stale-while-revalidate=604800
timing-allow-origin
*
content-length
7560
ads
securepubads.g.doubleclick.net/gampad/ 		353 B
229 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=829988948577741&correlator=2338363894634368&output=ldjh&impl=fif&adsid=NT&eid=21064366&vrg=2020060103&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dadhesion%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981686&dt=1591981688030&dlt=1591981687596&idt=281&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3064&adks=18817343&ucis=2&ifi=2&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&ga_vid=1712637215.1591981688&ga_sid=1591981688&ga_hid=642320834&fws=4&ohw=0&btvi=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
018fe08fe092b7423935a46a8e647f39510c468cee8c49a4d83b8a94dd00a2d0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
158
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		353 B
232 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=829988948577741&correlator=2338363894634368&output=ldjh&impl=fif&adsid=NT&eid=21064366&vrg=2020060103&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dfootnote%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous%26gdpr_banner%3Doff&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981686&dt=1591981688036&dlt=1591981687596&idt=281&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3065&adks=3189633427&ucis=3&ifi=3&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&ga_vid=1712637215.1591981688&ga_sid=1591981688&ga_hid=642320834&fws=4&ohw=0&btvi=2
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
e5c318b1b19a43ee6805632dda7b278da629b7cb630d6d085f56a6e71721e603
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
157
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		359 B
242 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=829988948577741&correlator=2338363894634368&output=ldjh&impl=fif&adsid=NT&eid=21064366&vrg=2020060103&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&ists=1&prev_scp=pos%3Doop_a%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous%26gdpr_banner%3Doff&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981686&dt=1591981688041&dlt=1591981687596&idt=281&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3066&adks=1633354223&ucis=4&ifi=4&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&ga_vid=1712637215.1591981688&ga_sid=1591981688&ga_hid=642320834&fws=4&ohw=0&btvi=3
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
aca8c88f5bfb59ef1ebe22f9693138b6cc5e5d32e99bed8ea3f083f55cdd6bba
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
167
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		13 KB
6 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=829988948577741&correlator=2338363894634368&output=ldjh&impl=fif&adsid=NT&eid=21064366&vrg=2020060103&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250&prev_scp=pos%3D300_1_lft%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981686&dt=1591981688047&dlt=1591981687596&idt=281&frm=20&biw=1600&bih=1200&oid=3&adxs=219&adys=548&adks=92038381&ucis=5&ifi=5&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x250&msz=0x250&ga_vid=1712637215.1591981688&ga_sid=1591981688&ga_hid=642320834&fws=4&ohw=0&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
ba0f2ef9f9a9da800749eb7d3680adea984802610e14ad9a599b1a3c91e75dae
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6025
x-xss-protection
0
google-lineitem-id
5374575282
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138312304633
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		353 B
229 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=829988948577741&correlator=2338363894634368&output=ldjh&impl=fif&adsid=NT&eid=21064366&vrg=2020060103&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&ists=1&prev_scp=pos%3Dwrap%26combo%3Dwrap%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981686&dt=1591981688053&dlt=1591981687596&idt=281&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3067&adks=4017216366&ucis=6&ifi=6&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&ga_vid=1712637215.1591981688&ga_sid=1591981688&ga_hid=642320834&fws=4&ohw=0&btvi=4
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
b8c4dd002a2674ea6e3f6b017dd2e81037794fde3d73c09de2a765bad56dc197
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
158
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
penton-legal-comm-get-message
www.globalpharmainsights.com/ajax/ 		821 B
2 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/ajax/penton-legal-comm-get-message
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
8b9aec49be5d5cc900eec1c08755f843459d9995a7bae3f6375037da6c01c487
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept
*/*
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:09 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff, nosniff
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-cache
Miss from cloudfront
status
200
content-length
821
x-ua-compatible
IE=edge,chrome=1
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options
SAMEORIGIN
content-language
en
cache-control
no-cache, must-revalidate
content-type
text/html; charset=UTF-8
x-amz-cf-id
bUOT7z54DSlwe7sCJ4qQf6mJQ9QvaXr0s7nHG3JoNXZmk4AM2_XjKA==
expires
Sun, 19 Nov 1978 05:00:00 GMT
RC4488730ca17f46b783d3193a682c14ba-source.min.js
assets.adobedtm.com/100e8b570010/c89496dc0f21/0eadc58b531c/ 		994 B
838 B 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.adobedtm.com/100e8b570010/c89496dc0f21/0eadc58b531c/RC4488730ca17f46b783d3193a682c14ba-source.min.js
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:10c:387::1e80 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
4b2699af5cddfe0118e20f883a6f4993c3482a7160e35bd1b8f609f45b89589d

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
gzip
last-modified
Wed, 27 May 2020 12:11:51 GMT
server
AkamaiNetStorage
etag
"e296c46fda28eead0a6917455448db77:1590581511.027982"
vary
Accept-Encoding
content-type
application/x-javascript
status
200
cache-control
max-age=3600
accept-ranges
bytes
timing-allow-origin
*
content-length
593
expires
Fri, 12 Jun 2020 18:08:08 GMT
ckeditor.config.js
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor.config.js?&t=I3I8
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
fd21533b25982658fb3d45f7e662bfa071b0e58204e5b44587b955d46f4fe203
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:19 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 09:29:07 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5569
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
gW7gkA06-cPq1yKyEAMUPdLd6GC8hv3meOOHjZ4QXE6Mr1qlmu_86w==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:19 GMT
s53872780506634
informaglobalexhibitions.d3.sc.omtrdc.net/b/ss/informaglobalpharmainsights.com,informaglobalprod/1/JS-2.20.0-LATI/ 		43 B
448 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://informaglobalexhibitions.d3.sc.omtrdc.net/b/ss/informaglobalpharmainsights.com,informaglobalprod/1/JS-2.20.0-LATI/s53872780506634
Requested by
Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/extensions/EP308220a2a4c4403f97fc1960100db40f/AppMeasurement.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
15.236.9.100 Paris, France, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-15-236-9-100.eu-west-3.compute.amazonaws.com
Software
jag /
Resource Hash
55c9d2f019f9d7ddfd69b2ad0351c5617338a222362aebb02b3b98a4dbc18486
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
x-content-type-options
nosniff
x-c
master-1308.I3d0a82.M0-421
p3p
CP="This is not a P3P policy"
status
200
content-length
43
x-xss-protection
1; mode=block
pragma
no-cache
last-modified
Sat, 13 Jun 2020 17:08:08 GMT
server
jag
xserver
anedge-6f7565dc8b-g7lfk
etag
3418754642980732928-4614440551384413165
vary
*
content-type
image/gif;charset=utf-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, no-store, max-age=0, no-transform, private
access-control-allow-credentials
true
expires
Thu, 11 Jun 2020 17:08:08 GMT
l
use.typekit.net/af/f80f1d/00000000000000003b9aefb8/27/ 		32 KB
32 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/af/f80f1d/00000000000000003b9aefb8/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n7&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
4a85a057330bbc6272c3dd4c02a15317b08a92b4de7514d9fda7d8cbf82a3cac

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin
https://www.globalpharmainsights.com

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
server
nginx
etag
"5b1424bf708a1baf048831772af7891cda52e1e0"
status
200
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
timing-allow-origin
*
content-length
32980
l
use.typekit.net/af/29352b/00000000000000003b9aefb9/27/ 		33 KB
33 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/af/29352b/00000000000000003b9aefb9/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=i7&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
39492f3c9f87d34d4d53b7fa1fc66d5003f986552288bb55ac10e7507d4c69dd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin
https://www.globalpharmainsights.com

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
server
nginx
etag
"41bd63e072fcddb931e4f5c670a122a6ae75b1a8"
status
200
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
timing-allow-origin
*
content-length
34024
l
use.typekit.net/af/af96c8/00000000000000003b9aefc0/27/ 		31 KB
31 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/af/af96c8/00000000000000003b9aefc0/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n4&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
1e71dfd2075bdd8ab13805b0c9bc396c00c1a3d982d3e9ddde63ccfaf4f2eaaf

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin
https://www.globalpharmainsights.com

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
server
nginx
etag
"625d31c6ff36363142e14c9d9cf9f2747ce3803a"
status
200
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
timing-allow-origin
*
content-length
31984
l
use.typekit.net/af/20aa1e/00000000000000003b9aefc1/27/ 		33 KB
33 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/af/20aa1e/00000000000000003b9aefc1/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=i4&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
1ccdbe5fba95906eb04fed55b6d5fe05d4130f09d1ef62a2a195b07bfcd20d98

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin
https://www.globalpharmainsights.com

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
server
nginx
etag
"0a37e0f13f84c73347be23130bb6d2063bc1d8a8"
status
200
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
timing-allow-origin
*
content-length
33796
l
use.typekit.net/af/13a799/00000000000000003b9adee3/27/ 		18 KB
18 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://use.typekit.net/af/13a799/00000000000000003b9adee3/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n6&v=3
Requested by
Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software
nginx /
Resource Hash
f7d3a5e83ab0db74bd9ce3800f7e2b57083a45d72048eb0a1ec59ea71d5d1c7d

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin
https://www.globalpharmainsights.com

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
server
nginx
etag
"92db5ca13edfead8cacb9b7663621adc030e2d76"
status
200
content-type
application/font-woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
timing-allow-origin
*
content-length
18560
hotjar-1097635.js
static.hotjar.com/c/ 		3 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://static.hotjar.com/c/hotjar-1097635.js?sv=6
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.100.189 Central, Hong Kong, ASN54825 (PACKET, US),
Reverse DNS
pkt-ams-k2-shared-ingress1
Software
/
Resource Hash
b2cb52bb8c63c9d5e163fd70dd504b7ad01d64a12a414b61c98d7c9e032a0ef3
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-content-type-options
nosniff
content-type
application/javascript
section-io-tag
hotjarjs
age
56
status
200
section-io-cache
Hit
vary
Accept-Encoding
content-length
1537
cache-control
max-age=60
etag
W/569503578b4b1bf002f775286437293f
access-control-max-age
600
section-io-origin-status
304
access-control-allow-origin
*
x-cache-hit
1
section-io-origin-time-seconds
0.020
accept-ranges
bytes
section-io-id
390e013300dff9bbf1ef19cbd9facfaf
section-origin-responded
true
dpm_8effee409c625e1a2d8f5033631840e6ce1dcb64.min.js
s.dpmsrv.com/ 		743 KB
85 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s.dpmsrv.com/dpm_8effee409c625e1a2d8f5033631840e6ce1dcb64.min.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.107 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-107.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
74445353848aede9be7ebc099b2865512031747c9d487c53a5e0d8bbb6b3da13

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Thu, 11 Jun 2020 21:00:34 GMT
Content-Encoding
gzip
Last-Modified
Thu, 11 Jun 2020 21:00:22 GMT
Server
AmazonS3
Age
72454
ETag
"d89e045af5d76c46f5a0fead6a4d9875"
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 45de888accabe1a1cb5a389e8c9c1e07.cloudfront.net (CloudFront)
Connection
keep-alive
X-Amz-Cf-Pop
FRA50-C1
Accept-Ranges
bytes
Content-Length
86057
X-Amz-Cf-Id
55EKnS59iwxYM452rCScZvU2Jq770XXlnEQ2anxl6E7Zi493ZSdxkA==
pinit_main.js
assets.pinterest.com/js/ 		69 KB
21 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.pinterest.com/js/pinit_main.js?0.19721620367996517
Requested by
Host: assets.pinterest.com
URL: https://assets.pinterest.com/js/pinit.js?_=1591981687714
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:eb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
fb3c1eca6871a3f5a4504450ce3723ebca58e2d62dc113011e31eb4be36c94a6

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-cdn
cloudflare
status
200
etag
W/"e8887b4f8f70f289103ee0c74e6b81d6"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
x-cdn
cache-control
max-age=300
cf-ray
5a252c0ed89d05c8-FRA
cf-request-id
034b19dd44000005c8de16d200000001
server
cloudflare
fbevents.js
connect.facebook.net/en_US/ 		131 KB
32 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
4cb61e44bf63a9e090e666898cd04d382e4c33b55b62cc5e9ff7dab055fbf787
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-27=":443"; ma=3600
content-length
31766
x-xss-protection
0
pragma
public
x-fb-debug
ISNt8mPSXO1ABUhYV+jEgP51fIysqHopjZ596XNBNnRjPB5tSsv45Wnbp9KGm7mNFMyL1QKRHEPqkAYVqv68lQ==
x-fb-trip-id
664085054
x-frame-options
DENY
date
Fri, 12 Jun 2020 17:08:08 GMT, Fri, 12 Jun 2020 17:08:08 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
conversion_async.js
www.googleadservices.com/pagead/ 		29 KB
12 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googleadservices.com/pagead/conversion_async.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=AW-998237655&l=dataLayer
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.21.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s12-in-f194.1e100.net
Software
cafe /
Resource Hash
760eb9892eb9014f738852a504554e1a90d5e06e2e3adb4e848323eb745d5c78
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
11025
x-xss-protection
0
server
cafe
etag
15479961422638236731
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Fri, 12 Jun 2020 17:08:08 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame DA96 		0
0 		Fetch
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss4WTVNljQcAab30eXO8ePmWD4JdWJ2rMTcfMjsRFSl7wY9vChxY5yJJm9c89hHZH_T2JUtpdLfEOo712rDTWgBiOFoSftmjjDACNdLf5GSal1_XmCIaG9hMIsAaAWCRHv8jWYeoqUy3iPif2PCw4hmB5qQlVGSKy1Ezjf9cutLmS28qw5uVpNQUx5xNtQLqHsDLw3aSkxhmk7EK3SaHF1OBmqiAF86B9pFmQNIEXSSW9CYqpjez59fvgBDQe98GiG-3Swj9V6TPX5nFltdJX4NQbx4KwGHARPu1KsDrJ1S_XxF4kZr6F_GqRL2Pu2sNgzD5xv3p7VP32MnJR55T0XKdDss&sig=Cg0ArKJSzHj8dlDVc5JpEAE&adurl=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 12 Jun 2020 17:08:08 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/ Frame DA96 		3 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7d2d1f9c78d8c0755bb8830fd20121d6d05c949c89b20536a89b6643f748c600
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Wed, 10 Jun 2020 00:53:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
231268
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1479
x-xss-protection
0
server
cafe
etag
9751230926324105381
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 24 Jun 2020 00:53:40 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame DA96 		73 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
84058f4935f4a903f78426d22151ce5ca07e601bcf127fdc75f316b725be4c40
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1591788966119694"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
28177
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:08 GMT
moatad.js
z.moatads.com/pentonmedia53440730609/ Frame DA96 		290 KB
98 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://z.moatads.com/pentonmedia53440730609/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
7c86268aee3ee868908336bbb2a43d11dd200942de23762f1851e54c25233441

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
gzip
last-modified
Tue, 09 Jun 2020 16:53:21 GMT
server
AmazonS3
x-amz-request-id
C0C4DCF45926DF98
etag
"635e31427ca583c8b5d9961b3e554e44"
vary
Accept-Encoding
content-type
application/x-javascript
status
200
cache-control
max-age=62253
accept-ranges
bytes
content-length
100310
x-amz-id-2
NqI9NXdScjp197aIuegCvGSlq0kJgeA7k2ifOBN4VZJnV1HfPzlJeqBCKNUtOZ+vokwIEPWfQ78=
8783790369963399186
tpc.googlesyndication.com/simgad/ Frame DA96 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://tpc.googlesyndication.com/simgad/8783790369963399186
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
348ca2d79ab4ee80d72d725484651deb121af2c6ea349e6c18eef7ca833fae74
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 09:13:15 GMT
x-content-type-options
nosniff
age
28493
x-dns-prefetch-control
off
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
16265
x-xss-protection
0
last-modified
Tue, 19 May 2020 07:50:29 GMT
server
sffe
content-type
image/gif
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 12 Jun 2021 09:13:15 GMT
osd.js
www.googletagservices.com/activeview/js/current/ 		73 KB
27 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
2d233c1838084b7e804e0e7a887190eeeb356132b1f625c7fa96ed3efd61e8b2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1591788966119694"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
27882
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:08 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		356 B
230 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=829988948577741&correlator=2338363894634368&output=ldjh&impl=fif&adsid=NT&eid=21064366&vrg=2020060103&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=970x90%7C970x250%7C728x90&prev_scp=pos%3D728_1_a%26combo%3Dwrap%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981686&dt=1591981688180&dlt=1591981687596&idt=281&frm=20&biw=1600&bih=1200&oid=3&adxs=800&adys=36&adks=3469502249&ucis=7&ifi=7&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=53&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x90&msz=0x90&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9tWYU7vaXiSxT2eOMrdncCrdwvkZHNZz4MtZ03pY5zUYN-AiLlEVNmc_xi9i_BjWojsnJVKA4TX5-fYLuM5c8LL6vJOqLFx30FPg&ga_vid=1712637215.1591981688&ga_sid=1591981688&ga_hid=642320834&fws=4&ohw=0&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
4b630d680fcc3c8178ab7ecde7c8bec21ae3ee36da025a60585ebdd895e31ed2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
159
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		356 B
234 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=829988948577741&correlator=2338363894634368&output=ldjh&impl=fif&adsid=NT&eid=21064366&vrg=2020060103&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=320x50&fluid=height&prev_scp=pos%3Dnativekey_1_lft%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981686&dt=1591981688188&dlt=1591981687596&idt=281&frm=20&biw=1600&bih=1200&oid=3&adxs=209&adys=490&adks=3442640145&ucis=8&ifi=8&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=53&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x0&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9tWYU7vaXiSxT2eOMrdncCrdwvkZHNZz4MtZ03pY5zUYN-AiLlEVNmc_xi9i_BjWojsnJVKA4TX5-fYLuM5c8LL6vJOqLFx30FPg&ga_vid=1712637215.1591981688&ga_sid=1591981688&ga_hid=642320834&fws=4&ohw=0&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
f85fdf31bf4fe919396461e0429e3e9a803a0d5ae8a23972f590c94689f6a635
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
159
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		356 B
236 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=829988948577741&correlator=2338363894634368&output=ldjh&impl=fif&adsid=NT&eid=21064366&vrg=2020060103&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=320x50&fluid=height&prev_scp=pos%3Dnativekey_2_lft%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981686&dt=1591981688196&dlt=1591981687596&idt=281&frm=20&biw=1600&bih=1200&oid=3&adxs=209&adys=936&adks=668711188&ucis=9&ifi=9&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=53&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x0&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9tWYU7vaXiSxT2eOMrdncCrdwvkZHNZz4MtZ03pY5zUYN-AiLlEVNmc_xi9i_BjWojsnJVKA4TX5-fYLuM5c8LL6vJOqLFx30FPg&ga_vid=1712637215.1591981688&ga_sid=1591981688&ga_hid=642320834&fws=4&ohw=0&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
d83e42169d006df744be9b96c0af4c47e44f8f6678374fa81fcc309649fa4872
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
162
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		13 KB
6 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=829988948577741&correlator=2338363894634368&output=ldjh&impl=fif&adsid=NT&eid=21064366&vrg=2020060103&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250%7C300x600&prev_scp=pos%3D300_1_rht%26article_number%3D1%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D3f1a7122d508715a%3AT%3D1591981685%3AS%3DALNI_MYCNX8uHim-A9hbLEejVFUpD86pCA&bc=31&abxe=1&lmt=1591981686&dt=1591981688207&dlt=1591981687596&idt=281&frm=20&biw=1600&bih=1200&oid=3&adxs=1355&adys=1180&adks=2860219998&ucis=a&ifi=10&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=53&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x250&msz=0x250&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9tWYU7vaXiSxT2eOMrdncCrdwvkZHNZz4MtZ03pY5zUYN-AiLlEVNmc_xi9i_BjWojsnJVKA4TX5-fYLuM5c8LL6vJOqLFx30FPg&ga_vid=1712637215.1591981688&ga_sid=1591981688&ga_hid=642320834&fws=4&ohw=0&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
211ff8bbfbdfb27dc5d50c36a239d32606b2acd5d975f3d9394fc570849aa72d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6160
x-xss-protection
0
google-lineitem-id
5374575282
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138312304672
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		466 B
412 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=829988948577741&correlator=2338363894634368&output=ldjh&impl=fif&adsid=NT&eid=21064366&vrg=2020060103&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dinarticlevideo_1_a%26article_number%3D1%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie_enabled=1&bc=31&abxe=1&lmt=1591981686&dt=1591981688217&dlt=1591981687596&idt=281&frm=20&biw=1600&bih=1200&oid=3&adxs=-12245933&adys=-12245933&adks=3389234302&ucis=b&ifi=11&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=53&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x0&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9tWYU7vaXiSxT2eOMrdncCrdwvkZHNZz4MtZ03pY5zUYN-AiLlEVNmc_xi9i_BjWojsnJVKA4TX5-fYLuM5c8LL6vJOqLFx30FPg&ga_vid=1712637215.1591981688&ga_sid=1591981688&ga_hid=642320834&fws=132&ohw=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
2bf4bf9ca914f2be90c9e9995f5177d2c0009836d0b6d75684111284495989da
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
243
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.globalpharmainsights.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
p.gif
p.typekit.net/ 		35 B
201 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://p.typekit.net/p.gif?s=1&k=ntl8rdl&ht=tk&h=www.globalpharmainsights.com&f=139.140.175.176.17391&a=4139614&js=1.19.2&app=typekit&e=js&_=1591981688253
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:10c:28a::19fd , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
nginx /
Resource Hash
9b9265c69a5cc295d1ab0d04e0273b3677db1a6216ce2ccf4efc8c277ed84b39

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
last-modified
Fri, 15 Feb 2019 23:43:47 GMT
server
nginx
etag
"5c674eb3-23"
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
max-age=604800
accept-ranges
bytes
content-length
35
expires
Mon, 26 Aug 2019 13:32:57 GMT
editor.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/skins/moono-lisa/ 		46 KB
6 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/skins/moono-lisa/editor.css?t=I3I8
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
f6cd5dec07fd04b7db1a02aa063ff9550f6f595f7902a23bf466a6044bde796e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:06:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 14:50:39 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
118
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
IsBoM1h09M6GAP7rL6qE4eRvr14QrjAkyyb5e8DpkS3H4-SCo4pTTw==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 20:06:10 GMT
en.js
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/lang/ 		19 KB
7 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/lang/en.js?t=I3I8
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
69a9941f0ab4a5c4851d9286d9aaf981f7b6c8f1b716c057e77102a2759dc9e7
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:06:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 14:48:44 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
118
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
h_3pkyashbTL9JBJo8QNUio2wgfAwxYJRdSTOnfPXz6YtOvijnDqMg==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 20:06:10 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame DA96 		0
287 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuHfNJ7BtAqq4Ewuoncu_FTiNxv8_tAGX29HVhpUMWYjkuZSW94rwTDXrTjhunPwdBqqN4imsefMLq7pJOPk6Y3fs_cBho99wBH_SQRRwZdKywS-XYU9IRLzVmdQwLK_JmH-GWa0tShCfTGqfDiULEpJfygfpOkPrLXp-9L7uOGpucj3XL9GKvUMPtSw7kCTL3MkSXCX_LH3ZOFihXypSoRW7IFZ0iLTtb02cgGWN4qPBbXyNLvqm-HrtFMLCKgt-Y7esYV5gkJNO_WawAmhneh7UfzgLOruMJhGpOU1zz5J-s7M24Pr3ERy2kDHQ-iZsYOWB1Wdw44KwfDU06XFUkLdNUk7rQ&sig=Cg0ArKJSzKZX58ZOJ7Z2EAE&adurl=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 12 Jun 2020 17:08:08 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:08 GMT
truncated
/ Frame DA96 		216 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
be75268cef6cbf4404133eca258120598834af35d6951ccdcb27015cb296bd55

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
tag.aspx
ml314.com/ Frame DA96 		26 KB
12 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ml314.com/tag.aspx?1252020
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/pentonmedia53440730609/moatad.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.251.220.194 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-251-220-194.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
9c6af299685617864c257472040f437ef951afec994720a24781931cc3527017

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 12 Jun 2020 17:08:07 GMT
Content-Encoding
gzip
Last-Modified
Fri, 12 Jun 2020 04:25:34 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, max-age=40645
Connection
keep-alive
Content-Length
11933
Expires
Sat, 13 Jun 2020 04:25:34 GMT
n.js
geo.moatads.com/ 		100 B
274 B 		Script
General
Check archive.org
Download Go to
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&i=PENTONMEDIA1&hp=1&wf=1&vb=11&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688317&de=315830167958&m=0&ar=c34ad4f880-clean&iw=821c7c5&q=2&cb=0&ym=0&cu=1591981688317&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&zMoatPS=300_1_lft&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&gw=pentonmedia53440730609&fd=1&ac=1&it=500&ti=0&ih=1&pe=1%3A1305%3A1305%3A0%3A1187&fs=181543&na=1742877939&cs=0&callback=MoatDataJsonpRequest_76420707
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/pentonmedia53440730609/moatad.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.8.225.221 London, United Kingdom, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-3-8-225-221.eu-west-2.compute.amazonaws.com
Software
TornadoServer/4.5.3 /
Resource Hash
5ad3dc94999d6453e1cf088d191a74813dfd66e13d91ecbcd8a8416d192aa491

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
server
TornadoServer/4.5.3
etag
"e5b322ef15d3c6a5cc12ef93a4fb25196c542dd7"
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=900
timing-allow-origin
*
content-length
100
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=17&i=PENTONMEDIA1&hp=1&wf=1&vb=11&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688317&de=315830167958&m=0&ar=c34ad4f880-clean&iw=821c7c5&q=3&cb=0&ym=0&cu=1591981688317&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&zMoatPS=300_1_lft&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&gw=pentonmedia53440730609&fd=1&ac=1&it=500&ti=0&ih=1&pe=1%3A1305%3A1305%3A0%3A1187&fs=181543&na=1400922862&cs=0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:08 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:08 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame A447 		0
0 		Fetch
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvLudxE-2G_XiLNiIVC90Yn_rWXWZ4L9BDHk3NjudnxoL8WMwqaaZW_ojr-V1NS5DvHzHjSZLeHhBbeU74u8L99_LUCkMwlSu3jqsM34Okq1Caki2UuXlTwcGQ2qmEKDZZMiYSZ74zCqdKZ62cBg1FBSkYH9s5rAWJYN1o9n4WOEOp9ZH_8fqgM0OddFw5PoJobAQ5QKAiUgn5SKWlgsqH4-OPq1GnOo8_8GOolfSWh2lCGki1J4hIg7iHGsZyUiKL2I4rOCHWcKAHUgbS1ROxJ_tADjiJEMKLMStcBw-xPqbIAo1efH1Gz6HuBFZWXAhvy6ZosaZgC_QZvuhlGyZZW5T9u&sig=Cg0ArKJSzLLcWVkSvPQUEAE&adurl=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 12 Jun 2020 17:08:08 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
8783790369963399186
tpc.googlesyndication.com/simgad/ Frame A447 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://tpc.googlesyndication.com/simgad/8783790369963399186
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
348ca2d79ab4ee80d72d725484651deb121af2c6ea349e6c18eef7ca833fae74
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 09:13:15 GMT
x-content-type-options
nosniff
age
28493
x-dns-prefetch-control
off
status
200
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
16265
x-xss-protection
0
last-modified
Tue, 19 May 2020 07:50:29 GMT
server
sffe
content-type
image/gif
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 12 Jun 2021 09:13:15 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/ Frame A447 		3 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7d2d1f9c78d8c0755bb8830fd20121d6d05c949c89b20536a89b6643f748c600
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Wed, 10 Jun 2020 00:53:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
231268
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1479
x-xss-protection
0
server
cafe
etag
9751230926324105381
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 24 Jun 2020 00:53:40 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame A447 		73 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
84058f4935f4a903f78426d22151ce5ca07e601bcf127fdc75f316b725be4c40
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1591788966119694"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
28177
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:08 GMT
l
www.google.com/ads/measurement/ Frame A447 		0
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRULmYD8_os71R0hotEYviQFCfp3875a7V_q97V9qzszpHIaBFJGUesnuhS_bYimnpF21NNIAAgU-j0woFc-34o_9yeog
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers
moatad.js
z.moatads.com/pentonmedia53440730609/ Frame A447 		290 KB
98 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://z.moatads.com/pentonmedia53440730609/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
7c86268aee3ee868908336bbb2a43d11dd200942de23762f1851e54c25233441

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
gzip
last-modified
Tue, 09 Jun 2020 16:53:21 GMT
server
AmazonS3
x-amz-request-id
C0C4DCF45926DF98
etag
"635e31427ca583c8b5d9961b3e554e44"
vary
Accept-Encoding
content-type
application/x-javascript
status
200
cache-control
max-age=62253
accept-ranges
bytes
content-length
100310
x-amz-id-2
NqI9NXdScjp197aIuegCvGSlq0kJgeA7k2ifOBN4VZJnV1HfPzlJeqBCKNUtOZ+vokwIEPWfQ78=
1026610140874609
connect.facebook.net/signals/config/ 		147 KB
37 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/signals/config/1026610140874609?v=2.9.18&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
2d0f94a6c3feaec5930c8a7bc2b5e5b5350f416a89a1496d7032ff2039278064
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-27=":443"; ma=3600
content-length
37522
x-xss-protection
0
pragma
public
x-fb-debug
fVnTcrk5lTYi8r0PKvCH7tqwRR7vL+dkAE7GhgqofgL+M3kXNeVkxu9xIXhtzpaiXWTup5c2hLJlG6Eh3TuW7w==
x-fb-trip-id
664085054
x-frame-options
DENY
date
Fri, 12 Jun 2020 17:08:08 GMT, Fri, 12 Jun 2020 17:08:08 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
modules.5cd4945c79de888b7e62.js
script.hotjar.com/ 		369 KB
70 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://script.hotjar.com/modules.5cd4945c79de888b7e62.js
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-1097635.js?sv=6
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.101.5 Central, Hong Kong, ASN54825 (PACKET, US),
Reverse DNS
pkt-ams-k2-shared-ingress16
Software
/
Resource Hash
998dddc13ee0857954656d34d9546ff47b99f6daea732de0dd99d17f5d5db79f

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
age
43289
status
200
section-io-cache
Hit
content-length
71510
last-modified
Thu, 11 Jun 2020 15:36:15 GMT
etag
"5fe7ffce3019c5c5010d946c7e87cef9"
vary
Accept-Encoding
section-io-origin-status
200
access-control-allow-origin
*
cache-control
max-age=31536000
section-io-origin-time-seconds
0.043
section-io-id
e425c29086b3e8f68767e389e1996373
accept-ranges
bytes
content-type
application/javascript
section-origin-responded
true
/
googleads.g.doubleclick.net/pagead/viewthroughconversion/998237655/ 		5 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://googleads.g.doubleclick.net/pagead/viewthroughconversion/998237655/?random=1591981688389&cv=9&fst=1591981688389&num=1&bg=ffffff&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa640&sendb=1&ig=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&tiba=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20remdesivir%20%7C%20Global%20Pharma%20Insights&hn=www.googleadservices.com&async=1&rfmt=3&fmt=4
Requested by
Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion_async.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
c7e0e8febe38f21a8c3686525dc2f342124a5082cae5ac66ba7b3e3015bc47b2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
cache-control
no-cache, must-revalidate
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
1406
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D55%26pixelIndex%3D0%26r%3D192308%26tzOffset%3D-120%26url%3Dhttps%253A%252F%252Fwww.globalpharmain...
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D55%2526pixelIndex%253D0%2526r%253D192308%2526tzOffset%253...
  • https://a.dpmsrv.com/dpmpxl/index.php?id=5483712037672564577&q=xImp&v=1.x&cl=55&pixelIndex=0&r=192308&tzOffset=-120&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgile...
242 B
995 B 		Script
General
Check archive.org
Download Go to
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?id=5483712037672564577&q=xImp&v=1.x&cl=55&pixelIndex=0&r=192308&tzOffset=-120&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5&_=1591981688417
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.229.100.58 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-229-100-58.compute-1.amazonaws.com
Software
/
Resource Hash
96b427b05820bb52b142c3c8099f1ef1a91a099f37f1e3f759e1d573d1cce11c

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
218
Expires
0

Redirect headers

Pragma
no-cache
Date
Fri, 12 Jun 2020 17:08:10 GMT
X-Proxy-Origin
195.242.213.99; 195.242.213.99; 727.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.107:80
AN-X-Request-Uuid
a12f3c59-8286-4fba-9f1d-2b3b4565c974
Server
nginx/1.13.4
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://a.dpmsrv.com/dpmpxl/index.php?id=5483712037672564577&q=xImp&v=1.x&cl=55&pixelIndex=0&r=192308&tzOffset=-120&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5&_=1591981688417
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
truncated
/ 		1 KB
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
e6119ad52adef631ee4fb2539d02ed906dee8f8f3e64b4d8a091ea0fb864b9f4

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
box-469cf41adb11dc78be68c1ae7f9457a4.html
vars.hotjar.com/ Frame CFD2 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://vars.hotjar.com/box-469cf41adb11dc78be68c1ae7f9457a4.html
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-1097635.js?sv=6
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.102.199 Central, Hong Kong, ASN54825 (PACKET, US),
Reverse DNS
pkt-ams-k2-shared-ingress10
Software
/
Resource Hash

Request headers

:method
GET
:authority
vars.hotjar.com
:scheme
https
:path
/box-469cf41adb11dc78be68c1ae7f9457a4.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Response headers

status
200
date
Fri, 12 Jun 2020 17:08:08 GMT
content-type
text/html
content-length
851
last-modified
Wed, 03 Jun 2020 11:24:24 GMT
etag
"d594f1d4c3e5dbd6b556c60d34e0daea"
cache-control
max-age=31536000
content-encoding
br
section-io-origin-status
200
section-io-origin-time-seconds
0.120
section-origin-responded
true
age
739653
vary
Accept-Encoding
section-io-cache
Hit
accept-ranges
bytes
section-io-id
2fa9710da084da2635e3717a14d77753
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=0&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=https%3A%2F%2Ftpc.googlesyndication.com%2Fsimgad%2F8783790369963399186&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&bq=0&g=0&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688317&de=315830167958&cu=1591981688317&m=35&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=2832&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A-%3A-&pe=1%3A1305%3A1305%3A0%3A1187&as=0&ag=13&an=0&gf=13&gg=0&ix=13&ic=13&ez=1&aj=1&pg=100&pf=0&ib=0&cc=0&bw=13&bx=0&dj=1&aa=0&ad=0&cn=0&gk=0&gl=0&ik=0&im=0&in=0&pd=0&em=0&en=0&st=1&su=1&of=1&oz=1&oe=0%3A0%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=26&cd=0&ah=26&am=0&rf=0&re=0&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=848267410&cs=0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:08 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:08 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame A447 		0
54 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstx8fsi6CLHDSBg8KeAIFUxnmvZgf3QgBn6suPisRZvsPGNEz3-R-mJSDy3u6PjQZtBXN4PQAqD75JznkHCC2OWj_O-bYJKxz6jJslbDTT1IYHaYo-_nwZ-c7Q-8QuayK2Ty1NDkJjDPSowaj7xP0nzIXLl8K5QDlN-b_lruG6KeSI-qqBGbwxsS_QS9jROIS2HSk1Ea5i84BXNG57XmuyasUU8Mhtnx7US_YLeCOFYOPTb9uWo6y1l1aElmlqtP0KP5evguyoMW-O8xQutIua-iJBoyxc85iiX0X-X0KPJbjaoo-FDa0Q7zaFWhhOwie2ZLlRHeNgEiJ8RG7Zbv_PZQ44aBMk&sig=Cg0ArKJSzIi-LkR92OLoEAE&adurl=
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s16-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 12 Jun 2020 17:08:08 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
/
www.facebook.com/tr/ 		44 B
361 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.facebook.com/tr/?id=1026610140874609&ev=PageView&dl=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&rl=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&if=false&ts=1591981688493&sw=1600&sh=1200&v=2.9.18&r=stable&ec=0&o=28&fbp=fb.1.1591981688492.882865879&it=1591981688380&coo=false&rqm=GET
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT, Fri, 12 Jun 2020 17:08:08 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-27=":443"; ma=3600
content-length
44
expires
Fri, 12 Jun 2020 17:08:08 GMT
/
www.google.com/pagead/1p-user-list/998237655/ 		42 B
339 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.com/pagead/1p-user-list/998237655/?random=1591981688389&cv=9&fst=1591981200000&num=1&bg=ffffff&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa640&sendb=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&tiba=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20remdesivir%20%7C%20Global%20Pharma%20Insights&async=1&fmt=3&is_vtc=1&random=2044525031&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:08 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.google.de/pagead/1p-user-list/998237655/ 		42 B
582 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.de/pagead/1p-user-list/998237655/?random=1591981688389&cv=9&fst=1591981200000&num=1&bg=ffffff&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa640&sendb=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&ref=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&tiba=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20remdesivir%20%7C%20Global%20Pharma%20Insights&async=1&fmt=3&is_vtc=1&random=2044525031&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:824::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:08 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-security-policy
script-src 'none'; object-src 'none'
content-type
image/gif
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame A447 		217 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8ee9be4c4b511acbc517f1b3b5a096acc0d0fdada3472d71b534485a559e454d

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=17&i=PENTONMEDIA1&hp=1&wf=1&vb=11&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688504&de=965935724186&m=0&ar=c34ad4f880-clean&iw=821c7c5&q=7&cb=0&ym=0&cu=1591981688504&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4874126281%3A2696286467%3A5374575282%3A138312304672&zMoatPS=300_1_rht&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&bo=21946295198&bp=21988232143&bd=300_1_rht&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&gw=pentonmedia53440730609&fd=1&ac=1&it=500&ti=0&ih=1&pe=1%3A1305%3A1305%3A0%3A1187&fs=181543&na=490257820&cs=0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:08 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:08 GMT
visit-data
in.hotjar.com/api/v2/client/sites/1097635/ 		178 B
320 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://in.hotjar.com/api/v2/client/sites/1097635/visit-data?sv=6
Requested by
Host: script.hotjar.com
URL: https://script.hotjar.com/modules.5cd4945c79de888b7e62.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.254.3.164 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-254-3-164.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
6154d5f7f6961e042d013bab33fd02b691970d873f44f3c32d8fcc6e79ef5bcd

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain; charset=UTF-8

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
status
200
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
access-control-max-age
86400
access-control-allow-credentials
true
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=0&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=https%3A%2F%2Ftpc.googlesyndication.com%2Fsimgad%2F8783790369963399186&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&bq=0&g=0&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688504&de=965935724186&cu=1591981688504&m=17&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=2919&le=1&gm=1&io=1&vv=1&vw=1%3A3%3A0&vp=72&vx=72%3A-%3A-&pe=1%3A1305%3A1305%3A0%3A1187&as=0&ag=2&an=0&gf=0&gg=0&ix=0&ic=0&ez=1&aj=1&pg=72&pf=0&ib=1&cc=0&bw=2&bx=0&dj=1&aa=0&ad=0&cn=0&gk=0&gl=0&ik=0&im=0&in=0&pd=0&em=0&en=0&st=1&su=1&of=1&oz=1&oe=0%3A0%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=4&cd=0&ah=4&am=0&rf=0&re=0&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304672&bo=21946295198&bp=21988232143&bd=300_1_rht&zMoatPS=300_1_rht&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&oq=0&ot=cc&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=56254890&cs=0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:08 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:08 GMT
pinit.js
assets.pinterest.com/js/ 		361 B
300 B 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.pinterest.com/js/pinit.js?_=1591981687715
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:eb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3faadebc89cdb21d11634a032816f152462d1cb8903eb21d0642501fcad065de

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:08 GMT
content-encoding
br
x-cdn
cloudflare
status
200
etag
W/"82bfd941d2c9b3b9e0650a27c9d11737"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
x-cdn
cache-control
max-age=300
cf-ray
5a252c126ab105c8-FRA
cf-request-id
034b19df82000005c8de192200000001
server
cloudflare
get_poll
www.globalpharmainsights.com/ 		4 KB
1 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/get_poll
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
12d8e0080d1669ba74fa5b83dbcca0cba8de78eb158ff75cdc1d5f1d9611ba7c
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept
*/*
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:09 GMT
content-encoding
gzip
x-content-type-options
nosniff, nosniff
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-cache
Miss from cloudfront
status
200
x-ua-compatible
IE=edge,chrome=1
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options
SAMEORIGIN
vary
Accept-Encoding,Cookie
content-language
en
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
no-cache, must-revalidate
x-drupal-cache
MISS
content-type
application/json
x-amz-cf-id
4QvXY1JvDGmHg1P9wgzP-cZzaVv7zaK-3c81tRHERuJ0Hyqz-RpMFA==
expires
Sun, 19 Nov 1978 05:00:00 GMT
ckeditor.styles.js
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor.styles.js?t=I3I8
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
b937394951285201e18e193006731ebafcc0336f1249c737f74a4df37c8f5f7b
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 14:50:39 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5567
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
r3lHfd2OPOGCoyhSYIp5Q9BUPywPyPSumJkJRYFBBpbJ7VuFpxitiw==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:21 GMT
plugin.js
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/plugins/drupalbreaks/ 		6 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/plugins/drupalbreaks/plugin.js?t=I3I8
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
293153343c929ef767fad32776072237665ed6286d473bfba46fcf3957e37754
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:22 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 14:48:44 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5566
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
CLBmzZCCYYOZk9GmmNwiDoi8WlR3ZWh5MlAlpdOvw9l6K4zBFNnvKg==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:22 GMT
scayt.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/skins/moono-lisa/ 		356 B
778 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/skins/moono-lisa/scayt.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
94465f8a7abf4da8295e0fa93a60eba1287830dfc41e3698fb3d20091b95d58c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
5565
x-cache
Hit from cloudfront
status
200
content-length
356
last-modified
Fri, 12 Jun 2020 14:48:44 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"164-5a7e42c7be8e5"
content-type
text/css
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
h3LBlrakDUAndVIul4FfXLSMUs2IVTtl1UaPHDOo-HN-YnJZt1QkEA==
expires
Fri, 12 Jun 2020 18:35:23 GMT
dialog.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/dialogs/ 		396 B
819 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/dialogs/dialog.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
75e0679953e586ffac55af12700c15b9a4b7d49765103c16fd8943c24162bf0c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
5565
x-cache
Hit from cloudfront
status
200
content-length
396
last-modified
Fri, 12 Jun 2020 14:50:39 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"18c-5a7e4335ab44f"
content-type
text/css
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
1DID3xtczsFAGIoHPg0IexDZBPWTyRDZM3715qxz2UTgBGh0jjzNFA==
expires
Fri, 12 Jun 2020 18:35:23 GMT
tableselection.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/ 		1 KB
850 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/tableselection.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
654307a47b37c66a953bb6a536cd2960a05b4e52140b2fd5e9da3a85b9a8f245
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 12:19:52 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5566
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
naH5su9zcLq6NLio68a1ExK3ljDn7362dXVFWB7scBqmMllHQpMmPQ==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
wsc.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/wsc/skins/moono-lisa/ 		1 KB
739 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/wsc/skins/moono-lisa/wsc.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
a0fc7fe1ba275090a93038c52950ddb538963b336f0009f4c6efd1722717404f
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 01:48:43 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5565
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
ADxglR5zfb0_85re8jdSUdXyMukeWJqvUx1MtwEB75q8Ibk6Wa5hGg==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
copyformatting.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/ 		1 KB
1 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/copyformatting.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
7d39b20ee96b3b32389afdc846932865a236034fbabff52b230c7cb824a0f7f0
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 12:19:52 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5565
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
VYHXbH8CsWK42BuTI8_EM9tfadz0_AGKSqFIOei2QBgP9C3XweCjjg==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
ckeditor.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/css/ Frame 4FA4 		431 B
852 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/css/ckeditor.css?qbs4lh
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
f2470640af17a4eb9988eed14e1110ae897fc6314340d0df1bf050d2c8d38ea6
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
x-content-type-options
nosniff
age
5565
x-cache
Hit from cloudfront
status
200
content-length
431
last-modified
Fri, 12 Jun 2020 01:48:43 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag
"1af-5a7d946f0c302"
content-type
text/css
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
ubXgW__P4OaVhwMrmPV7_dkmdGVHC1tb6s_jX_com_G3vok_h8HAQA==
expires
Fri, 12 Jun 2020 18:35:23 GMT
contents.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ Frame 4FA4 		3 KB
2 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/contents.css?qbs4lh
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
09f958e32d737ce88d6be77af3e519297dd86db7847405c3c9f1a5a1da4a1609
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 11:06:57 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5565
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
lmKU9FXXsj-DBq2SNdj3jQc1cVEV1yIkSwm8EOGD75f_e3CNWQDozw==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
copyformatting.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/ Frame 4FA4 		1 KB
1 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/copyformatting.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
7d39b20ee96b3b32389afdc846932865a236034fbabff52b230c7cb824a0f7f0
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 12:19:52 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5565
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
eH-ewKMkQCjwGyrrgQ-l9Hr8rLqvX-F9RRmwGuoICgz-Ouo-ks4JMQ==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
tableselection.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/ Frame 4FA4 		1 KB
851 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/tableselection.css
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /
Resource Hash
654307a47b37c66a953bb6a536cd2960a05b4e52140b2fd5e9da3a85b9a8f245
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 15:35:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 12 Jun 2020 13:40:29 GMT
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age
5565
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=10800
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
uqujKrXBFbpT9tQoRQn4UYUe96QoaDqJnt7w1cX_OB9DsdmePBNMBw==
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
expires
Fri, 12 Jun 2020 18:35:23 GMT
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=5483712037672564577&pixelIndex=0&_=1591981688418
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5483712037672564577&pixelIndex=0&_=1591981688418&google_gid=CAESEDI98Gc3AD2xdiuFAbYh1JU&google_cver=1
0
597 B 		Script
General
Check archive.org
Download Go to
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5483712037672564577&pixelIndex=0&_=1591981688418&google_gid=CAESEDI98Gc3AD2xdiuFAbYh1JU&google_cver=1
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.229.100.58 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-229-100-58.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
0
Expires
0

Redirect headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:09 GMT
server
HTTP server (unknown)
status
302
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5483712037672564577&pixelIndex=0&_=1591981688418&google_gid=CAESEDI98Gc3AD2xdiuFAbYh1JU&google_cver=1
cache-control
no-cache, must-revalidate
content-type
text/html; charset=UTF-8
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
368
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
423396.gif
idsync.rlcdn.com/ 		0
59 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://idsync.rlcdn.com/423396.gif?partner_uid=5483712037672564577
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.241.8.149 , Ascension Island, ASN15169 (GOOGLE, US),
Reverse DNS
149.8.241.35.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
204
date
Fri, 12 Jun 2020 17:08:09 GMT
via
1.1 google
alt-svc
clear
pinit.js
assets.pinterest.com/js/ 		361 B
431 B 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.pinterest.com/js/pinit.js?_=1591981687716
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:eb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3faadebc89cdb21d11634a032816f152462d1cb8903eb21d0642501fcad065de

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:09 GMT
content-encoding
br
x-cdn
cloudflare
status
200
etag
W/"82bfd941d2c9b3b9e0650a27c9d11737"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
x-cdn
cache-control
max-age=300
cf-ray
5a252c15bc1d05c8-FRA
cf-request-id
034b19e193000005c8de1cd200000001
server
cloudflare
get_poll
www.globalpharmainsights.com/ 		4 KB
1 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/get_poll
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
7ce35a3018ed3e643dd7a9878179a4820876347e15186f82dd67832e1e211b84
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept
*/*
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:09 GMT
content-encoding
gzip
x-content-type-options
nosniff, nosniff
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-cache
Miss from cloudfront
status
200
x-ua-compatible
IE=edge,chrome=1
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options
SAMEORIGIN
vary
Accept-Encoding,Cookie
content-language
en
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
no-cache, must-revalidate
x-drupal-cache
MISS
content-type
application/json
x-amz-cf-id
E3pCWSV8mwhBUvp7EOurm8O0WyNslvxVFI1ks5XYgkmucV1adKTMoA==
expires
Sun, 19 Nov 1978 05:00:00 GMT
pinit.js
assets.pinterest.com/js/ 		361 B
301 B 		Script
General
Check archive.org
Download Go to
Full URL
https://assets.pinterest.com/js/pinit.js?_=1591981687717
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:eb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3faadebc89cdb21d11634a032816f152462d1cb8903eb21d0642501fcad065de

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:09 GMT
content-encoding
br
x-cdn
cloudflare
status
200
etag
W/"82bfd941d2c9b3b9e0650a27c9d11737"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
x-cdn
cache-control
max-age=300
cf-ray
5a252c164db105c8-FRA
cf-request-id
034b19e1e8000005c8de1d6200000001
server
cloudflare
get_poll
www.globalpharmainsights.com/ 		4 KB
1 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.globalpharmainsights.com/get_poll
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.89.87 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-89-87.fra50.r.cloudfront.net
Software
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31
Resource Hash
09e704a392855e152b05ef45887c381da3ca4d9a8779a456599474278d167944
Security Headers
Name Value
X-Content-Type-Options nosniff, nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept
*/*
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:09 GMT
content-encoding
gzip
x-content-type-options
nosniff, nosniff
x-amz-cf-pop
FRA50-C1
x-powered-by
PHP/7.2.31
x-cache
Miss from cloudfront
status
200
x-ua-compatible
IE=edge,chrome=1
server
Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options
SAMEORIGIN
vary
Accept-Encoding,Cookie
content-language
en
via
1.1 baaf38f0a0d54e4834bf934fa5189ceb.cloudfront.net (CloudFront)
cache-control
no-cache, must-revalidate
x-drupal-cache
MISS
content-type
application/json
x-amz-cf-id
BpBrlVYw4cu5YZLeGlP3actQJjOLW0ONtVU489DAJblgYnnXTw-rVw==
expires
Sun, 19 Nov 1978 05:00:00 GMT
/
log.pinterest.com/ 		0
330 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://log.pinterest.com/?type=pidget&guid=2BjVCM7iWpbr&tv=2020060301&event=init&sub=www&button_count=1&follow_count=0&pin_count=0&profile_count=0&board_count=0&section_count=0&lang=en&nvl=en-US&via=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.36.84 Amsterdam, Netherlands, ASN54113 (FASTLY, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:09 GMT
via
1.1 varnish
server
envoy
x-timer
S1591981689.432417,VS0,VE95
x-served-by
cache-ams21052-AMS
x-cache
MISS
status
200
x-envoy-upstream-service-time
8
x-pinterest-rid
5788040866173587
accept-ranges
bytes
content-length
0
x-cache-hits
0
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=37&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&bq=0&g=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688317&de=315830167958&cu=1591981688317&m=1104&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1305%3A1305%3A0%3A1187&as=1&ag=1084&an=13&gi=1&gf=1084&gg=13&ix=1084&ic=1084&ez=1&ck=1084&kw=852&aj=1&pg=100&pf=100&ib=0&cc=1&bw=1084&bx=13&ci=1084&jz=852&dj=1&aa=0&ad=979&cn=0&gk=979&gl=0&ik=979&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=852&cd=26&ah=852&am=26&rf=0&re=1&ft=979&fv=0&fw=979&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=593592980&cs=0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:09 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:09 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame DA96 		42 B
107 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstqMSJ3UaFlVM5MEaR2C_5ojthnkFYj4r67IEyKV-z-KlAiYKROHcFUYVsa8pLqHSESfGOrYUMWWe3Qh_trpukiawte-QXaj-zHAk9_IVg&sig=Cg0ArKJSzKfhvbkK2AOVEAE&adk=92038381&tt=-1&bs=1600%2C1200&mtos=1102,1102,1102,1102,1102&tos=1102,0,0,0,0&p=428,219,678,519&mcvt=1102&rs=0&ht=0&tfs=3&tls=1131&mc=1&lte=1&bas=0&bac=0&met=mue&avms=nio&exg=1&md=2&btr=0&lm=2&rst=1591981688167&dlt&rpt=301&isd=0&msd=0&ext&xdi=0&ps=1600%2C3004&ss=1600%2C1200&pt=-1&bin=4&deb=1-0-0-11-3-10-10-0-0-0&tvt=1129&is=300%2C250&iframe_loc=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&r=v&id=osdim&vs=4&uc=11&upc=1&tgt=DIV&cl=1&cec=1&wf=0&cac=1&cd=300x250&itpl=3&v=20200610
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:09 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=5&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&bq=0&g=2&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688317&de=315830167958&cu=1591981688317&m=1105&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1305%3A1305%3A0%3A1187&as=1&ag=1084&an=1084&gi=1&gf=1084&gg=1084&ix=1084&ic=1084&ez=1&ck=1084&kw=852&aj=1&pg=100&pf=100&ib=0&cc=1&bw=1084&bx=1084&ci=1084&jz=852&dj=1&aa=0&ad=979&cn=979&gk=979&gl=979&ik=979&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=852&cd=852&ah=852&am=852&rf=0&re=1&ft=979&fv=979&fw=979&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=1223941601&cs=0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:09 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:09 GMT
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=37&q=1&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&bq=0&g=3&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688317&de=315830167958&cu=1591981688317&m=1106&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1305%3A1305%3A0%3A1187&as=1&ag=1084&an=1084&gi=1&gf=1084&gg=1084&ix=1084&ic=1084&ez=1&ck=1084&kw=852&aj=1&pg=100&pf=100&ib=0&cc=1&bw=1084&bx=1084&ci=1084&jz=852&dj=1&aa=0&ad=979&cn=979&gk=979&gl=979&ik=979&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=852&cd=852&ah=852&am=852&rf=0&re=1&ft=979&fv=979&fw=979&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=1988119233&cs=0
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:09 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:09 GMT
sodar
pagead2.googlesyndication.com/getconfig/ 		7 KB
6 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gpt&tv=2020060103&st=env
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
637c9117983933baec6ce49effd03cd32e2f51303d7eb97365fe5a91d5fb4553
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 12 Jun 2020 17:08:09 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
private
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
5648
x-xss-protection
0
rt=ifr
bcp.crwdcntrl.net/5/ct=y/c=7499/rand=326341516/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3... Frame 9BD3
Redirect Chain
  • https://bcp.crwdcntrl.net/5/c=7499/rand=326341516/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%2...
  • https://bcp.crwdcntrl.net/5/ct=y/c=7499/rand=326341516/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsig...
0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://bcp.crwdcntrl.net/5/ct=y/c=7499/rand=326341516/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr
Requested by
Host: tags.crwdcntrl.net
URL: https://tags.crwdcntrl.net/c/7499/cc_af.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.211.146.59 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-211-146-59.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

:method
GET
:authority
bcp.crwdcntrl.net
:scheme
https
:path
/5/ct=y/c=7499/rand=326341516/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
_cc_cc=ctst
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Response headers

status
200
date
Fri, 12 Jun 2020 17:08:09 GMT
content-type
text/html;charset=UTF-8
content-length
1066
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
cache-control
no-cache
pragma
no-cache
expires
0
x-server
10.45.3.149
set-cookie
_cc_dc=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 09-Mar-2021 17:03:00 GMT;SameSite=None;Secure _cc_id=87d17f732c6bb149118ce69cff41a467;Path=/;Domain=crwdcntrl.net;Expires=Tue, 09-Mar-2021 17:03:00 GMT;SameSite=None;Secure _cc_cc="ACZ4nGNQsDBPMTRPMzc2SjZLSjI0sTQ0tEhONbNMTkszMUw0MTNnAIK4x9sqGeCA98apY6qMp60Y%2FjMyMiz%2FUwhj%2Fv1sCWNeWDyHBcY%2Be1Idxjx39BAzjD1n%2FVNuGPvy8zuyMPZhJK3THn5WgbEvnXrEBmN%2FaLgvALd14xS4egBUb0M1";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 09-Mar-2021 17:03:00 GMT;Max-Age=23328000;SameSite=None;Secure _cc_aud="ABR4nGNgYGCIe7ytkgEGmBgYH4qAWZNvAAkAUngE1A%3D%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 09-Mar-2021 17:03:00 GMT;Max-Age=23328000;SameSite=None;Secure
access-control-allow-origin
*

Redirect headers

status
302
date
Fri, 12 Jun 2020 17:08:09 GMT
content-length
0
location
https://bcp.crwdcntrl.net/5/ct=y/c=7499/rand=326341516/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
cache-control
no-cache
pragma
no-cache
expires
0
x-server
10.45.6.44
set-cookie
_cc_cc=ctst;Path=/;Domain=crwdcntrl.net;SameSite=None;Secure
sodar2.js
tpc.googlesyndication.com/sodar/ 		14 KB
6 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060103.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
08f50e9e70388c99977ca13b6af3a49f8f48c83e79230d51ea72a56c0735bd0c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:09 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1591403518460474"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
5540
x-xss-protection
0
expires
Fri, 12 Jun 2020 17:08:09 GMT
roundtrip.js
s.adroll.com/j/ 		35 KB
12 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s.adroll.com/j/roundtrip.js
Requested by
Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.247.224.172 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-224-172.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
0b5b4a374d6dfb06f111c288ba9042d5c4e1305b3da110bea8116f3090bce2e5

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
ehJgGpzGzAbK8GzMvrCmhGB9QIvRjX3O
Content-Encoding
gzip
ETag
"493863a9069eb4663881ed7b590bc370"
x-amz-request-id
8393F29BD54D87DE
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
11133
x-amz-id-2
miMLhnoXTzMbkpI/Ji2w3CyUXZw4pZXEFmJZKsS61LZ0pZLqpMoZS7tKKnTP2qGfg1jGmaqQFew=
Last-Modified
Tue, 02 Jun 2020 21:58:20 GMT
Server
AmazonS3
Date
Fri, 12 Jun 2020 17:08:09 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
text/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=5&q=1&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=4&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688317&de=315830167958&cu=1591981688317&m=1307&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1305%3A1305%3A0%3A1187&as=1&ag=1288&an=1084&gi=1&gf=1288&gg=1084&ix=1288&ic=1288&ez=1&ck=1084&kw=852&aj=1&pg=100&pf=100&ib=0&cc=1&bw=1288&bx=1084&ci=1084&jz=852&dj=1&aa=1&ad=1183&cn=979&gn=1&gk=1183&gl=979&ik=1183&co=1183&cp=1097&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=1097&cd=852&ah=1097&am=852&rf=0&re=1&ft=1183&fv=979&fw=979&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=856047984&cs=0
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:09 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:09 GMT
runner.html
tpc.googlesyndication.com/sodar/sodar2/210/ Frame ADE8 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/210/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
tpc.googlesyndication.com
:scheme
https
:path
/sodar/sodar2/210/runner.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Response headers

status
200
accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
content-length
4590
date
Fri, 12 Jun 2020 16:51:09 GMT
expires
Sat, 12 Jun 2021 16:51:09 GMT
last-modified
Wed, 26 Feb 2020 19:47:50 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
1020
alt-svc
h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
index.js
s.adroll.com/j/exp/
Redirect Chain
  • https://s.adroll.com/j/exp/IXZC4QKE6BDSVNBBOX54JQ/index.js
  • https://s.adroll.com/j/exp/index.js
28 B
747 B 		Script
General
Check archive.org
Download Go to
Full URL
https://s.adroll.com/j/exp/index.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.247.224.172 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-224-172.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
f59e5f34a941183aacaed25322ac0856628493c2cfd936ded3fddc0a49510e52

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
MvaZYW7xXR9M9hUcWDgUVAWVyUlL21ST
Content-Encoding
gzip
ETag
"5816cced8568d223aa09d889f300692b"
x-amz-request-id
3F87A35F219B4CEA
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
48
x-amz-id-2
j0gRIfdWAmMono3re8RAgQhTHKTcGReQALszGck6lZDA6y+qanswCu7Zc4mE9aslf8juJNaOUyU=
Last-Modified
Fri, 05 Jun 2020 15:32:25 GMT
Server
AmazonS3
Date
Fri, 12 Jun 2020 17:08:09 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*

Redirect headers

Date
Fri, 12 Jun 2020 17:08:09 GMT
Server
AkamaiGHost
Location
https://s.adroll.com/j/exp/index.js
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
false
Connection
keep-alive
Access-Control-Allow-Headers
*
Content-Length
0
index.js
s.adroll.com/j/pre/IXZC4QKE6BDSVNBBOX54JQ/3BQ2N447KNEODAIZTDTY2B/ 		0
773 B 		Script
General
Check archive.org
Download Go to
Full URL
https://s.adroll.com/j/pre/IXZC4QKE6BDSVNBBOX54JQ/3BQ2N447KNEODAIZTDTY2B/index.js
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/roundtrip.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.247.224.172 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-224-172.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
TFDLRSmk.5uUkVOXm8IDqIof4oJzquU5
Content-Encoding
gzip
ETag
"d41d8cd98f00b204e9800998ecf8427e"
x-amz-request-id
78AB0DB26BD24A94
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
20
x-amz-id-2
3Hmfe85xKph4wbt2ZtYW/SW+HWeUGNjHGDzXJS1waDDfHrZu22OxQCDKDGl+bq3Ytb3s4A8RCGI=
Last-Modified
Thu, 11 Jun 2020 19:57:43 GMT
Server
AmazonS3
Date
Fri, 12 Jun 2020 17:08:09 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
text/javascript; charset=utf-8
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
/
d.adroll.com/consent/check/IXZC4QKE6BDSVNBBOX54JQ/
Redirect Chain
  • https://d.adroll.mgr.consensu.org/consent/iabcheck/IXZC4QKE6BDSVNBBOX54JQ?_s=128a0949b4e3cd0b1540e0764d7c5632&_b=2
  • https://d.adroll.com/consent/check/IXZC4QKE6BDSVNBBOX54JQ/?_s=128a0949b4e3cd0b1540e0764d7c5632&_b=2
132 B
600 B 		Script
General
Check archive.org
Download Go to
Full URL
https://d.adroll.com/consent/check/IXZC4QKE6BDSVNBBOX54JQ/?_s=128a0949b4e3cd0b1540e0764d7c5632&_b=2
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.241.194.225 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-241-194-225.eu-west-1.compute.amazonaws.com
Software
nginx/1.16.1 /
Resource Hash
683fcf2fe2ac4aade540893ebac977eb936bfcd4c0ff327687d640bbf5e7a6c7

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:09 GMT
server
nginx/1.16.1
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
status
200
cache-control
no-store, no-cache, must-revalidate
content-type
application/javascript
content-length
132

Redirect headers

status
302
date
Fri, 12 Jun 2020 17:08:09 GMT
server
nginx/1.16.1
content-length
105
location
https://d.adroll.com/consent/check/IXZC4QKE6BDSVNBBOX54JQ/?_s=128a0949b4e3cd0b1540e0764d7c5632&_b=2
gen_204
pagead2.googlesyndication.com/pagead/ 		0
57 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar2&v=210&t=2&li=gpt_2020060103&jk=829988948577741&bg=!_P-l_-dY9Eoqn6B3tFkCAAAAQVIAAAAPmQGE55RO-ajBgKPqfOIOv2Y6NrxBPBysO-pbmAaa0oFkezE2MbqczQWv-enHMUGxiTs1DKUnbtO4AU9rRdo0HH3jKbnM2J0D-14Yc9rAVfSQbnNgfGKU0Fuvw5z8dUXIxY8DcQwzEJlkDRReOe26nvwML-n4JXrS6ZMVjtF26YdCsucNJED-V2_7k6Set7M1dat7zcrUUIJGfz84kYJng9QCazXvfqS3Vdrp9G-GpMQhBuS93D5g8eAcvVxc-BX-Lznt3AXBmy0BaMdoRzWXQXOX6O5U3uGjAjhth9l62cBOdp-WZMdczO5qL3KG9gV4wZ3FmPdfhaZkhzGM23oRHSWNbXWi4ys2OO95AUB_dydZF2CYaQp6R1XJoEyGi82x_kx85isCrfJmRm1y7DLSBERjFfplrvshwc3MvsoWmUkyZkpih1L7Cm5e_rajE0NKXNzBXE3FOOpOT9OAvxZpTVi6wCFkaoMOzea_RzgN4G9aEzjWwx-kuElfvY3GXnMzxkE1qOK3YQ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:09 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
204
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
45GZFZBG65GTZP2EESFCXP.js
s.adroll.com/pixel/IXZC4QKE6BDSVNBBOX54JQ/3BQ2N447KNEODAIZTDTY2B/
Redirect Chain
  • https://d.adroll.com/pixel/IXZC4QKE6BDSVNBBOX54JQ/3BQ2N447KNEODAIZTDTY2B?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-...
  • https://s.adroll.com/pixel/IXZC4QKE6BDSVNBBOX54JQ/3BQ2N447KNEODAIZTDTY2B/45GZFZBG65GTZP2EESFCXP.js
4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s.adroll.com/pixel/IXZC4QKE6BDSVNBBOX54JQ/3BQ2N447KNEODAIZTDTY2B/45GZFZBG65GTZP2EESFCXP.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.247.224.172 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-224-172.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
6bf1f37f9fec3dcf3c4192f35b469b661dbaef58cee7377e32088b5df7c69a73

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
vSlEOb3PoizU.M4mSL9gHrMbRUSMqez2
Content-Encoding
gzip
ETag
"2c892eab28b211c1ae2fbf289ddc5f31"
x-amz-request-id
0BDE2052465D4E20
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
1486
x-amz-id-2
EwDZ3iwHMOofhOo/Go1ux3LhPsM+gnvIP8f8Z2J0mfD7bdZ+Jb/cjFJENXNEM6I3A7/w+TW1Oj0=
Last-Modified
Tue, 04 Feb 2020 01:54:22 GMT
Server
AmazonS3
Date
Fri, 12 Jun 2020 17:08:10 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
text/javascript; charset=utf-8
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*

Redirect headers

date
Fri, 12 Jun 2020 17:08:09 GMT
x-segment-display-name
Visitors to Unsegmented Pages
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
status
302
content-length
0
pragma
no-cache
x-conversion-value
0.00
server
nginx/1.16.1
x-rule
*
x-segment-eid
45GZFZBG65GTZP2EESFCXP
location
https://s.adroll.com/pixel/IXZC4QKE6BDSVNBBOX54JQ/3BQ2N447KNEODAIZTDTY2B/45GZFZBG65GTZP2EESFCXP.js
cache-control
no-store, no-cache, must-revalidate
x-pixel-eid
3BQ2N447KNEODAIZTDTY2B
x-segment-name
*
x-advertisable-eid
IXZC4QKE6BDSVNBBOX54JQ
x-conversion-currency
669533596489996
connect.facebook.net/signals/config/ 		516 KB
129 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/signals/config/669533596489996?v=2.9.18&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
e8b265078d3c584bedbbb44f2d0f69d2ca294232de4ecbfa124c04b07577020d
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-27=":443"; ma=3600
content-length
131681
x-xss-protection
0
pragma
public
x-fb-debug
h+zPPUAK5ZsjW7x9Dm84g0FukDjl3rIGWZiVHLTCXupgG84lulJWl9e6S9EPokKkXg9NiObzstzt3A/QcPPxtw==
x-fb-trip-id
664085054
x-frame-options
DENY
date
Fri, 12 Jun 2020 17:08:10 GMT, Fri, 12 Jun 2020 17:08:10 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
sync
ups.analytics.yahoo.com/ups/55980/
Redirect Chain
  • https://d.adroll.com/cm/aol/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-gen...
  • https://pixel.advertising.com/ups/55980/sync?uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&_origin=1&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA
  • https://pixel.advertising.com/ups/55980/sync?uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&_origin=1&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA&verify=true
  • https://ups.analytics.yahoo.com/ups/55980/sync?uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&_origin=1&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA&apid=UP4ad481f9-accf-11ea-8ddd-06...
0
977 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ups.analytics.yahoo.com/ups/55980/sync?uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&_origin=1&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA&apid=UP4ad481f9-accf-11ea-8ddd-069d9e483036
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
18.156.0.31 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-0-31.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.113 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 12 Jun 2020 17:08:10 GMT
Server
ATS/7.1.2.113
Connection
keep-alive
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

status
302
date
Fri, 12 Jun 2020 17:08:10 GMT
location
https://ups.analytics.yahoo.com/ups/55980/sync?uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&_origin=1&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA&apid=UP4ad481f9-accf-11ea-8ddd-069d9e483036
content-length
0
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
rum
dsum-sec.casalemedia.com/
Redirect Chain
  • https://d.adroll.com/cm/index/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-g...
  • https://dsum-sec.casalemedia.com/rum?cm_dsp_id=105&external_user_id=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&expiration=1623517690
43 B
1003 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=105&external_user_id=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&expiration=1623517690
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.247.225.98 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-225-98.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 12 Jun 2020 17:08:10 GMT
Server
Apache
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Expires
Fri, 12 Jun 2020 17:08:10 GMT

Redirect headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:10 GMT
server
nginx/1.16.1
status
302
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
location
https://dsum-sec.casalemedia.com/rum?cm_dsp_id=105&external_user_id=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&expiration=1623517690
cache-control
no-store, no-cache, must-revalidate
content-length
139
tap.php
pixel.rubiconproject.com/
Redirect Chain
  • https://d.adroll.com/cm/n/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-gener...
  • https://pixel.rubiconproject.com/tap.php?v=194538&nid=3644&put=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&expires=365
42 B
755 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://pixel.rubiconproject.com/tap.php?v=194538&nid=3644&put=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&expires=365
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
69.173.144.138 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
content-length
42
X-RPHost
704c1e4d3fcc922a3031d436b584678b
Content-Type
image/gif

Redirect headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:10 GMT
server
nginx/1.16.1
status
302
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
location
https://pixel.rubiconproject.com/tap.php?v=194538&nid=3644&put=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&expires=365
cache-control
no-store, no-cache, must-revalidate
content-length
124
cookie-sync
sync.outbrain.com/
Redirect Chain
  • https://d.adroll.com/cm/outbrain/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreement...
  • https://sync.outbrain.com/cookie-sync?p=adroll&uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
  • https://sync.outbrain.com/cookie-sync?p=adroll&uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&rdrctExp=true
0
452 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://sync.outbrain.com/cookie-sync?p=adroll&uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&rdrctExp=true
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
70.42.32.95 , United States, ASN22075 (AS-OUTBRAIN, US),
Reverse DNS
ny.outbrain.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

X-TraceId
55597623c05093b45f188f25c3b07ae9
Date
Fri, 12 Jun 2020 17:08:10 GMT
Content-Length
0

Redirect headers

Location
https://sync.outbrain.com/cookie-sync?p=adroll&uid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&rdrctExp=true
Date
Fri, 12 Jun 2020 17:08:10 GMT
X-TraceId
cd856b54295a21b92cc3c16a6626e643
Content-Length
0
Pug
simage2.pubmatic.com/AdServer/
Redirect Chain
  • https://d.adroll.com/cm/pubmatic/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreement...
  • https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MzMwNiZ0bD01MjU2MDA&piggybackCookie=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&gdpr=0&gdpr_consent=BOOoKswOOoKswA2ABBENA...
1 B
1010 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MzMwNiZ0bD01MjU2MDA&piggybackCookie=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&gdpr=0&gdpr_consent=BOOoKswOOoKswA2ABBENAkwAAAAXyACACYAIIA
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.190.80 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
Apache/2.2.24 (Unix) mod_ssl/2.2.24 OpenSSL/1.0.0-fips mod_fastcgi/2.4.6 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

X-Cnection
close
Pragma
no-cache
Date
Fri, 12 Jun 2020 17:08:10 GMT
X-lat
Pug23009:0:262
Server
Apache/2.2.24 (Unix) mod_ssl/2.2.24 OpenSSL/1.0.0-fips mod_fastcgi/2.4.6
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Cache-Control
no-store, no-cache, private
Content-Type
text/html; charset=utf-8
Content-Length
1

Redirect headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:10 GMT
server
nginx/1.16.1
status
302
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
location
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZqcz0xJmNvZGU9MzMwNiZ0bD01MjU2MDA&piggybackCookie=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&gdpr=0&gdpr_consent=BOOoKswOOoKswA2ABBENAkwAAAAXyACACYAIIA
cache-control
no-store, no-cache, must-revalidate
content-length
220
in
d.adroll.com/cm/r/
Redirect Chain
  • https://d.adroll.com/cm/r/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-gener...
  • https://ads.yahoo.com/cms/v1?esig=1~bf4e7dc4546a90c08591652d78a230d3f2ef5733&nwid=10001032567&sigv=1&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA
  • https://d.adroll.com/cm/r/in?xid=E0&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA
42 B
500 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://d.adroll.com/cm/r/in?xid=E0&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.241.194.225 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-241-194-225.eu-west-1.compute.amazonaws.com
Software
nginx/1.16.1 /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:10 GMT
server
nginx/1.16.1
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
status
200
cache-control
no-store, no-cache, must-revalidate
content-type
image/gif
content-length
42

Redirect headers

date
Fri, 12 Jun 2020 17:08:10 GMT
referrer-policy
no-referrer-when-downgrade
server
ATS
age
0
status
302
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
strict-transport-security
max-age=15552000
p3p
policyref="https://policies.yahoo.com/w3c/p3p.xml", CP="CAO DSP COR CUR ADM DEV TAI PSA PSD IVAi IVDi CONi TELo OTPi OUR DELi SAMi OTRi UNRi PUBi IND PHY ONL UNI PUR FIN COM NAV INT DEM CNT STA POL HEA PRE LOC GOV"
location
https://d.adroll.com/cm/r/in?xid=E0&gdpr=0&gdpr_consent=BOOla_OOOla_OA2ABBENAkwAAAAXyACAAyAIIA
x-xss-protection
1; mode=block
content-length
0
x-content-type-options
nosniff
/
trc.taboola.com/sg/adroll-network/1/rtb-h/
Redirect Chain
  • https://d.adroll.com/cm/taboola/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements...
  • https://trc.taboola.com/sg/adroll-network/1/rtb-h/?taboola_hm=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
0
283 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://trc.taboola.com/sg/adroll-network/1/rtb-h/?taboola_hm=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
10
date
Fri, 12 Jun 2020 17:08:10 GMT
via
1.1 varnish
server
nginx
x-timer
S1591981690.322347,VS0,VE10
x-cache
MISS
status
204
x-cache-hits
0
accept-ranges
bytes
x-served-by
cache-fra19150-FRA

Redirect headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:10 GMT
server
nginx/1.16.1
status
302
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
location
https://trc.taboola.com/sg/adroll-network/1/rtb-h/?taboola_hm=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
cache-control
no-store, no-cache, must-revalidate
content-length
111
xuid
eb2.3lift.com/
Redirect Chain
  • https://d.adroll.com/cm/triplelift/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreeme...
  • https://eb2.3lift.com/xuid?mid=4714&xuid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&dongle=c85e
  • https://eb2.3lift.com/xuid?ld=1&mid=4714&xuid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&dongle=c85e&gdpr=1&cmp_cs=&us_privacy=
37 B
352 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://eb2.3lift.com/xuid?ld=1&mid=4714&xuid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&dongle=c85e&gdpr=1&cmp_cs=&us_privacy=
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.196.179.110 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-196-179-110.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
200
date
Fri, 12 Jun 2020 17:08:10 GMT
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
content-length
37
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"

Redirect headers

status
302
date
Fri, 12 Jun 2020 17:08:10 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
0
location
/xuid?ld=1&mid=4714&xuid=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg&dongle=c85e&gdpr=1&cmp_cs=&us_privacy=
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
sync
x.bidswitch.net/ul_cb/
Redirect Chain
  • https://d.adroll.com/cm/b/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-gener...
  • https://x.bidswitch.net/sync?dsp_id=44&user_id=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
  • https://x.bidswitch.net/ul_cb/sync?dsp_id=44&user_id=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
43 B
411 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://x.bidswitch.net/ul_cb/sync?dsp_id=44&user_id=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.120.19.19 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-3-120-19-19.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
200
date
Fri, 12 Jun 2020 17:08:10 GMT
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
content-length
43
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"

Redirect headers

status
302
date
Fri, 12 Jun 2020 17:08:10 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
0
location
https://x.bidswitch.net/ul_cb/sync?dsp_id=44&user_id=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
setuid
ib.adnxs.com/
Redirect Chain
  • https://d.adroll.com/cm/x/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-gener...
  • https://ib.adnxs.com/setuid?entity=172&code=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
0
591 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ib.adnxs.com/setuid?entity=172&code=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.90 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
727.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 12 Jun 2020 17:08:12 GMT
X-Proxy-Origin
195.242.213.99; 195.242.213.99; 727.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.40:80
AN-X-Request-Uuid
4d36e05b-66e4-4f84-8199-e7ec9a271035
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT

Redirect headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:10 GMT
server
nginx/1.16.1
status
302
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
location
https://ib.adnxs.com/setuid?entity=172&code=NzJlOGY1NmQ1ZDMxODI0MjJhZWM2Yzc0ZDA3MGFkZjg
cache-control
no-store, no-cache, must-revalidate
content-length
93
377928.gif
idsync.rlcdn.com/
Redirect Chain
  • https://d.adroll.com/cm/l/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-gener...
  • https://idsync.rlcdn.com/377928.gif?partner_uid=72e8f56d5d3182422aec6c74d070adf8
0
37 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://idsync.rlcdn.com/377928.gif?partner_uid=72e8f56d5d3182422aec6c74d070adf8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.241.8.149 , Ascension Island, ASN15169 (GOOGLE, US),
Reverse DNS
149.8.241.35.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status
204
date
Fri, 12 Jun 2020 17:08:10 GMT
via
1.1 google
alt-svc
clear

Redirect headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:10 GMT
server
nginx/1.16.1
status
302
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
location
https://idsync.rlcdn.com/377928.gif?partner_uid=72e8f56d5d3182422aec6c74d070adf8
cache-control
no-store, no-cache, must-revalidate
content-length
86
sd
us-u.openx.net/w/1.0/
Redirect Chain
  • https://d.adroll.com/cm/o/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-gener...
  • https://us-u.openx.net/w/1.0/sd?id=537103138&val=72e8f56d5d3182422aec6c74d070adf8
  • https://us-u.openx.net/w/1.0/sd?cc=1&id=537103138&val=72e8f56d5d3182422aec6c74d070adf8
43 B
180 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://us-u.openx.net/w/1.0/sd?cc=1&id=537103138&val=72e8f56d5d3182422aec6c74d070adf8
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
218.64.98.34.bc.googleusercontent.com
Software
OXGW/16.188.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:10 GMT
via
1.1 google
server
OXGW/16.188.0
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
private, max-age=0, no-cache
content-type
image/gif
alt-svc
clear
content-length
43
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

date
Fri, 12 Jun 2020 17:08:10 GMT
via
1.1 google
server
OXGW/16.188.0
status
302
p3p
CP="CUR ADM OUR NOR STA NID"
location
https://us-u.openx.net/w/1.0/sd?cc=1&id=537103138&val=72e8f56d5d3182422aec6c74d070adf8
alt-svc
clear
content-length
0
in
d.adroll.com/cm/g/
Redirect Chain
  • https://d.adroll.com/cm/g/out?adroll_fpc=f13ad803d291b489fad4cab63ac07475-1591981689913&arrfrr=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-gener...
  • https://cm.g.doubleclick.net/pixel?google_sc&google_nid=artb&google_hm=cuj1bV0xgkIq7Gx00HCt-A
  • https://d.adroll.com/cm/g/in
42 B
536 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://d.adroll.com/cm/g/in
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.241.194.225 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-241-194-225.eu-west-1.compute.amazonaws.com
Software
nginx/1.16.1 /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:10 GMT
server
nginx/1.16.1
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
status
200
cache-control
no-store, no-cache, must-revalidate
content-type
image/gif
content-length
42
x-result
g.-1.-1.-1

Redirect headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:10 GMT
server
HTTP server (unknown)
status
302
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://d.adroll.com/cm/g/in
cache-control
no-cache, must-revalidate
content-type
text/html; charset=UTF-8
alt-svc
h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
225
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.facebook.com/tr/ 		44 B
147 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.facebook.com/tr/?id=669533596489996&ev=PageView&dl=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&rl=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&if=false&ts=1591981690126&cd[segment_eid]=45GZFZBG65GTZP2EESFCXP%2CMKA2HHY3ENHVJD5V4RQ4BI%2CXRCCG2RSDBGFDEB4AN5IPE&sw=1600&sh=1200&v=2.9.18&r=stable&ec=0&o=29&fbp=fb.1.1591981688492.882865879&it=1591981688380&coo=false&rqm=GET
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 12 Jun 2020 17:08:10 GMT, Fri, 12 Jun 2020 17:08:10 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-27=":443"; ma=3600
content-length
44
expires
Fri, 12 Jun 2020 17:08:10 GMT
utsync.ashx
ml314.com/ Frame DA96 		36 B
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=62439&ct=js&pi=&fp=&clid=&if=1&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&pv=1591981688497_0q5q731gm&bl=en-us&cb=2618767&return=&ht=&d=&dc=&si=1591981688497_0q5q731gm&cid=&s=1600x1200&rp=
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?1252020
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.251.220.194 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-251-220-194.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
296cd2b74ca0d1c2e2fa3dfe0ab9c29e451434407618ad08e753c008bc4d79fa

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 12 Jun 2020 17:08:10 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
private
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
158
Expires
0
ud.ashx
in.ml314.com/ Frame DA96 		20 B
481 B 		Script
General
Check archive.org
Download Go to
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=1252020
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?1252020
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.84.119.213 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-84-119-213.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Fri, 12 Jun 2020 17:08:11 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public
Connection
keep-alive
Content-Length
138
Expires
Sat, 13 Jun 2020 17:08:11 GMT
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=9&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=5&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688317&de=315830167958&cu=1591981688317&m=5149&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1305%3A1305%3A0%3A1187&as=1&ag=5130&an=1288&gi=1&gf=5130&gg=1288&ix=5130&ic=5130&ez=1&ck=1084&kw=852&aj=1&pg=100&pf=100&ib=0&cc=1&bw=5130&bx=1288&ci=1084&jz=852&dj=1&aa=1&ad=5025&cn=1183&gn=1&gk=5025&gl=1183&ik=5025&co=1183&cp=1097&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=4942&cd=1097&ah=4942&am=1097&rf=0&re=1&ft=5025&fv=1183&fw=979&wb=2&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=751859513&cs=0
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:13 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:13 GMT
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=9&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688504&de=965935724186&cu=1591981688504&m=5347&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&vv=1&vw=1%3A3%3A0&vp=38&vx=38%3A38%3A-&pe=1%3A1305%3A1305%3A0%3A1187&as=0&ag=780&an=2&gf=0&gg=0&ix=0&ic=0&ez=1&aj=1&pg=72&pf=72&ib=1&cc=0&bw=780&bx=2&dj=1&aa=0&ad=653&cn=0&gk=0&gl=0&ik=0&cq=1&im=0&in=0&pd=0&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=5137&cd=4&ah=5137&am=4&rf=0&re=0&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304672&bo=21946295198&bp=21988232143&bd=300_1_rht&zMoatPS=300_1_rht&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&oq=0&ot=cc&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=586763755&cs=0
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:13 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:13 GMT
pixel.gif
px.moatads.com/ 		43 B
260 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://px.moatads.com/pixel.gif?e=9&q=1&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=6&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=https%3A%2F%2Fwww.globalpharmainsights.com&t=1591981688317&de=315830167958&cu=1591981688317&m=10205&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1305%3A1305%3A0%3A1187&as=1&ag=10186&an=5130&gi=1&gf=10186&gg=5130&ix=10186&ic=10186&ez=1&ck=1084&kw=852&aj=1&pg=100&pf=100&ib=0&cc=1&bw=10186&bx=5130&ci=1084&jz=852&dj=1&aa=1&ad=10081&cn=5025&gn=1&gk=10081&gl=5025&ik=10081&co=1183&cp=1097&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=9998&cd=4942&ah=9998&am=4942&rf=0&re=1&ft=5126&fv=5025&fw=979&wb=2&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=896354958&cs=0
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a72-247-226-64.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 12 Jun 2020 17:08:18 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
AkamaiNetStorage
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Fri, 12 Jun 2020 17:08:18 GMT

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
www.globalpharmainsights.com
URL
https://www.globalpharmainsights.com/no_cache/feeds/ajax/rss/News?fromPath=
Domain
a.dpmsrv.com
URL
https://a.dpmsrv.com/dpmpxl/index.php?id=453945625446112413&q=xImp&v=1.x&cl=55&pixelIndex=0&r=817261&tzOffset=-120&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5&_=1591981686319
Domain
www.globalpharmainsights.com
URL
https://www.globalpharmainsights.com/get_poll
Domain
www.globalpharmainsights.com
URL
https://www.globalpharmainsights.com/get_poll
Domain
pagead2.googlesyndication.com
URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstVQ6vJCTRQ35nEWPq9LjyC8y_8USjlC53URAqyJko_83cx3sblSw3P85hlongMPnyN-X4F36Vc3cgVIdCmbWV1g2c0zKw-nmFL7NkGb9A&sig=Cg0ArKJSzJ0UlsRyptTDEAE&adk=2518684364&tt=-1&bs=1600%2C1200&mtos=918,918,918,918,918&tos=1347,0,0,0,0&p=428,219,678,519&mcvt=918&rs=0&ht=0&tfs=8&tls=1394&mc=1&lte=1&bas=0&bac=0&met=mue&avms=nio&exg=1&md=2&btr=0&lm=2&rst=1591981685968&dlt&rpt=462&isd=0&msd=0&ext&xdi=0&ps=1600%2C3004&ss=1600%2C1200&pt=-1&bin=4&deb=1-0-0-12-6-11-11-0-0-0&tvt=1389&is=300%2C250&iframe_loc=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&r=u&id=osdtos&vs=3&uc=12&upc=1&tgt=DIV&cl=1&cec=1&wf=0&cac=1&cd=300x250&itpl=3&v=20200610
Domain
pagead2.googlesyndication.com
URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsv3ZzVbQlN4AVA6BnafSYeu-bWpfnC1Jg9tQHAV2STyjWpXv5bWhHksVFNnK5uEFqAerouQAUcFs2Bjj5hFJiBFbAK2h0OGEBFkB_I8l74&sig=Cg0ArKJSzJjE8btaS2UpEAE&adk=556191258&tt=-1&bs=1600%2C1200&mtos=0,0,485,1093,1093&tos=0,0,485,608,0&p=1105,1055,1355,1355&mcvt=485&rs=0&ht=0&tfs=3&tls=1097&mc=0.71&lte=0.71&bas=0&bac=0&met=mue&avms=nio&exg=1&md=2&btr=0&lm=2&rst=1591981686125&dlt&rpt=391&isd=0&msd=0&ext&xdi=0&ps=1600%2C3004&ss=1600%2C1200&pt=-1&bin=4&deb=1-0-0-11-3-10-10-0-0-0&tvt=1095&is=300%2C250&iframe_loc=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&r=u&id=osdtos&vs=3&uc=11&upc=1&tgt=DIV&cl=1&cec=1&wf=0&cac=1&cd=300x250&itpl=3&v=20200610

Verdicts & Comments Add Verdict or Comment

162 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onformdata object| onpointerrawupdate string| gdpr_cookie boolean| cookieEnabled number| is_cookie string| isblocked string| pathname string| adu number| adblockOn object| googletag boolean| allow_welcome_ad object| targ_arr object| digitalData undefined| $ function| jQuery object| ggeac object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleTokenSync number| google_srt function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter undefined| google_measure_js_timing number| __google_ad_urls_id number| google_unique_id object| gaGlobal object| Drupal object| jQuery11020023431952636401077 object| uc_file_list function| _uc_file_delete_list_populate function| uc_file_update_download string| CKEDITOR_BASEPATH object| _satellite boolean| __satelliteLoaded object| adobe function| Visitor object| s_c_il number| s_c_in function| AppMeasurement_Module_ActivityMap function| AppMeasurement function| s_gi function| s_pgicq number| s_objectID number| s_giq object| s object| LimelightPlayerUtil function| _createClass function| _possibleConstructorReturn function| _inherits function| _classCallCheck function| Emitter function| Dropzone function| without function| camelize function| detectVerticalSquash function| drawImageIOSFix function| ExifRestore function| contentLoaded function| __guard__ function| __guardMethod__ function| DFPHelper function| DFPIframe object| eloquaTrackingEnabled string| eloquaSiteId function| getEloquaCustomerGUIDinput function| _getCustomerGUID function| _requestGUIDfunction object| breaky object| PentonSingleHeader number| byline string| timeout_dfp boolean| flag_for_topbanner boolean| flag_for_infinitescroll_banner boolean| help_of_position boolean| help_of_position_topbanner boolean| save_top_offset_for_topbanner boolean| save_top_offset_for_interscroller boolean| flag_for_timer boolean| stickybannerhelpheader number| stickybannertimer1 boolean| topbanner1 number| ads_shown_count number| forum_ads_shown_count object| fixFontObserver object| PentonSingleSidebar object| PentonSingleSidebarBanner function| hcSticky function| loadCSS function| LegalAlert function| LegalPopup function| LegalCommunication function| ckeditor_imceSendTo object| CKEDITOR object| dataLayer function| gtag string| cleanstep1 string| cleanstep2 object| cleanstep3 string| cleanstep4 string| f0 object| s_i_informaglobalpharmainsights.com_informaglobalprod number| PIN_18425 object| Typekit object| LOTCC_7499 object| LOTCC undefined| qry_params_str undefined| params string| adroll_adv_id string| adroll_pix_id function| hj object| _hjSettings object| google_tag_manager function| fbq function| _fbq object| google_tag_data object| __google_ad_urls boolean| google_osd_loaded boolean| google_onload_fired object| ampInaboxIframes object| ampInaboxPendingMessages object| Moat#G26 boolean| Moat#EVA object| MoatSuperV26 boolean| attachedML object| MoatDataJsonpRequest_76420707 object| PIN_1591981688357 object| PinUtils object| hjSiteSettings function| hjBootstrap object| hjBootstrapCalled function| GooglemKTybQhCsO function| google_trackConversion object| GooglebQhCsO function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb function| Dpxl object| dpmPixels object| jQuery111107700957990315453 number| data-cke-expando boolean| __adroll_loaded object| GoogleGcLKhOms string| adroll_sid object| __adroll boolean| adroll_optout object| adroll_ext_network object| adroll_callbacks undefined| adroll_tpc_callback object| google_image_requests boolean| __adroll_consent boolean| __adroll_consent_is_gdpr object| __adroll_consent_data string| __adroll_consent_user_country string| __adroll_consent_adv_country number| adroll_xavier_called number| __adroll_xid_ch object| adroll_currency object| adroll_conversion_value object| adroll_conversion_value_in_dollars object| adroll_exp_list

13 Cookies

Domain/Path Name / Value
.globalpharmainsights.com/ Name: s_ppv
Value: Gilead%2520signs%2520agreements%2520with%2520generics%2520firms%2520to%2520manufacture%2520and%2520market%2520remdesivir%2C40%2C40%2C1200
.globalpharmainsights.com/ Name: s_tp
Value: 3004
www.globalpharmainsights.com/ Name: Drupal.legal[119][confirm]
Value: 0
www.globalpharmainsights.com/ Name: Drupal.legal[119][for_review]
Value: 0
www.globalpharmainsights.com/ Name: Drupal.legal[119][count]
Value: 1
www.globalpharmainsights.com/ Name: Drupal.legal[119][nid]
Value: 119
.globalpharmainsights.com/ Name: __gads
Value: ID=137541b16180f419:T=1591981688:S=ALNI_MbLs-HxhdSNO1_LLjfjIHiBZCk5HQ
www.globalpharmainsights.com/ Name: dpm_time_site
Value: 1.008
www.globalpharmainsights.com/manufacturing-outsourcing Name: hasLiveRampMatch
Value: true
www.globalpharmainsights.com/ Name: _hjIncludedInSample
Value: 1
.globalpharmainsights.com/ Name: _hjid
Value: aa9587b8-cfe6-4346-9ef0-511be20f896d
.globalpharmainsights.com/ Name: _fbp
Value: fb.1.1591981688492.882865879
www.globalpharmainsights.com/ Name: dpm_url_count
Value: 1

13 Console Messages

Source Level URL
Text
console-api log URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 68)
Message:
gdpr cookie not set
console-api log URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 73)
Message:
gdprCookie==>on
console-api log URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 77)
Message:
lpage==>notblocked
console-api log URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 126)
Message:
emptyInterstitial
console-api log URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js(Line 6)
Message:
Account - ,informaglobalprod
console-api log URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js(Line 6)
Message:
MC Rule: email:Eloqua::::HLN00GPI-ES-AWARENESS-EM1/1-FEATURES:f3bea1f6-c791-47dc-8d2d-b71160403f3f:Others:Introducing your new knowledge platform: Global Pharma Insights
console-api log URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 73)
Message:
gdprCookie==>off
console-api log URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 77)
Message:
lpage==>notblocked
console-api log URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js(Line 6)
Message:
Account - informaglobalpharmainsights.com,informaglobalprod
console-api log URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js(Line 6)
Message:
MC Rule:
console-api log URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 126)
Message:
emptyInterstitial
console-api log URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 110)
Message:
adblockval
console-api log URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 110)
Message:
0

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
X-Content-Type-Options nosniff nosniff
X-Frame-Options SAMEORIGIN

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

38683bacb692dc3ca6a4b9092b6a8b4e.safeframe.googlesyndication.com
a.dpmsrv.com
ads.yahoo.com
adservice.google.de
app.go02.informamarkets.com
assets.adobedtm.com
assets.pinterest.com
b1ff9ba2a5a6fa8f594604dadd847edf.safeframe.googlesyndication.com
bcp.crwdcntrl.net
cm.everesttech.net
cm.g.doubleclick.net
connect.facebook.net
d.adroll.com
d.adroll.mgr.consensu.org
dpm.demdex.net
dsum-sec.casalemedia.com
eb2.3lift.com
geo.moatads.com
googleads.g.doubleclick.net
ib.adnxs.com
idsync.rlcdn.com
in.hotjar.com
in.ml314.com
informaglobalexhibitions.d3.sc.omtrdc.net
informaglobalexhibitions.demdex.net
log.pinterest.com
ml314.com
p.typekit.net
pagead2.googlesyndication.com
pixel.advertising.com
pixel.rubiconproject.com
px.moatads.com
s.adroll.com
s.delvenetworks.com
s.dpmsrv.com
s734445500.t.eloqua.com
script.hotjar.com
securepubads.g.doubleclick.net
simage2.pubmatic.com
static.hotjar.com
sync.outbrain.com
tags.crwdcntrl.net
tpc.googlesyndication.com
trc.taboola.com
ups.analytics.yahoo.com
us-u.openx.net
use.typekit.net
vars.hotjar.com
vc.hotjar.io
video.limelight.com
www.facebook.com
www.globalpharmainsights.com
www.google.com
www.google.de
www.googleadservices.com
www.googletagmanager.com
www.googletagservices.com
x.bidswitch.net
z.moatads.com
a.dpmsrv.com
pagead2.googlesyndication.com
www.globalpharmainsights.com
141.145.8.13
141.145.8.14
143.204.89.107
143.204.89.116
143.204.89.121
143.204.89.70
143.204.89.87
147.75.100.189
147.75.101.5
147.75.102.199
15.236.175.233
15.236.9.100
151.101.13.44
151.101.36.84
172.217.18.2
172.217.21.194
172.217.22.34
178.79.227.0
178.79.227.128
178.79.245.71
178.79.245.72
18.156.0.31
18.196.179.110
18.202.138.86
18.202.93.59
185.33.221.90
185.64.190.80
216.58.210.2
2606:4700::6812:eb0
2606:4700::6812:fb0
2a00:1288:f03d:1fa::4000
2a00:1450:4001:802::2001
2a00:1450:4001:809::2001
2a00:1450:4001:80b::2002
2a00:1450:4001:815::2004
2a00:1450:4001:819::2004
2a00:1450:4001:81f::2002
2a00:1450:4001:820::2001
2a00:1450:4001:824::2003
2a00:1450:4001:825::2008
2a01:4a0:1338:28::c38a:ff0a
2a02:26f0:10c:28a::19fd
2a02:26f0:10c:382::1e80
2a02:26f0:10c:387::1e80
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8183:face:b00c:0:25de
3.120.19.19
3.229.100.58
3.8.225.221
34.241.194.225
34.251.220.194
34.254.3.164
34.98.64.218
35.178.2.28
35.241.8.149
52.211.146.59
54.171.1.253
54.84.119.213
54.93.143.252
66.117.28.86
69.173.144.138
70.42.32.95
72.247.224.172
72.247.225.98
72.247.226.64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